<SUBMISSION>
<ACCESSION-NUMBER>0001021408-01-500312
<TYPE>DEF 14A
<PUBLIC-DOCUMENT-COUNT>2
<PERIOD>20010523
<FILING-DATE>20010424
<FILER>
<COMPANY-DATA>
<CONFORMED-NAME>DIAMETRICS MEDICAL INC
<CIK>0000895380
<ASSIGNED-SIC>3845
<IRS-NUMBER>411663185
<STATE-OF-INCORPORATION>MN
<FISCAL-YEAR-END>1231
</COMPANY-DATA>
<FILING-VALUES>
<FORM-TYPE>DEF 14A
<ACT>34
<FILE-NUMBER>000-21982
<FILM-NUMBER>1609789
</FILING-VALUES>
<BUSINESS-ADDRESS>
<STREET1>2658 PATTON RD
<CITY>ROSEVILLE
<STATE>MN
<ZIP>55113
<PHONE>6516398035
</BUSINESS-ADDRESS>
<MAIL-ADDRESS>
<STREET1>2658 PATTON ROAD
<CITY>ROSEVILLE
<STATE>MN
<ZIP>55113
</MAIL-ADDRESS>
</FILER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>ddef14a.htm
<DESCRIPTION>DEFINATIVE PROXY STATEMENT
<TEXT>

<HTML>
<HEAD>
 <TITLE>DEFINATIVE PROXY STATEMENT</TITLE>
</HEAD>
<BODY BGCOLOR="#FFFFFF">
<P ALIGN="center"><FONT SIZE="2" FACE="Times New Roman, Times, serif"><B>SCHEDULE 14A</B></FONT> </P>
<P ALIGN="center"><FONT SIZE="2" FACE="Times New Roman, Times, serif"><B>PROXY STATEMENT PURSUANT TO SECTION 14(a)
<BR>
OF THE SECURITIES EXCHANGE ACT OF 1934 </B></FONT></P>
<TABLE WIDTH="100%" CELLSPACING="0" CELLPADDING="0">
<TR>
<TD COLSPAN="2"><FONT SIZE="2" FACE="Times New Roman, Times, serif">Filed by the Registrant</FONT></TD>
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="56%"><FONT SIZE="2" FACE="Times New Roman, Times, serif"><FONT FACE="wingdings">x</FONT></FONT></TD>
</TR>
<TR>
<TD COLSPAN="2"><FONT SIZE="2" FACE="Times New Roman, Times, serif">Filed by a Party other than the Registrant&nbsp;</FONT></TD>
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="56%"><FONT FACE="wingdings">o</FONT><FONT SIZE="2" FACE="Times New Roman, Times, serif"> </FONT></TD>
</TR>
<TR>
<TD COLSPAN="2">&nbsp;</TD>
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="56%">&nbsp;</TD>
</TR>
<TR>
<TD COLSPAN="4"><FONT SIZE="2" FACE="Times New Roman, Times, serif">Check the appropriate box:</FONT></TD>
</TR>
<TR>
<TD WIDTH="6%"><FONT FACE="wingdings">o</FONT></TD>
<TD COLSPAN="3"><FONT FACE="Times New Roman, Times, serif" SIZE="2">Preliminary Proxy Statement</FONT></TD>
</TR>
<TR>
<TD WIDTH="6%"><FONT FACE="wingdings">o</FONT></TD>
<TD COLSPAN="3"><FONT SIZE="2" FACE="Times New Roman, Times, serif">Confidential, for Use of the Commision Only (as permitted by Rule 14a-6(e)(2))</FONT></TD>
</TR>
<TR>
<TD WIDTH="6%" HEIGHT="15"><FONT FACE="wingdings">x</FONT></TD>
<TD COLSPAN="3" HEIGHT="15"><FONT SIZE="2" FACE="Times New Roman, Times, serif">Definitive Proxy Statement</FONT><B><FONT SIZE="2" FACE="Times New Roman, Times, serif"> </FONT></B></TD>
</TR>
<TR>
<TD WIDTH="6%"><FONT FACE="wingdings">o</FONT></TD>
<TD COLSPAN="3"><FONT SIZE="2" FACE="Times New Roman, Times, serif">Definitive Additional Materials </FONT></TD>
</TR>
<TR>
<TD WIDTH="6%"><FONT FACE="wingdings">o</FONT></TD>
<TD COLSPAN="3"><FONT SIZE="2" FACE="Times New Roman, Times, serif">Soliciting Material Pursuant to (S) 240.14a-11(c) or (S) 240.14a-12</FONT></TD>
</TR>
</TABLE>
<P ALIGN="center"><FONT SIZE="2" FACE="Times New Roman, Times, serif"><B>DIAMETRICS MEDICAL, INC.
<BR>
(NAME OF REGISTRANT AS SPECIFIED IN ITS CHARTER)</B></FONT>
<P ALIGN="center"><FONT SIZE="2" FACE="Times New Roman, Times, serif"><B>
<BR>
</B> </FONT> <HR NOSHADE ALIGN="center" WIDTH="70%" SIZE="1"> <DIV ALIGN="center"> <FONT SIZE="2" FACE="Times New Roman, Times, serif">(Name of Person(s) Filing Proxy Statement, if other than the Registrant)</FONT> </DIV>
<P>
<TABLE WIDTH="100%" BORDER="0" CELLSPACING="0" CELLPADDING="0">
<TR>
<TD COLSPAN="6"><FONT SIZE="2" FACE="Times New Roman, Times, serif">Payment of Filing Fee (Check the appropriate box):</FONT></TD>
</TR>
<TR>
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="69%">&nbsp;</TD>
<TD WIDTH="21%">&nbsp;</TD>
</TR>
<TR>
<TD WIDTH="3%"><FONT FACE="wingdings">x</FONT></TD>
<TD WIDTH="2%">&nbsp;</TD>
<TD COLSPAN="4"><FONT SIZE="2" FACE="Times New Roman, Times, serif">No fee required.</FONT></TD>
</TR>
<TR>
<TD WIDTH="3%"><FONT FACE="wingdings">o</FONT></TD>
<TD WIDTH="2%">&nbsp;</TD>
<TD COLSPAN="4"><FONT SIZE="2" FACE="Times New Roman, Times, serif">Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11. </FONT></TD>
</TR>
<TR>
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="69%">&nbsp;</TD>
<TD WIDTH="21%">&nbsp;</TD>
</TR>
<TR>
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="3%"><FONT SIZE="2" FACE="Times New Roman, Times, serif">1)</FONT></TD>
<TD WIDTH="2%">&nbsp;</TD>
<TD COLSPAN="2"><FONT SIZE="2" FACE="Times New Roman, Times, serif">Title of each class of securities to which transaction applies:</FONT><B><FONT SIZE="2" FACE="Times New Roman, Times, serif"></FONT></B></TD>
</TR>
<TR>
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="69%">&nbsp;</TD>
<TD WIDTH="21%">&nbsp;</TD>
</TR>
<TR>
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="2%">&nbsp;</TD>
<TD COLSPAN="2"><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;________________________________________________</U> </TR>
<TR>
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="2%">&nbsp;</TD>
<TD COLSPAN="2">&nbsp;</TD>
</TR>
<TR>
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="3%"><FONT SIZE="2" FACE="Times New Roman, Times, serif">2)</FONT></TD>
<TD WIDTH="2%">&nbsp;</TD>
<TD COLSPAN="2"><FONT SIZE="2" FACE="Times New Roman, Times, serif">Aggregate number of securities to which transaction applies: &nbsp;&nbsp;_____________________________</FONT> </TR>
<TR>
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="2%"><FONT SIZE="2" FACE="Times New Roman, Times, serif"></FONT></TD>
<TD WIDTH="69%">&nbsp;</TD>
<TD WIDTH="21%">&nbsp;</TD>
</TR>
<TR>
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top"><FONT SIZE="2" FACE="Times New Roman, Times, serif">3)</FONT></TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD COLSPAN="2">
<P><FONT SIZE="2" FACE="Times New Roman, Times, serif">Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (Set forth the
<BR>
amount </FONT><FONT SIZE="2" FACE="Times New Roman, Times, serif">on which the filing fee is calculated and state how it was determined):</FONT><B><FONT SIZE="2" FACE="Times New Roman, Times, serif"></FONT></B></P>
</TD>
</TR>
<TR>
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="69%">&nbsp;</TD>
<TD WIDTH="21%">&nbsp;</TD>
</TR>
<TR>
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="2%">&nbsp;</TD>
<TD COLSPAN="2"><FONT SIZE="2" FACE="Times New Roman, Times, serif">_____________________________________________________________________________</FONT> </TR>
<TR>
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="2%"><FONT SIZE="2" FACE="Times New Roman, Times, serif"></FONT></TD>
<TD WIDTH="69%">&nbsp;</TD>
<TD WIDTH="21%">&nbsp;</TD>
</TR>
<TR>
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="3%"><FONT SIZE="2" FACE="Times New Roman, Times, serif">4)</FONT></TD>
<TD WIDTH="2%">&nbsp;</TD>
<TD COLSPAN="2"><FONT SIZE="2" FACE="Times New Roman, Times, serif">Proposed maximum aggregate value of transaction: ______________________________________</FONT> </TR>
<TR>
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="2%"><FONT SIZE="2" FACE="Times New Roman, Times, serif"></FONT></TD>
<TD WIDTH="69%">&nbsp;</TD>
<TD WIDTH="21%">&nbsp;</TD>
</TR>
<TR>
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top"><FONT SIZE="2" FACE="Times New Roman, Times, serif">5)</FONT></TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD WIDTH="69%"><FONT SIZE="2" FACE="Times New Roman, Times, serif">Total fee paid: ______________________________________</FONT>__________________________________ </TR>
<TD WIDTH="3%">&nbsp;</TD>
<TR>
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="2%"><FONT SIZE="2" FACE="Times New Roman, Times, serif"></FONT></TD>
<TD WIDTH="69%">&nbsp;</TD>
<TD WIDTH="21%">&nbsp;</TD>
</TR>
<TR>
<TD WIDTH="3%"><FONT FACE="wingdings">o</FONT></TD>
<TD WIDTH="2%">&nbsp;</TD>
<TD COLSPAN="4"><FONT SIZE="2" FACE="Times New Roman, Times, serif">Fee paid previously with preliminary materials.</FONT></TD>
</TR>
<TR>
<TD WIDTH="3%" VALIGN="top"><FONT FACE="wingdings">o</FONT></TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD COLSPAN="4" VALIGN="top"><FONT SIZE="2" FACE="Times New Roman, Times, serif">Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously.
Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.</FONT></TD>
</TR>
<TR>
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="69%">&nbsp;</TD>
<TD WIDTH="21%">&nbsp;</TD>
</TR>
<TR>
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="3%"><FONT SIZE="2" FACE="Times New Roman, Times, serif">1)</FONT></TD>
<TD WIDTH="2%">&nbsp;</TD>
<TD COLSPAN="2"><FONT SIZE="2" FACE="Times New Roman, Times, serif">Amount previously paid __________________________________________________________</FONT> </TR>
<TR>
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="69%">&nbsp;</TD>
<TD WIDTH="21%">&nbsp;</TD>
</TR>
<TR>
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="3%"><FONT SIZE="2" FACE="Times New Roman, Times, serif">2)</FONT></TD>
<TD WIDTH="2%">&nbsp;</TD>
<TD COLSPAN="2"><FONT SIZE="2" FACE="Times New Roman, Times, serif">Form, Schedule or Registration Statement No.: &nbsp;_________________________________________</FONT> </TR>
<TR>
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="69%">&nbsp;</TD>
<TD WIDTH="21%">&nbsp;</TD>
</TR>
<TR>
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top"><FONT SIZE="2" FACE="Times New Roman, Times, serif">3)</FONT></TD>
<TD WIDTH="2%">&nbsp;</TD>
<TD COLSPAN="2"><FONT SIZE="2" FACE="Times New Roman, Times, serif">Filing Party:____________________________________________________________________&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U> </U></FONT> </TR>
<TR>
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="69%">&nbsp;</TD>
<TD WIDTH="21%">&nbsp;</TD>
</TR>
<TR>
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="2%">&nbsp;</TD>
<TD WIDTH="3%"><FONT SIZE="2" FACE="Times New Roman, Times, serif">4)</FONT></TD>
<TD WIDTH="2%">&nbsp;</TD>
<TD COLSPAN="2"><FONT SIZE="2" FACE="Times New Roman, Times, serif">Date Filed:</FONT> &nbsp;<FONT SIZE="2" FACE="Times New Roman, Times, serif">____________________________________________________________________</FONT></TD>
</TR>
</TABLE>
<DIV><FONT SIZE="1">&nbsp;</FONT></DIV>
<DIV ALIGN="center"><FONT SIZE="3" COLOR="#000000" FACE="'Times New Roman', Times"> <B>DIAMETRICS MEDICAL, INC.</B></FONT></DIV>
<DIV ALIGN="center"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times"><B>2658 Patton Road</B></FONT></DIV>
<DIV ALIGN="center"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times"><B>Roseville, Minnesota 55113</B></FONT></DIV>
<DIV><FONT SIZE="6">&nbsp;</FONT></DIV>
<DIV ALIGN="center"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times"><B>NOTICE OF ANNUAL MEETING OF SHAREHOLDERS</B></FONT></DIV>
<DIV ALIGN="center"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times"><B>May 23, 2001</B></FONT></DIV>
<DIV><FONT SIZE="6">&nbsp;</FONT></DIV>
<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">TO THE SHAREHOLDERS OF DIAMETRICS MEDICAL, INC.:</FONT></DIV>
<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>
<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Notice is hereby given that the Annual Meeting of Shareholders of Diametrics Medical, Inc. (the
&#147;Company&#148;) will be held at 3:30 p.m. on Wednesday, May 23, 2001, at the Minneapolis Marriot City Center, 30 South Seventh Street, Minneapolis, Minnesota, for the following purposes:</FONT></DIV>
<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>

<TABLE WIDTH="100%" BORDER="0" CELLPADDING="0" CELLSPACING="0">
<TR>
<TD WIDTH="4%" ALIGN="left" VALIGN="top"></TD>
<TD WIDTH="4%" ALIGN="left" VALIGN="top"><DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">(1)</FONT></DIV>
</TD>
<TD WIDTH="92%" ALIGN="left" VALIGN="top"> <DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">To elect three members to the Board of Directors to serve for a term beginning May 23, 2001 and until their terms expire and
until their successors are elected and qualified.</FONT></DIV>
</TD>
</TR>
</TABLE>
<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>

<TABLE WIDTH="100%" BORDER="0" CELLPADDING="0" CELLSPACING="0">
<TR>
<TD WIDTH="4%" ALIGN="left" VALIGN="top"></TD>
<TD WIDTH="4%" ALIGN="left" VALIGN="top"><DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">(2) </FONT></DIV>
</TD>
<TD WIDTH="92%" ALIGN="left" VALIGN="top"> <DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">To approve an amendment to the Company&#146;s Amended and Restated Articles of Incorporation to (i) increase the number of
authorized shares of all classes of stock from 40,000,000 to 50,000,000, and (ii) to increase the number of authorized shares of Common Stock, par value $.01 per share, from 35,000,000 to 45,000,000.</FONT></DIV>
</TD>
</TR>
</TABLE>
<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>

<TABLE WIDTH="100%" BORDER="0" CELLPADDING="0" CELLSPACING="0">
<TR>
<TD WIDTH="4%" ALIGN="left" VALIGN="top"></TD>
<TD WIDTH="4%" ALIGN="left" VALIGN="top"><DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">(3) </FONT></DIV>
</TD>
<TD WIDTH="92%" ALIGN="left" VALIGN="top"> <DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">To approve an amendment to the Company&#146;s 1990 Stock Option Plan to increase the number of shares authorized for issuance
under such plan.</FONT></DIV>
</TD>
</TR>
</TABLE>
<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>

<TABLE WIDTH="100%" BORDER="0" CELLPADDING="0" CELLSPACING="0">
<TR>
<TD WIDTH="4%" ALIGN="left" VALIGN="top"></TD>
<TD WIDTH="4%" ALIGN="left" VALIGN="top"><DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">(4) </FONT></DIV>
</TD>
<TD WIDTH="92%" ALIGN="left" VALIGN="top"> <DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">To approve an amendment to the Company&#146;s 1993 Directors&#146; Stock Option Plan to increase the number of shares
authorized for issuance under such plan.</FONT></DIV>
</TD>
</TR>
</TABLE>
<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>

<TABLE WIDTH="100%" BORDER="0" CELLPADDING="0" CELLSPACING="0">
<TR>
<TD WIDTH="4%" ALIGN="left" VALIGN="top"></TD>
<TD WIDTH="4%" ALIGN="left" VALIGN="top"><DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">(5) </FONT></DIV>
</TD>
<TD WIDTH="92%" ALIGN="left" VALIGN="top"> <DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">To approve an amendment to the Company&#146;s 1995 Employee Stock Purchase Plan to increase the number of shares authorized
for issuance under such plan.</FONT></DIV>
</TD>
</TR>
</TABLE>
<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>

<TABLE WIDTH="100%" BORDER="0" CELLPADDING="0" CELLSPACING="0">
<TR>
<TD WIDTH="4%" ALIGN="left" VALIGN="top"></TD>
<TD WIDTH="4%" ALIGN="left" VALIGN="top"><DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">(6) </FONT></DIV>
</TD>
<TD WIDTH="92%" ALIGN="left" VALIGN="top"> <DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">To consider and act upon such other matters as may properly come before the meeting or any adjournment thereof.</FONT></DIV>
</TD>
</TR>
</TABLE>
<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>
<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Board of Directors has fixed the close of business on April 4, 2001 as the record date for the
determination of shareholders entitled to notice of and to vote at the meeting or any adjournment thereof. A copy of the Company&#146;s Annual Report is included with this mailing, which is being first made available on approximately the date shown
below.</FONT></DIV>
<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>
<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;We encourage you to take part in the affairs of your Company either in person or by executing and returning
the enclosed proxy.</FONT></DIV>
<DIV><FONT SIZE="1">&nbsp;</FONT></DIV>

<TABLE WIDTH="100%" BORDER="0" CELLPADDING="0" CELLSPACING="0">
<TR>
<TD WIDTH="52%" ALIGN="left" VALIGN="top"></TD>
<TD ALIGN="left" VALIGN="top"> <DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">By Order of the Board of Directors,</FONT></DIV>
</TD>
</TR>
</TABLE>

<TABLE WIDTH="100%" BORDER="0" CELLPADDING="0" CELLSPACING="0">
<TR>
<TD WIDTH="52%" ALIGN="left" VALIGN="top"></TD>
<TD ALIGN="left" VALIGN="top"> <DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times"> </FONT></DIV>
</TD>
</TR>
</TABLE>

<TABLE WIDTH="100%" BORDER="0" CELLPADDING="0" CELLSPACING="0">
<TR>
<TD WIDTH="52%" ALIGN="left" VALIGN="top"></TD>
<TD ALIGN="left" WIDTH="48%" VALIGN="top"> <DIV ALIGN="left"><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times">/s/&nbsp;&nbsp;&nbsp;&nbsp;Kenneth L. Cutler</FONT></DIV>
</TD>
</TR>
</TABLE>

<TABLE WIDTH="100%" BORDER="0" CELLPADDING="0" CELLSPACING="0">
<TR>
<TD WIDTH="52%" ALIGN="left" VALIGN="top"></TD>
<TD ALIGN="left" VALIGN="top"> <DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">Kenneth L. Cutler</FONT></DIV>
</TD>
</TR>
</TABLE>

<TABLE WIDTH="100%" BORDER="0" CELLPADDING="0" CELLSPACING="0">
<TR>
<TD WIDTH="52%" ALIGN="left" VALIGN="top"></TD>
<TD ALIGN="left" VALIGN="top"> <DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times"><I>Secretary</I></FONT></DIV>
</TD>
</TR>
</TABLE>
<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>


<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">Dated: April 24, 2001</FONT></DIV>

<DIV><FONT SIZE="6">&nbsp;</FONT></DIV>
<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times"><B>WHETHER OR NOT YOU PLAN TO ATTEND THIS MEETING, PLEASE MARK, DATE AND SIGN THE ENCLOSED PROXY AND RETURN IT PROMPTLY IN THE ENCLOSED ENVELOPE. IF YOU LATER DESIRE TO
REVOKE YOUR PROXY, YOU MAY DO SO AT ANY TIME BEFORE IT IS EXERCISED.</B></FONT></DIV>
<DIV><FONT SIZE="1">&nbsp;</FONT></DIV>
<DIV ALIGN="center"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times"> <B>DIAMETRICS MEDICAL, INC.</B></FONT></DIV>
<DIV ALIGN="center"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times"><B>2658 Patton Road</B></FONT></DIV>
<DIV ALIGN="center"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times"><B>Roseville, Minnesota 55113</B></FONT></DIV>
<DIV><FONT SIZE="3">&nbsp;</FONT></DIV>
<DIV ALIGN="center"><HR WIDTH="21%" SIZE="1" NOSHADE></DIV>
<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>
<DIV ALIGN="center"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times"><B>PROXY STATEMENT</B></FONT></DIV>
<DIV ALIGN="center"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times"><B>FOR</B></FONT></DIV>
<DIV ALIGN="center"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times"><B>ANNUAL MEETING OF SHAREHOLDERS</B></FONT></DIV>
<DIV ALIGN="center"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times"><B>May 23, 2001</B></FONT></DIV>
<DIV><FONT SIZE="5">&nbsp;</FONT></DIV>


<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This Proxy Statement is furnished in connection with the solicitation of the enclosed proxy by the Board of
Directors of Diametrics Medical, Inc. (the &#147;Company&#148;) for use at the Annual Meeting of Shareholders to be held on Wednesday, May 23, 2001, at the Minneapolis Marriot City Center, 30 South Seventh Street, Minneapolis, Minnesota at 3:30
p.m., Minneapolis time, and at any adjournment thereof, for the purposes set forth in the Notice of Annual Meeting of Shareholders. This Proxy Statement and the form of proxy enclosed are being mailed to shareholders commencing on or about April 24,
2001.</FONT></DIV>

<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>


<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;All holders of the Common Stock, $.01 par value per share (the &#147;Common Stock&#148;), whose names appear
of record on the Company&#146;s books at the close of business on April 4, 2001 will be entitled to vote at the Annual Meeting or any adjournment thereof. At the close of business on April 4, 2001, a total of 26,734,525 shares of Common Stock were
outstanding, each share being entitled to one vote. The holders of a majority of the Common Stock entitled to vote shall constitute a quorum for the transaction of business at the Annual Meeting. If such quorum shall not be present or represented at
the Annual Meeting, the shareholders present or represented at the Annual Meeting may adjourn the Annual Meeting from time to time without notice other than announcement at the Annual Meeting until a quorum shall be present or represented. Officers,
directors and regular employees of the Company, who will receive no extra compensation for their services, may solicit proxies by telephone or in person. Expenses in connection with the solicitation of proxies will be paid by the
Company.</FONT></DIV>

<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>
<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If the enclosed proxy is properly executed and returned, and if a shareholder specifies a choice on the
proxy, shares of the Common Stock represented by the proxy will be voted in the manner directed by the shareholder. If the proxy is signed and returned but no direction is made, the proxy will be voted FOR the election of the nominees for director
named in this Proxy Statement, FOR the amendment to the Company&#146;s Amended and Restated Articles of Incorporation, FOR the amendment of the Company&#146;s 1990 Stock Option Plan, FOR the amendment of the Company&#146;s 1993 Directors&#146; Stock
Option Plan, and FOR the amendment of the Company&#146;s 1995 Employee Stock Purchase Plan. Shares voted as abstentions on any matter will be counted as shares that are present and entitled to vote for purposes of determining the presence of a
quorum at the meeting and as unvoted, although present and entitled to vote, for purposes of determining the approval of each matter as to which the shareholder has abstained. If a broker submits a proxy which indicates that the broker does not have
discretionary authority as to certain shares to vote on one or more matters, those shares will be counted as shares that are present and entitled to vote for purposes of determining the presence of a quorum at the meeting, but will not be considered
as present and entitled to vote with respect to such matters. Proxies may be revoked at any time before being exercised by delivery to the Secretary of the Company of a written notice of termination of the proxies&#146; authority or a duly executed
proxy bearing a later date. Any proxy also may be revoked by the shareholder attending the Annual Meeting and voting in person. A notice of revocation need not be on any specific form.</FONT></DIV>
<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>
<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company did not receive written notice of any stockholder proposal prior to February 16, 2001 as
required by the Company&#146;s Bylaws and, as of the date of this Proxy Statement, the Board of Directors of the Company knows of no business that will be presented for consideration at the Annual Meeting other than the matters described in the
Notice of Annual Meeting of Shareholders mailed together with this Proxy Statement. If any other matters are properly brought before the Annual Meeting, the persons named in the enclosed form of
proxy will vote on such matters in accordance with their best judgment. The enclosed proxy card confers discretionary authority to vote with respect to matters not properly presented by a shareholder in accordance with the Company&#146;s
Bylaws.</FONT></DIV>
<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>
<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;A copy of the Company&#146;s Annual Report for the year ended December 31, 2000 is being furnished to each
shareholder with this Proxy Statement.</FONT></DIV>
<DIV><FONT SIZE="6">&nbsp;</FONT></DIV>
<DIV ALIGN="center"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times"><B>PROPOSAL ONE:</B></FONT></DIV>
<DIV ALIGN="center"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times"><B>ELECTION OF DIRECTORS</B></FONT></DIV>
<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>
<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company&#146;s Articles of Incorporation provide for a &#147;classified board&#148; of directors. The
number of members of the Board of Directors is currently set at seven, and the directors are divided into three classes comprised as follows: (i) Gerald L. Cohn and Mark B. Knudson, Ph.D., whose terms expire at the Annual Meeting; (ii) David T.
Giddings and Andr&#233; de Bruin, whose terms expire at the annual meeting in 2002; and (iii) Roy S. Johnson, Hans-Guenter Hohmann and Carl S. Goldfischer, M.D., whose terms expire at the annual meeting in 2003 (or, in all cases, when their
respective successors are elected and qualified). The Board has nominated Mr. Cohn and Dr. Knudson for reelection to the Board of Directors at the Annual Meeting for terms expiring at the annual meeting in 2004. Additionally, Dr. Goldfischer was
elected by the Board to fill the vacancy left by the resignation of David Milligan, who had been elected last year by the shareholders for a term expiring at the annual meeting in 2003. In accordance with the Company&#146;s Bylaws, the shareholders
are requested to approve the election of Dr. Goldfischer for a term expiring at the annual meeting in 2003. The nominees have indicated a willingness to serve, but in case a nominee is not a candidate at the meeting, for reasons not now known to the
Company, the proxies named in the enclosed form of proxy may vote for a substitute nominee in their discretion. The other directors of the Company will continue in office for their existing terms. The affirmative vote of a majority of the shares of
Common Stock represented at the meeting is required for the election of the nominees for director.</FONT></DIV>
<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>
<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Certain biographical information furnished by the Company&#146;s current directors and nominees for director
is presented below.</FONT></DIV>
<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>

<TABLE ALIGN="center" WIDTH="615" CELLSPACING=0 CELLPADDING=0>
<TR>
<TH VALIGN="bottom" NOWRAP ALIGN="left"><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"><B>Name</B></FONT><FONT SIZE="1"><HR ALIGN="left" WIDTH="100%" SIZE="1" NOSHADE></FONT></TH>
<TH><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TH>
<TH VALIGN="bottom" NOWRAP ALIGN="center"><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"><B>Age</B></FONT><FONT SIZE="1"><HR ALIGN="center" WIDTH="100%" SIZE="1" NOSHADE></FONT></TH>
<TH><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TH>
<TH VALIGN="bottom" NOWRAP ALIGN="center"><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"><B>Position</B></FONT><FONT SIZE="1"><HR ALIGN="center" WIDTH="100%" SIZE="1" NOSHADE></FONT></TH>
</TR>
<TR>
<TD VALIGN="top" NOWRAP ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">David T. Giddings<SUP></SUP>
</FONT><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"><SUP>(1)</SUP>
</FONT><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"></FONT><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"><SUP></SUP>
</FONT><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"><SUP></SUP>
</FONT><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times"></FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">57</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" NOWRAP ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">President, Chief Executive Officer and Chairman
<BR>
of the Board</FONT></TD>
</TR>
<TR>
<TD VALIGN="top" NOWRAP ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">Gerald L. Cohn<SUP></SUP>
</FONT><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"><SUP>(2)(3)</SUP>
</FONT><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"></FONT><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"><SUP></SUP>
</FONT><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"><SUP></SUP>
</FONT><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times"></FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">72</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" NOWRAP ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">Director</FONT></TD>
</TR>
<TR>
<TD VALIGN="top" NOWRAP ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">Andr&#233; de Bruin<SUP></SUP>
</FONT><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"><SUP>(1)(3)</SUP>
</FONT><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"></FONT><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"><SUP></SUP>
</FONT><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"><SUP></SUP>
</FONT><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times"></FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">54</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" NOWRAP ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">Director</FONT></TD>
</TR>
<TR>
<TD VALIGN="top" NOWRAP ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">Hans-Guenter Hohmann<SUP></SUP>
</FONT><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"><SUP>(2)</SUP>
</FONT><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"></FONT><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"><SUP></SUP>
</FONT><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"><SUP></SUP>
</FONT><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times"></FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">58</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" NOWRAP ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">Director</FONT></TD>
</TR>
<TR>
<TD VALIGN="top" NOWRAP ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">Roy S. Johnson<SUP></SUP>
</FONT><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"><SUP>(1)</SUP>
</FONT><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"></FONT><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"><SUP></SUP>
</FONT><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"><SUP></SUP>
</FONT><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times"></FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">48</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" NOWRAP ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">Executive Vice President and President and
<BR>
Managing Director of Diametrics Medical, Ltd.,
<BR>
and Director</FONT></TD>
</TR>
<TR>
<TD VALIGN="top" NOWRAP ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">Mark B. Knudson, Ph.D.<SUP></SUP>
</FONT><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"><SUP>(2)</SUP>
</FONT><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"></FONT><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"><SUP></SUP>
</FONT><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"><SUP></SUP>
</FONT><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times"></FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">52</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" NOWRAP ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">Director</FONT></TD>
</TR>
<TR>
<TD VALIGN="top" NOWRAP ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">Carl S. Goldfischer, M.D.<SUP></SUP>
</FONT><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"><SUP>(3)</SUP>
</FONT><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"></FONT><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"><SUP></SUP>
</FONT><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"><SUP></SUP>
</FONT><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times"></FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">42</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="top" NOWRAP ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">Director</FONT></TD>
</TR>
</TABLE>
<DIV ALIGN="left"><HR WIDTH="10%" SIZE="1" NOSHADE></DIV>

<TABLE BORDER="0" WIDTH="100%" CELLPADDING="0" CELLSPACING="0">
<TR>
<TD WIDTH="4%" ALIGN="left" VALIGN="top"><DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">(1) </FONT></DIV>
</TD>
<TD WIDTH="96%" ALIGN="left" VALIGN="top"> <DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">Member of the Nominating Committee of the Board of Directors.</FONT></DIV>
</TD>
</TR>
</TABLE>
<DIV><FONT SIZE="1">&nbsp;</FONT></DIV>

<TABLE BORDER="0" WIDTH="100%" CELLPADDING="0" CELLSPACING="0">
<TR>
<TD WIDTH="4%" ALIGN="left" VALIGN="top"><DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">(2) </FONT></DIV>
</TD>
<TD WIDTH="96%" ALIGN="left" VALIGN="top"> <DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">Member of the Compensation Committee of the Board of Directors.</FONT></DIV>
</TD>
</TR>
</TABLE>
<DIV><FONT SIZE="1">&nbsp;</FONT></DIV>

<TABLE BORDER="0" WIDTH="100%" CELLPADDING="0" CELLSPACING="0">
<TR>
<TD WIDTH="4%" ALIGN="left" VALIGN="top"><DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">(3) </FONT></DIV>
</TD>
<TD WIDTH="96%" ALIGN="left" VALIGN="top"> <DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">Member of the Audit Committee of the Board of Directors.</FONT></DIV>
</TD>
</TR>
</TABLE>
<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>
<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Mr. Giddings </I>was appointed Chairman of the Board of Directors, President and Chief Executive Officer
of the Company in April 1996. Mr. Giddings was formerly President and Chief Operating Officer of the United States operations of Boehringer Mannheim Corporation (&#147;BMC&#148;), a U.S. subsidiary of Corange Limited, a private global healthcare
corporation. He joined BMC in 1992 after a 26 year career with Eastman Kodak Company (&#147;Kodak&#148;), where he held a number of senior management positions, including General Manager and Vice President of Marketing and Sales, clinical products
division. He also served as Vice President and General
Manager of Kodak&#146;s imaging information system group and of its printing and publishing division. Mr. Giddings is a director of Centra Systems, a private life sciences company.</FONT></DIV>
<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>
<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Mr. Cohn </I>has been a director of the Company since June 1996 and has been a private investor and
consultant since 1991. Mr. Cohn is a consultant to, and a director of, DVI, Inc., a healthcare finance company, and also a director of Niagara Corporation, a steel manufacturing company, Reliant Pharmaceuticals, a pharmaceutical products company,
and Syrrx, Inc., a biotechnology company. Although Mr. Cohn has been a director of the Company since 1996, Mr. Cohn also serves on the Board of Directors of the Company as a representative of BCC Acquisition II LLC. Pursuant to a Common Stock
Purchase Agreement dated June 30, 1998 among the Company, BCC Acquisition II LLC and certain other persons, the Company agreed to appoint two representatives of BCC Acquisition II LLC to serve as members of the Board of Directors, and to use its
reasonable best efforts to ensure that the two representatives will be included as nominees of the Board of Directors and elected to serve on the Board of Directors so long as BCC Acquisition II LLC and the other investors (or their assignees)
collectively own at least 5% of the Company&#146;s outstanding voting securities or at least 75% of the number of shares issued under the Common Stock Purchase Agreement. BCC Acquisition II LLC nominated Dr. Goldfischer and Mr. Cohn as their
representatives. Mr. Cohn is (1) a manager of Bay City Capital Management LLC, the general partner of The Bay City Capital Fund I, L.P., which is the managing member of BCC Acquisition II LLC, and (2) a manager of Bay City Capital LLC, which
provides investment advice to The Bay City Capital Fund I, L.P.</FONT></DIV>
<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>
<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Mr. de Bruin</I> has been a director of the Company since June 1996. He was appointed President and Chief
Executive Officer of Quidel Corporation (&#147;Quidel&#148;) in June 1998. Prior to that, Mr. de Bruin was Chairman, President and Chief Executive Officer of Somatogen, Inc. (&#147;Somatogen&#148;), a publicly held biotechnology company which he
joined in 1994. Immediately prior to joining Somatogen, he was Chairman, President and Chief Executive Officer of Boehringer Mannheim Corporation. Mr. de Bruin is also a director of Quidel and Metabolex, Inc., a private company founded to develop
therapeutics for diabetes and related metabolic diseases.</FONT></DIV>
<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>
<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Mr. Hohmann</I> has been a director of the Company since August 1999. Since November 1999, he has been
Managing Director of Agilent Technologies, GmbH, and from November 1999 to May 2000 he was General Manager of the Point-of-Care Diagnostics Division of Agilent Technologies, Inc. (&#147;Agilent&#148;). Agilent is the new company formed by the
realignment of the Hewlett-Packard Company (&#147;HP&#148;), and is a leading provider of test and measurement solutions and communications components. Mr. Hohmann&#146;s career at HP and Agilent has spanned 33 years, where he has held a variety of
management and engineering positions. From 1996 to November 1999, Mr. Hohmann was general manager of the Patient Monitoring Division within HP&#146;s Healthcare Solutions Group. From 1989 to 1996, he was general manager of HP&#146;s Chemical
Analysis Group-Europe. Other positions included: R&amp;D manager of the Boeblingen, Germany Medical Division, engineering manager of the Medical Products Group and division manager of the Waldbronn Analytical Division. Mr. Hohmann serves on the
Board of Directors as a representative of Agilent pursuant to a Common Stock Purchase Agreement dated June 6, 1999, between the Company and HP, signed concurrently with a Distribution Agreement between the two companies. HP assigned both agreements
to Agilent in November 1999, making Agilent the exclusive global distributor of the Company&#146;s Trendcare&reg; continuous blood gas monitoring systems and the IRMA&reg; SL point-of-care blood analysis system.</FONT></DIV>
<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>
<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Mr. Johnson</I> has been a director since he joined the Company in November 1996 as Executive Vice
President, and President and Managing Director of Diametrics Medical, Ltd. (&#147;DML&#148;), a subsidiary of the Company established in conjunction with the acquisition in November 1996 of Biomedical Sensors, Ltd. (&#147;BSL&#148;). DML markets a
line of indwelling monitoring systems for continuous blood and tissue assessment of critically ill patients. Beginning in 1977, Mr. Johnson served in a number of management positions for the predecessors of the BSL business, most recently as
President and Chief Executive Officer while it was a subsidiary of Orange Medical Instruments, Inc. and later when it was an operating unit of Pfizer Inc. Mr. Johnson started his career in 1974 with Burroughs Wellcome (&#147;Burroughs&#148;) in
pharmaceutical production management and was the head of manufacturing in Burroughs&#146; Sydney, Australia subsidiary.</FONT></DIV>
<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>
<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;  <I>Dr. Knudson</I> has been a director of the Company since March 1990. Dr. Knudson is Chairman and Chief
Executive Officer of Venturi Group, LLC, a venture capital medical device incubator, and President and Chief Executive Officer of Pi Medical, Inc., a private company developing products for the treatment of sleep disordered breathing. Since November
1996, Dr. Knudson has been the Chairman and founder of HeartStent Corp., a private company developing products for coronary revascularization. Dr. Knudson is a Partner of Medical Innovation Partners (&#147;MIP&#148;) and a General Partner of Medical
Innovation Partners II (&#147;MIP II&#148;), each a private investment partnership active in the formation, management, financing and development of start-up medical technology and service companies.</FONT></DIV>
<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>
<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Dr. Goldfischer</I> has been a director of the Company since November 2000, at which time he was elected
by the Board of Directors to fill the vacancy left by the resignation of David Milligan. Dr. Goldfischer is a private investor and a limited partner in Bay City Capital LLC of San Francisco, CA. Dr. Goldfischer served as chief financial officer of
ImClone Systems, Inc., a biopharmaceutical company, from 1996 to 2000. Prior to that, he was a healthcare analyst with the Reliance Insurance Company. From 1991 to 1994, he was director of research for D. Blech &amp; Co., an investment banking firm.
Dr. Goldfischer currently serves as a director for Immulogic Pharmaceutical Corp. and NeoRx Corp. Dr. Goldfischer serves on the Board of Directors of the Company as a representative of BCC Acquisition II LLC. Pursuant to a Common Stock Purchase
Agreement dated June 30, 1998 among the Company, BCC Acquisition II LLC and certain other persons, the Company agreed to appoint two representatives of BCC Acquisition II LLC to serve as members of the Board of Directors, and to use its reasonable
efforts to ensure that the two representatives will be included as nominees of the Board of Directors and elected to serve on the Board of Directors for so long as BCC Acquisition II LLC and the other investors (or their assignees) collectively own
at least 5% of the Company&#146;s outstanding voting securities or at least 75% of the number of shares issued under the Common Stock Purchase Agreement. BCC Acquisition II LLC nominated Dr. Goldfischer and Mr. Cohn (who had already been a director
of the Company since 1996) as their current representatives.</FONT></DIV>
<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>
<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times"><B>THE BOARD OF DIRECTORS RECOMMENDS A VOTE &#147;FOR&#148; THE ELECTION OF MR. COHN, DR. KNUDSON AND DR. GOLDFISCHER AS DIRECTORS OF THE COMPANY.</B></FONT></DIV>
<DIV><FONT SIZE="5">&nbsp;</FONT></DIV>
<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times"><B>Meetings and Committees of the Board of Directors</B></FONT></DIV>
<DIV><FONT SIZE="1">&nbsp;</FONT></DIV>
<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;During the year ended December 31, 2000, the Board of Directors held five meetings. All incumbent directors
attended at least 75% of the aggregate of those meetings of the Board and committees of which they were members that were held while they were serving on the Board or on such committees. The Company&#146;s Board and committees also act from time to
time by holding telephonic meetings or by written consent in lieu of meetings.</FONT></DIV>
<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>
<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Board of Directors has a Compensation Committee which consists of Dr. Knudson, Mr. Cohn and Mr. Hohmann.
The Compensation Committee held one meeting during the year ended December 31, 2000. The Compensation Committee of the Board of Directors makes recommendations concerning executive salaries and incentive compensation for employees of the Company,
subject to ratification by the full Board, and administers the Company&#146;s 1990 Stock Option Plan (the &#147;Stock Option Plan&#148;).</FONT></DIV>
<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>


<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Board of Directors of the Company has an Audit Committee which consists of Mr. Cohn, Mr. de Bruin and
Dr. Goldfischer. David Milligan was a member of the Audit Committee until his resignation in November 2000. The Audit Committee held two meetings during the year ended December 31, 2000. The Audit Committee reviews the results and scope of the audit
and other services provided by the Company&#146;s independent certified public accountants, as well as the Company&#146;s accounting principles and its system of internal controls, reports the results of their review to the full Board and to
management and recommends to the full Board that the Company&#146;s audited consolidated financial statements be included in the Company&#146;s Annual Report on Form 10-K filed with the Securities and Exchange Commission.</FONT></DIV>

<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>
<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Board of Directors of the Company has a Nominating Committee which consists of Messrs. Giddings, de
Bruin and Johnson. The Nominating Committee held one meeting during the year ended December 31, 2000. The Nominating Committee of the Board of Directors makes recommendations concerning members of the Board of Directors.</FONT></DIV>
<DIV><FONT SIZE="5">&nbsp;</FONT></DIV>
<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times"> <B>Compensation of Directors</B></FONT></DIV>
<DIV><FONT SIZE="1">&nbsp;</FONT></DIV>
<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Members of the Board of Directors who are not employees of the Company receive an annual retainer of $8,000
and $2,000 per Board meeting attended in person and $500 where the meeting is attended by means of telephonic communication, with the proviso that each non-employee Director shall be compensated for not less than six Board meetings in any 12-month
period. In addition, each non-employee member of the Board of Directors of the Company serving on the Compensation Committee, the Audit Committee and the Nominating Committee receives $500 per committee meeting attended. Each non-employee Director
may elect, not later than the last day of the Company&#146;s fiscal year, to be granted stock options in lieu of the compensation and fees otherwise payable to such Director for the next fiscal year. Such options shall be granted in quarterly
installments on the last day of each fiscal quarter in which such compensation and fees are earned, to be fully exercisable immediately. The number of shares covered by each option shall be determined by dividing the total amount of compensation and
fees payable at the end of each quarter by the option value of one share on the date of grant. The option value per share is determined using the Black Scholes option pricing model, and considers the annualized volatility of the Company&#146;s stock
price, its annualized risk-free interest rate and the expected life of the options. All Directors are reimbursed for expenses actually incurred in attending meetings of the Board of Directors and its committees.</FONT></DIV>
<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>
<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Non-employee Directors are eligible to participate in the Company&#146;s 1993 Directors&#146; Stock Option
Plan (the &#147;Directors&#146; Plan&#148;). The Directors&#146; Plan, as amended, provides for an automatic grant of nonqualified stock options to purchase 18,000 shares of Common Stock to non-employee Directors of the Company on the date such
individuals become directors of the Company (the &#147;Initial Grant&#148;), and an option to purchase 8,000 shares of Common Stock on each subsequent annual shareholder meeting date, subject to certain limitations (a &#147;Subsequent Grant&#148;).
Options granted in connection with the Initial Grant vest and become exercisable as to 50% of such shares on the twelve month anniversary of the date of such Initial Grant and 25% at each such successive anniversary date thereafter if the holder
remains a director on such dates. Subsequent Grants become exercisable six months subsequent to the date of grant.</FONT></DIV>
<DIV><FONT SIZE="6">&nbsp;</FONT></DIV>
<DIV ALIGN="center"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times"><B>EXECUTIVE COMPENSATION</B></FONT></DIV>
<DIV><FONT SIZE="5">&nbsp;</FONT></DIV>
<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times"><B>Report of Compensation Committee on Executive Compensation</B></FONT></DIV>
<DIV><FONT SIZE="1">&nbsp;</FONT></DIV>
<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Under rules established by the Securities and Exchange Commission, the Company is required to provide
certain data and information in regard to the compensation and benefits provided to the Company&#146;s Chief Executive Officer and its other executive officers. The disclosure requirements for these individuals include the use of tables and a report
explaining the rationale and considerations that led to fundamental executive compensation decisions affecting those individuals. In fulfillment of the report requirement, the Compensation Committee of the Board of Directors (the
&#147;Committee&#148;), at the direction of the Board of Directors, has prepared the following report for inclusion in this Proxy Statement.</FONT></DIV>
<DIV><FONT SIZE="5">&nbsp;</FONT></DIV>

<TABLE BORDER="0" WIDTH="100%" CELLPADDING="0" CELLSPACING="0">
<TR>
<TD WIDTH="4%" ALIGN="left" VALIGN="top"></TD>
<TD WIDTH="96%" ALIGN="left" VALIGN="top"> <DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times"><I>Overview</I></FONT></DIV>
</TD>
</TR>
</TABLE>
<DIV><FONT SIZE="1">&nbsp;</FONT></DIV>
<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Committee is responsible for establishing and making certain recommendations to the Board of Directors
concerning executive compensation, including annual base salaries, grants of stock options and other benefits. The Committee is composed entirely of independent outside directors of the Company. The Committee annually reviews and evaluates the
Company&#146;s corporate performance, compensation levels and equity ownership of its executive officers. The goal of the Committee is to establish compensation policies and programs that will attract and retain highly qualified executives and
provide an incentive to such executives to focus on the Company&#146;s long-term strategic goals by aligning their financial interests closely with long-term shareholder interests.</FONT></DIV>
<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>
<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;  The Committee intends to make the executive compensation program competitive with the marketplace, with
emphasis on compensation in the form of equity ownership, the value of which is contingent on the Company&#146;s long-term market performance. For this purpose, the Committee compares the Company with a selected group of emerging growth companies
with similar business characteristics and strategies, and has considered the recommendations of an independent compensation consultant to the Company.</FONT></DIV>
<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>
<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In evaluating compensation relative to Company performance, the Committee considers specific objective
goals, such as the Company&#146;s stock performance, its operating revenues and earnings, and its progress toward profitability. The Committee also ties compensation to performance goals that involve a more subjective element and take into account
the achievement of such nonfinancial goals such as the introduction of new products, optimization of manufacturing processes, growing market acceptance of the Company&#146;s products and implementation of the Company&#146;s strategy.</FONT></DIV>
<DIV><FONT SIZE="5">&nbsp;</FONT></DIV>

<TABLE BORDER="0" WIDTH="100%" CELLPADDING="0" CELLSPACING="0">
<TR>
<TD WIDTH="4%" ALIGN="left" VALIGN="top"></TD>
<TD WIDTH="96%" ALIGN="left" VALIGN="top"> <DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times"><I>Executive Compensation Program</I></FONT></DIV>
</TD>
</TR>
</TABLE>
<DIV><FONT SIZE="1">&nbsp;</FONT></DIV>
<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The components of the Company&#146;s executive compensation program which are subject to the discretion of
the Committee on an individual basis consist primarily of base salaries, bonuses and stock options. The ultimate composition of executive compensation reflects the Company&#146;s goals of attracting and retaining highly qualified personnel and
supporting a performance-oriented environment that rewards both corporate and personal performance over the long term.</FONT></DIV>
<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>
<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Base Salary and Bonus. </I>Annual base salaries and bonuses are established as a result of the
Committee&#146;s analysis of each executive officer&#146;s individual performance during the prior year, the overall performance of the Company during the prior year, historical compensation levels within the executive officer group and salary and
bonus levels offered by comparable companies.</FONT></DIV>
<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>


<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Stock Options</I>. In general, stock option grants are used to enhance the competitiveness of
compensation packages, to reward exceptional performance and provide incentive for reaching future performance goals. The Stock Option Plan is designed to align a portion of executive and other senior employee compensation with the long-term
interests of shareholders. The stock options give the holder the right to purchase shares of the Common Stock over a ten-year period, as shares become vested, at the fair market value per share as of the date the option is granted. In addition to
options, the Stock Option Plan permits the granting of several types of stock-based awards, including stock bonuses.</FONT></DIV>

<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>
<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In determining whether to grant options to an executive officer, the Committee typically considers the
individual&#146;s performance as such performance relates to the achievement of Company objectives and any planned change in functional responsibility. Although the stock option position of executive officers generally is reviewed on an annual
basis, the Company&#146;s policy is to not grant stock options annually, but to review each individual&#146;s stock option position, at which point the Committee may or may not grant additional options at its discretion. The determination of whether
any additional options will be granted to an executive officer is based on a number of factors, including Company performance, individual performance and levels of options granted by the comparable companies referred to above.</FONT></DIV>
<DIV><FONT SIZE="5">&nbsp;</FONT></DIV>

<TABLE BORDER="0" WIDTH="100%" CELLPADDING="0" CELLSPACING="0">
<TR>
<TD WIDTH="4%" ALIGN="left" VALIGN="top"></TD>
<TD WIDTH="96%" ALIGN="left" VALIGN="top"> <DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times"><I>Compensation of Chief Executive Officer</I></FONT></DIV>
</TD>
</TR>
</TABLE>
<DIV><FONT SIZE="1">&nbsp;</FONT></DIV>
<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Compensation for the Chief Executive Officer consists of the following components: base salary, incentive
bonus and stock options. Mr. Giddings joined the Company in April 1996 as Chief Executive Officer. His 2000 base salary increased to $350,000 from $300,000 in 1999. Mr. Giddings was also paid a cash bonus of $187,085 and was granted an option to
purchase 75,000 shares of the Company&#146;s Common Stock in 2000. Mr. Giddings&#146; incentive cash compensation considers the Company&#146;s 2000 financial performance against established objectives. The Committee believes that stock options
granted to Mr. Giddings provide a significant and appropriate tie between overall compensation and the performance of the Company over the long term.</FONT></DIV>
<DIV><FONT SIZE="5">&nbsp;</FONT></DIV>

<TABLE BORDER="0" WIDTH="100%" CELLPADDING="0" CELLSPACING="0">
<TR>
<TD WIDTH="4%" ALIGN="left" VALIGN="top"></TD>
<TD WIDTH="96%" ALIGN="left" VALIGN="top"> <DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times"> <I>Section 162(m)</I></FONT></DIV>
</TD>
</TR>
</TABLE>
<DIV><FONT SIZE="1">&nbsp;</FONT></DIV>
<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section 162(m) of the Internal Revenue Code of 1986, as amended, did not affect the deductibility of
compensation paid to the Company&#146;s executive officers in 2000 and is not anticipated to affect the deductibility of such compensation expected to be paid in 2001. The Committee will continue to monitor this matter and may propose additional
changes to the executive compensation program if warranted.</FONT></DIV>
<DIV><FONT SIZE="5">&nbsp;</FONT></DIV>

<TABLE WIDTH="100%" BORDER="0" CELLPADDING="0" CELLSPACING="0">
<TR>
<TD WIDTH="52%" ALIGN="left" VALIGN="top"></TD>
<TD ALIGN="left" VALIGN="top"> <DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">MARK B. KNUDSON,</FONT></DIV>
</TD>
</TR>
</TABLE>

<TABLE WIDTH="100%" BORDER="0" CELLPADDING="0" CELLSPACING="0">
<TR>
<TD WIDTH="52%" ALIGN="left" VALIGN="top"></TD>
<TD ALIGN="left" VALIGN="top"> <DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">GERALD L. COHN and</FONT></DIV>
</TD>
</TR>
</TABLE>

<TABLE WIDTH="100%" BORDER="0" CELLPADDING="0" CELLSPACING="0">
<TR>
<TD WIDTH="52%" ALIGN="left" VALIGN="top"></TD>
<TD ALIGN="left" VALIGN="top"> <DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">HANS-GUENTER HOHMANN</FONT></DIV>
</TD>
</TR>
</TABLE>

<TABLE WIDTH="100%" BORDER="0" CELLPADDING="0" CELLSPACING="0">
<TR>
<TD WIDTH="52%" ALIGN="left" VALIGN="top"></TD>
<TD ALIGN="left" VALIGN="top"> <DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">The Members of the Compensation Committee</FONT></DIV>
</TD>
</TR>
</TABLE>
<DIV><FONT SIZE="5">&nbsp;</FONT></DIV>
<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times"><B>Compensation Committee Interlocks and Insider Participation</B></FONT></DIV>
<DIV><FONT SIZE="1">&nbsp;</FONT></DIV>
<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dr. Knudson, Mr. Cohn and Mr. Hohmann served as members of the Company&#146;s Compensation Committee during
2000.</FONT></DIV>
<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>
<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Effective March 31, 1998, the Company secured a $1,000,000 receivable backed credit line with DVI Business
Credit Corporation. DVI Business Credit Corporation is a business unit of DVI, Inc. (&#147;DVI&#148;), of which Mr. Cohn is a director and consultant. The loan agreement requires the Company&#146;s accounts receivable collections be applied to
reduce the loan balance, including advances, interest and fees. All advances under the line of credit bear interest on the unpaid principal amount at a fluctuating rate equal to the Prime Rate plus three percent. Interest is payable monthly in
arrears. The loan agreement requires the monthly payment of an annualized unutilized loan fee equal to one half of one percent (0.5%) of the difference between the committed available loan amount and the average outstanding loan balance. The Company
has no outstanding balance drawn on the line of credit as of the date of this Proxy Statement.</FONT></DIV>
<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>


<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Beginning November 26, 1996, the Company entered into three note agreements totaling $1,557,933 with DVI.
The loan agreements require principal and interest payments in monthly installments at varying amounts through September 2002, at annual interest rates ranging from 10.1% to 10.95%. Maturity dates of the notes range from December 1, 2001 to
September 25, 2002, and all notes are secured by equipment. Additionally, effective January 2001, the Company&#146;s U.K. subsidiary, Diametrics Medical, Ltd., entered into a capital lease agreement with DVI in the amount of 319,500 British pounds
sterling. The capital lease agreement requires principal and interest payments in monthly installments through January 2005, at an annual interest rate of 12%. The capital lease agreement is secured by equipment.</FONT></DIV>

<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>
<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On June 6, 1999, the Company and HP signed an exclusive worldwide Distribution Agreement to market, sell and
distribute the Company&#146;s Trendcare&reg; continuous blood-gas monitoring systems and the IRMA&reg; SL point-of-care blood analysis system. Under the terms of the Distribution Agreement, the Company transferred full responsibility for marketing,
sales and distribution for these products to HP. The initial term of the Distribution Agreement is three and a half years, with the option for extensions. Concurrently with the execution of the Distribution Agreement, HP agreed to acquire $9.5
million of the Company&#146;s Common Stock at $7.00 per share, with a warrant to purchase 452,381 shares of Common Stock at $8.40 per share. The sale of shares of Common Stock to HP for $9.5 million was completed on June 28, 1999. In addition to
HP&#146;s equity investment, the Distribution Agreement also provides for minimum purchase commitments, market development commitments, research and development funding and royalty payments over the term of the agreement.</FONT></DIV>
<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>
<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Mr. Hohmann is an executive officer of Agilent, a leading provider of test and measurement solutions and
communications components, and serves on the Board of Directors of the Company as a representative of Agilent pursuant to the Common Stock Purchase Agreement between the Company and HP. In November 1999, HP assigned the Distribution Agreement, with
all its related rights and obligations, and its equity investment with the Company to Agilent. Agilent was formed as a new company and subsidiary of HP in November 1999. HP spun-off its ownership in Agilent to HP shareholders during
2000.<B></B></FONT></DIV>
<DIV><FONT SIZE="1">&nbsp;</FONT></DIV>
<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times"> <B>Summary Compensation Table</B></FONT></DIV>
<DIV><FONT SIZE="1">&nbsp;</FONT></DIV>
<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following table sets forth the cash and noncash compensation for each of the last three fiscal years
awarded to or earned by the Chief Executive Officer and the other most highly compensated executive officers of the Company whose salary and bonus earned in the fiscal year ended December 31, 2000 exceeded $100,000 for services rendered:</FONT></DIV>
<DIV><FONT SIZE="6">&nbsp;</FONT></DIV>
<DIV ALIGN="center"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times"><B>SUMMARY COMPENSATION TABLE</B></FONT></DIV>
<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>

<TABLE ALIGN="center" WIDTH="612" CELLSPACING=0 CELLPADDING=0>
<TR>
<TH VALIGN="bottom" ALIGN="center"><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;</FONT></TH>
<TH><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TH>
<TH VALIGN="bottom" ALIGN="center"><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;</FONT></TH>
<TH><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TH>
<TH COLSPAN=3 VALIGN="bottom" NOWRAP ALIGN="center"><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"><B>Annual Compensation</B></FONT><FONT SIZE="1"><HR ALIGN="center" WIDTH="100%" SIZE="1" NOSHADE></FONT></TH>
<TH><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TH>
<TH VALIGN="bottom" NOWRAP ALIGN="center"><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"><B></B><B></B><B>Long-Term
<BR>
Compensation
<BR>
Awards</B></FONT><FONT SIZE="1"><HR ALIGN="center" WIDTH="100%" SIZE="1" NOSHADE></FONT></TH>
</TR>
<TR>
<TH VALIGN="bottom" ALIGN="center"><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;</FONT></TH>
<TH><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TH>
<TH VALIGN="bottom" NOWRAP ALIGN="center"><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"><B>Year</B></FONT><FONT SIZE="1"><HR ALIGN="center" WIDTH="100%" SIZE="1" NOSHADE></FONT></TH>
<TH><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TH>
<TH VALIGN="bottom" NOWRAP ALIGN="center"><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"><B>Salary</B></FONT><FONT SIZE="1"><HR ALIGN="center" WIDTH="100%" SIZE="1" NOSHADE></FONT></TH>
<TH><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TH>
<TH VALIGN="bottom" NOWRAP ALIGN="center"><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"><B>Bonus</B></FONT><FONT SIZE="1"><HR ALIGN="center" WIDTH="100%" SIZE="1" NOSHADE></FONT></TH>
<TH><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TH>
<TH VALIGN="bottom" NOWRAP ALIGN="center"><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"><B>Stock Options
<BR>
(Shares)</B></FONT><FONT SIZE="1"><HR ALIGN="center" WIDTH="100%" SIZE="1" NOSHADE></FONT></TH>
<TH><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TH>
<TH COLSPAN=2 VALIGN="bottom" NOWRAP ALIGN="center"><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"><B>All Other
<BR>
Compensation</B></FONT><FONT SIZE="1"><HR ALIGN="center" WIDTH="100%" SIZE="1" NOSHADE></FONT></TH>
</TR>
<TR>
<TD VALIGN="bottom" NOWRAP ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">David T. Giddings</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">2000</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">$349,039</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">$187,085</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">75,000</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">$&nbsp;&nbsp;&nbsp;&nbsp;&#151;&nbsp;</FONT></TD>
<TD><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;</FONT></TD>
</TR>
<TR>
<TD VALIGN="bottom" NOWRAP ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;President, Chief Executive Officer</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">1999</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">300,000</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">292,000</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">100,000</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&#151;&nbsp;</FONT></TD>
<TD><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;</FONT></TD>
</TR>
<TR>
<TD VALIGN="bottom" NOWRAP ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;and Chairman of the Board</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">1998</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">300,000</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&#151;&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&#151;&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&#151;&nbsp;</FONT></TD>
<TD><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;</FONT></TD>
</TR>
<TR>
<TD COLSPAN=10 VALIGN="bottom" ALIGN="left"><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;</FONT></TD>
</TR>
<TR>
<TD VALIGN="bottom" NOWRAP ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">Roy S. Johnson</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">2000</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">$173,874</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">$&nbsp;&nbsp;52,782</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">20,000</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">$46,424<SUP></SUP>
</FONT><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"><SUP></SUP>
</FONT></TD>
<TD VALIGN="bottom" ALIGN="left"><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"><SUP>(1)</SUP>
</FONT><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"></FONT><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"><SUP></SUP>
</FONT><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"><SUP></SUP>
</FONT><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times"></FONT></TD>
</TR>
<TR>
<TD VALIGN="bottom" NOWRAP ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Executive Vice President and President</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">1999</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">177,169</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">108,722</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">30,000</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">49,675<SUP></SUP>
</FONT><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"><SUP></SUP>
</FONT></TD>
<TD VALIGN="bottom" ALIGN="left"><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"><SUP>(1)</SUP>
</FONT><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"></FONT><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"><SUP></SUP>
</FONT><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"><SUP></SUP>
</FONT><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times"></FONT></TD>
</TR>
<TR>
<TD VALIGN="bottom" NOWRAP ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;and Managing Director of DML</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">1998</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">189,000</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&#151;&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&#151;&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">48,804<SUP></SUP>
</FONT><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"><SUP></SUP>
</FONT></TD>
<TD VALIGN="bottom" ALIGN="left"><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"><SUP>(1)</SUP>
</FONT><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"></FONT><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"><SUP></SUP>
</FONT><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"><SUP></SUP>
</FONT><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times"></FONT></TD>
</TR>
<TR>
<TD COLSPAN=10 VALIGN="bottom" ALIGN="left"><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;</FONT></TD>
</TR>
<TR>
<TD VALIGN="bottom" NOWRAP ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">Laurence L. Betterley</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">2000</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">$186,654</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">$&nbsp;&nbsp;68,250</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">20,000</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">$&nbsp;&nbsp;&nbsp;&nbsp;&#151;&nbsp;</FONT></TD>
<TD><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;</FONT></TD>
</TR>
<TR>
<TD VALIGN="bottom" NOWRAP ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Senior Vice President</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">1999</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">175,000</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">94,063</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">25,000</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&#151;&nbsp;</FONT></TD>
<TD><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;</FONT></TD>
</TR>
<TR>
<TD VALIGN="bottom" NOWRAP ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;and Chief Financial Officer</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">1998</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">175,000</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">10,500</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&#151;&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&#151;&nbsp;</FONT></TD>
<TD><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;</FONT></TD>
</TR>
<TR>
<TD COLSPAN=10 VALIGN="bottom" ALIGN="left"><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;</FONT></TD>
</TR>
<TR>
<TD VALIGN="bottom" NOWRAP ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">James R. Miller(2)</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">2000</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">$178,885</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">$&nbsp;&nbsp;48,192</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">20,000</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">$&nbsp;&nbsp;&nbsp;&nbsp;&#151;&nbsp;</FONT></TD>
<TD><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;</FONT></TD>
</TR>
<TR>
<TD VALIGN="bottom" NOWRAP ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Senior Vice President of Sales and</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">1999</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">175,000</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">87,500</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">25,000</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&#151;&nbsp;</FONT></TD>
<TD><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;</FONT></TD>
</TR>
<TR>
<TD VALIGN="bottom" NOWRAP ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Marketing and Commercial Development</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">1998</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">175,000</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">11,813</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&#151;&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&#151;&nbsp;</FONT></TD>
<TD><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;</FONT></TD>
</TR>
</TABLE>
<DIV ALIGN="left"><HR WIDTH="10%" SIZE="1" NOSHADE></DIV>

<TABLE BORDER="0" WIDTH="100%" CELLPADDING="0" CELLSPACING="0">
<TR>
<TD WIDTH="4%" ALIGN="left" VALIGN="top"><DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">(1) </FONT></DIV>
</TD>
<TD WIDTH="96%" ALIGN="left" VALIGN="top"> <DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">Includes Company pension plan contributions made on Mr. Johnson&#146;s behalf and Company expenses related to Mr.
Johnson&#146;s use of a Company automobile.</FONT></DIV>
</TD>
</TR>
</TABLE>
<DIV><FONT SIZE="1">&nbsp;</FONT></DIV>

<TABLE BORDER="0" WIDTH="100%" CELLPADDING="0" CELLSPACING="0">
<TR>
<TD WIDTH="4%" ALIGN="left" VALIGN="top"><DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">(2) </FONT></DIV>
</TD>
<TD WIDTH="96%" ALIGN="left" VALIGN="top"> <DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">Mr. Miller resigned from the Company in February 2001.</FONT></DIV>
</TD>
</TR>
</TABLE>
<DIV><FONT SIZE="5">&nbsp;</FONT></DIV>
<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times"><B>Employment Contracts and Change in Control Agreements</B></FONT></DIV>
<DIV><FONT SIZE="1">&nbsp;</FONT></DIV>
<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Except as provided below, none of the Company&#146;s executive officers has a written employment agreement.
Pursuant to a Severance Pay Agreement dated July 31, 1998 (the &#147;Severance Pay Agreement&#148;), in addition to payment of full base salary, bonus and benefits earned through date of termination, Mr. Giddings will receive a lump-sum cash
severance payment equal to three times his full base salary in effect immediately prior to termination, plus the targeted bonus Mr. Giddings would have earned for the year in which termination is effective (assuming for such purpose the achievement
of targeted performance), under certain circumstances following a change in control of the Company, as defined in the Severance Pay Agreement, subject to certain tax adjustments. Mr. Giddings&#146; Severance Pay Agreement is for a three year term
and automatically renews for an additional three year term unless earlier canceled in writing. Mr. Giddings&#146; stock options also will vest immediately in the event of a change in control.</FONT></DIV>
<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>
<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Similar severance arrangements for the Company&#146;s executive officers, under certain circumstances
following a &#147;change in control,&#148; have been established, with lump-sum cash severance payments equal to two times full base salary in effect immediately prior to termination, plus the targeted bonus such executive officers would have earned
for the year in which termination is effective (assuming for such purpose the achievement of targeted performance), subject to certain tax adjustments. In addition, severance arrangements have been established for the Company&#146;s executive
officers in the event of termination for reasons other than &#147;cause,&#148; providing for the payment of full base salary, bonus and benefits earned through date of termination, as well as the continuation of
payment of the full base salary then in effect for an additional twelve month period, plus a pro rata portion of the targeted bonus such executive officer would have earned for the year in which termination is effective (assuming for such purpose
the achievement of targeted performance).</FONT></DIV>
<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>
<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As described below in footnote (1) to the table entitled &#147;Option Grants During Year Ended December 31,
2000,&#148; the exercisability of options granted to named executive officers is accelerated in the event of a &#147;change in control&#148; involving the Company.</FONT></DIV>
<DIV><FONT SIZE="5">&nbsp;</FONT></DIV>
<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times"><B>Stock Options</B></FONT></DIV>
<DIV><FONT SIZE="1">&nbsp;</FONT></DIV>
<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following table summarizes option grants during the year ended December 31, 2000 to the executive
officers named in the &#147;Summary Compensation Table&#148; above:</FONT></DIV>
<DIV><FONT SIZE="6">&nbsp;</FONT></DIV>
<DIV ALIGN="center"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times"><B>Option Grants During Year Ended December 31, 2000</B></FONT></DIV>
<DIV><FONT SIZE="5">&nbsp;</FONT></DIV>


<BR>

<TABLE ALIGN="center" WIDTH="612" CELLSPACING=0 CELLPADDING=0>
<TR>
<TH ROWSPAN=2 VALIGN="bottom" NOWRAP ALIGN="left"><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"><B>Name</B></FONT><FONT SIZE="1"><HR ALIGN="left" WIDTH="100%" SIZE="1" NOSHADE></FONT></TH>
<TH><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TH>
<TH ROWSPAN=2 VALIGN="bottom" NOWRAP ALIGN="center"><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"><B>Options
<BR>
Granted(1)</B></FONT><FONT SIZE="1"><HR ALIGN="center" WIDTH="100%" SIZE="1" NOSHADE></FONT></TH>
<TH><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TH>
<TH COLSPAN=2 ROWSPAN=2 VALIGN="bottom" NOWRAP ALIGN="center"><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"><B>% of Total
<BR>
Options
<BR>
Granted to
<BR>
Employees
<BR>
in FY 2000</B></FONT><FONT SIZE="1"><HR ALIGN="center" WIDTH="100%" SIZE="1" NOSHADE></FONT></TH>
<TH><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TH>
<TH ROWSPAN=2 VALIGN="bottom" NOWRAP ALIGN="center"><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"><B>Exercise
<BR>
Price Per
<BR>
Share(2)</B></FONT><FONT SIZE="1"><HR ALIGN="center" WIDTH="100%" SIZE="1" NOSHADE></FONT></TH>
<TH><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TH>
<TH ROWSPAN=2 VALIGN="bottom" NOWRAP ALIGN="center"><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"><B>Expiration
<BR>
Date</B></FONT><FONT SIZE="1"><HR ALIGN="center" WIDTH="100%" SIZE="1" NOSHADE></FONT></TH>
<TH><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TH>
<TH COLSPAN=3 VALIGN="bottom" NOWRAP ALIGN="center"><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"><B>Potential Realizable Value
<BR>
at Assumed Annual Rates
<BR>
of Stock Price
<BR>
Appreciation for Option
<BR>
Term(3)</B></FONT><FONT SIZE="1"><HR ALIGN="center" WIDTH="100%" SIZE="1" NOSHADE></FONT></TH>
</TR>
<TR>
<TH></TH>
<TH></TH>
<TH></TH>
<TH></TH>
<TH><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TH>
<TH VALIGN="bottom" NOWRAP ALIGN="center"><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"><B>5%</B></FONT><FONT SIZE="1"><HR ALIGN="center" WIDTH="100%" SIZE="1" NOSHADE></FONT></TH>
<TH><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TH>
<TH VALIGN="bottom" NOWRAP ALIGN="center"><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"><B>10%</B></FONT><FONT SIZE="1"><HR ALIGN="center" WIDTH="100%" SIZE="1" NOSHADE></FONT></TH>
</TR>
<TR>
<TD VALIGN="bottom" NOWRAP ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">David T. Giddings</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">75,000</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">26</FONT></TD>
<TD VALIGN="bottom" ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">%</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">$12.00</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">3/16/10</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">$566,005</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">$2,334,368</FONT></TD>
</TR>
<TR>
<TD VALIGN="bottom" NOWRAP ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">Roy S. Johnson</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">20,000</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">7</FONT></TD>
<TD><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">12.00</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">3/16/10</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">150,935</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">622,498</FONT></TD>
</TR>
<TR>
<TD VALIGN="bottom" NOWRAP ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">Laurence L. Betterley</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">20,000</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">7</FONT></TD>
<TD><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">12.00</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">3/16/10</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">150,935</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">622,498</FONT></TD>
</TR>
<TR>
<TD VALIGN="bottom" NOWRAP ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">James R. Miller</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">20,000</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">7</FONT></TD>
<TD><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">12.00</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">3/16/10</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">150,935</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">622,498</FONT></TD>
</TR>
</TABLE>


<BR>
<DIV><FONT SIZE="1">&nbsp;</FONT></DIV>
<DIV ALIGN="left"><HR WIDTH="10%" SIZE="1" NOSHADE></DIV>

<TABLE BORDER="0" WIDTH="100%" CELLPADDING="0" CELLSPACING="0">
<TR>
<TD WIDTH="4%" ALIGN="left" VALIGN="top"><DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">(1) </FONT></DIV>
</TD>
<TD WIDTH="96%" ALIGN="left" VALIGN="top"> <DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">Each option represents the right to purchase one share of Common Stock and all grants were made pursuant to the Stock Option
Plan. Stock options were granted to Messrs. Giddings, Johnson, Miller and Betterley in March 2000 and become exercisable with respect to one-quarter of the shares on each of the first four anniversaries of the grant date. To the extent not already
exercisable, the options granted to all four individuals become exercisable in the event of a &#147;change in control&#148; (as defined in the stock option agreements) involving the Company.</FONT></DIV>
</TD>
</TR>
</TABLE>
<DIV><FONT SIZE="1">&nbsp;</FONT></DIV>


<TABLE BORDER="0" WIDTH="100%" CELLPADDING="0" CELLSPACING="0">
<TR>
<TD WIDTH="4%" ALIGN="left" VALIGN="top"><DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">(2) </FONT></DIV>
</TD>
<TD WIDTH="96%" ALIGN="left" VALIGN="top"> <DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">The exercise price is equal to the fair market value of the Common Stock on the date of grant in the case of each of such
grants. The exercise price may be paid in cash, in shares of Common Stock with a market value as of the date of exercise at least equal to the option price or a combination of cash and shares of Common Stock.</FONT></DIV>
</TD>
</TR>
</TABLE>

<DIV><FONT SIZE="1">&nbsp;</FONT></DIV>

<TABLE BORDER="0" WIDTH="100%" CELLPADDING="0" CELLSPACING="0">
<TR>
<TD WIDTH="4%" ALIGN="left" VALIGN="top"><DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">(3) </FONT></DIV>
</TD>
<TD WIDTH="96%" ALIGN="left" VALIGN="top"> <DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">The compounding assumes a ten year exercise period for all option grants. These amounts represent certain assumed rates of
appreciation only. Actual gains, if any, on stock option exercises are dependent on the future performance of the Common Stock and overall stock market conditions. The amounts reflected in this table may not necessarily be achieved.</FONT></DIV>
</TD>
</TR>
</TABLE>
<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>
<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;  The following table summarizes the value realized upon the exercise of options in the year ended December
31, 2000 and the value of all options held at December 31, 2000 by the executive officers named in the &#147;Summary Compensation Table&#148; above:</FONT></DIV>
<DIV><FONT SIZE="6">&nbsp;</FONT></DIV>
<DIV ALIGN="center"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times"><B>Aggregate Option Exercises in Year Ended December 31, 2000 and</B></FONT></DIV>
<DIV ALIGN="center"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times"><B>Aggregate Value of Options Held At December 31, 2000</B></FONT></DIV>
<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>


<BR>

<TABLE ALIGN="center" WIDTH="613" CELLSPACING=0 CELLPADDING=0>
<TR>
<TH ROWSPAN=2 VALIGN="bottom" NOWRAP ALIGN="left"><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"><B>Name</B></FONT><FONT SIZE="1"><HR ALIGN="left" WIDTH="100%" SIZE="1" NOSHADE></FONT></TH>
<TH><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TH>
<TH ROWSPAN=2 VALIGN="bottom" NOWRAP ALIGN="center"><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"><B>Shares
<BR>
Acquired
<BR>
on
<BR>
Exercise</B></FONT><FONT SIZE="1"><HR ALIGN="center" WIDTH="100%" SIZE="1" NOSHADE></FONT></TH>
<TH><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TH>
<TH ROWSPAN=2 VALIGN="bottom" NOWRAP ALIGN="center"><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"><B>Value
<BR>
Realized</B></FONT><FONT SIZE="1"><HR ALIGN="center" WIDTH="100%" SIZE="1" NOSHADE></FONT></TH>
<TH><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TH>
<TH COLSPAN=3 VALIGN="bottom" NOWRAP ALIGN="center"><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"><B>Number of Unexercised
<BR>
Options Held at
<BR>
December 31, 2000(1)</B></FONT><FONT SIZE="1"><HR ALIGN="center" WIDTH="100%" SIZE="1" NOSHADE></FONT></TH>
<TH><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TH>
<TH COLSPAN=3 VALIGN="bottom" NOWRAP ALIGN="center"><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"><B>Value of Unexercised
<BR>
In-the-Money Options Held
<BR>
at December 31, 2000(2)</B></FONT><FONT SIZE="1"><HR ALIGN="center" WIDTH="100%" SIZE="1" NOSHADE></FONT></TH>
</TR>
<TR>
<TH></TH>
<TH></TH>
<TH><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TH>
<TH VALIGN="bottom" NOWRAP ALIGN="center"><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"><B>Exercisable</B></FONT><FONT SIZE="1"><HR ALIGN="center" WIDTH="100%" SIZE="1" NOSHADE></FONT></TH>
<TH><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TH>
<TH VALIGN="bottom" NOWRAP ALIGN="center"><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"><B>Unexercisable</B></FONT><FONT SIZE="1"><HR ALIGN="center" WIDTH="100%" SIZE="1" NOSHADE></FONT></TH>
<TH><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TH>
<TH VALIGN="bottom" NOWRAP ALIGN="center"><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"><B>Exercisable</B></FONT><FONT SIZE="1"><HR ALIGN="center" WIDTH="100%" SIZE="1" NOSHADE></FONT></TH>
<TH><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TH>
<TH VALIGN="bottom" NOWRAP ALIGN="center"><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"><B>Unexercisable</B></FONT><FONT SIZE="1"><HR ALIGN="center" WIDTH="100%" SIZE="1" NOSHADE></FONT></TH>
</TR>
<TR>
<TD VALIGN="bottom" NOWRAP ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">David T. Giddings</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&#151;&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&#151;&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">600,000</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">175,000</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">$137,000</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">$68,125</FONT></TD>
</TR>
<TR>
<TD VALIGN="bottom" NOWRAP ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">Roy S. Johnson</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&#151;&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&#151;&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">176,250</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">48,750</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">208,088</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">5,513</FONT></TD>
</TR>
<TR>
<TD VALIGN="bottom" NOWRAP ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">Laurence L. Betterley</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&#151;&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&#151;&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">140,000</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">55,000</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">167,781</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">15,219</FONT></TD>
</TR>
<TR>
<TD VALIGN="bottom" NOWRAP ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">James R. Miller</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">20,000</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;122,094</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">129,000</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">45,000</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">17,531</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">4,594</FONT></TD>
</TR>
</TABLE>


<BR>
<DIV ALIGN="left"><HR WIDTH="10%" SIZE="1" NOSHADE></DIV>

<TABLE BORDER="0" WIDTH="100%" CELLPADDING="0" CELLSPACING="0">
<TR>
<TD WIDTH="4%" ALIGN="left" VALIGN="top"><DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">(1) </FONT></DIV>
</TD>
<TD WIDTH="96%" ALIGN="left" VALIGN="top"> <DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">Each option represents the right to purchase one share of Common Stock and all grants were made pursuant to the Stock Option
Plan. To the extent not already exercisable, the options granted to the named executive officers become exercisable in the event of a &#147;change in control&#148; (as defined in the stock option agreements) involving the Company.</FONT></DIV>
</TD>
</TR>
</TABLE>
<DIV><FONT SIZE="1">&nbsp;</FONT></DIV>

<TABLE BORDER="0" WIDTH="100%" CELLPADDING="0" CELLSPACING="0">
<TR>
<TD WIDTH="4%" ALIGN="left" VALIGN="top"><DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">(2) </FONT></DIV>
</TD>
<TD WIDTH="96%" ALIGN="left" VALIGN="top"> <DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">Value based on the difference between the fair market value of the shares of Common Stock at December 31, 2000 ($6.125) and
the exercise price of the options.</FONT></DIV>
</TD>
</TR>
</TABLE>
<DIV><FONT SIZE="1">&nbsp;</FONT></DIV>
<DIV ALIGN="center"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times"> <B>COMPARATIVE STOCK PERFORMANCE</B></FONT></DIV>
<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>
<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The graph below compares the cumulative total shareholder return on the Company&#146;s Common Stock with the
cumulative total return of the Nasdaq Stock Market Index and the Nasdaq Medical Devices, Instruments and Supplies Manufacturer Index over the same five year period from December 29, 1995 to December 29, 2000 (assuming the investment in the Common
Stock and each index was $100 on December 29, 1995, and that dividends, if any, were reinvested).</FONT></DIV>
<DIV><FONT SIZE="6">&nbsp;</FONT></DIV>
<DIV ALIGN="center"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times"><B>Comparison of Cumulative Total Return Since December 29, 1995</B></FONT></DIV>
<DIV ALIGN="center"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times"><B>Among Diametrics Medical, Inc., The Nasdaq Stock Market Index and</B></FONT></DIV>
<DIV ALIGN="center"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times"><B>The Nasdaq Medical Devices, Instruments and Supplies Manufacturer Index</B></FONT></DIV>
<DIV><FONT SIZE="7">&nbsp;</FONT></DIV>
<DIV ALIGN="center"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times"><B>
<IMG SRC="g3344733447palan01.jpg" WIDTH="623" HEIGHT="423"></B></FONT></DIV>
<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>

<TABLE ALIGN="center" WIDTH="615" CELLSPACING=0 CELLPADDING=0>
<TR>
<TH VALIGN="bottom" ALIGN="center"><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;</FONT></TH>
<TH><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TH>
<TH VALIGN="bottom" NOWRAP ALIGN="center"><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"><B>12/29/95</B></FONT><FONT SIZE="1"><HR ALIGN="center" WIDTH="100%" SIZE="1" NOSHADE></FONT></TH>
<TH><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TH>
<TH VALIGN="bottom" NOWRAP ALIGN="center"><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"><B>12/31/96</B></FONT><FONT SIZE="1"><HR ALIGN="center" WIDTH="100%" SIZE="1" NOSHADE></FONT></TH>
<TH><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TH>
<TH VALIGN="bottom" NOWRAP ALIGN="center"><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"><B>12/31/97</B></FONT><FONT SIZE="1"><HR ALIGN="center" WIDTH="100%" SIZE="1" NOSHADE></FONT></TH>
<TH><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TH>
<TH VALIGN="bottom" NOWRAP ALIGN="center"><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"><B>12/31/98</B></FONT><FONT SIZE="1"><HR ALIGN="center" WIDTH="100%" SIZE="1" NOSHADE></FONT></TH>
<TH><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TH>
<TH VALIGN="bottom" NOWRAP ALIGN="center"><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"><B>12/31/99</B></FONT><FONT SIZE="1"><HR ALIGN="center" WIDTH="100%" SIZE="1" NOSHADE></FONT></TH>
<TH><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TH>
<TH VALIGN="bottom" NOWRAP ALIGN="center"><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"><B>12/29/00</B></FONT><FONT SIZE="1"><HR ALIGN="center" WIDTH="100%" SIZE="1" NOSHADE></FONT></TH>
</TR>
<TR>
<TD VALIGN="bottom" NOWRAP ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">Diametrics Medical, Inc.</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">$100.00</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">$90.00</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">$114.00</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">$101.00</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">$176.00</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">$126.00</FONT></TD>
</TR>
<TR>
<TD VALIGN="bottom" NOWRAP ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">Nasdaq Stock Market Index</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">100.00</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">123.00</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">151.00</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">213.00</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">395.00</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">238.00</FONT></TD>
</TR>
<TR>
<TD VALIGN="bottom" NOWRAP ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">Nasdaq Medical Devices, Instruments and
<BR>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Supplies Manufacturer Index</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">100.00</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">94.00</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">107.00</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">120.00</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">146.00</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">151.00</FONT></TD>
</TR>
</TABLE>
<DIV><FONT SIZE="1">&nbsp;</FONT></DIV>
<DIV ALIGN="center"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times"> <B>CERTAIN TRANSACTIONS</B></FONT></DIV>
<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>
<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Effective March 31, 1998, the Company secured a $1,000,000 receivable backed credit line with DVI Business
Credit Corporation. DVI Business Credit Corporation is a business unit of DVI, Inc., of which Mr. Cohn is a director and consultant. The loan agreement requires the Company&#146;s accounts receivable collections be applied to reduce the loan
balance, including advances, interest and fees. All advances under the line of credit bear interest on the unpaid principal amount at a fluctuating rate equal to the Prime Rate plus three percent. Interest is payable monthly in arrears. The loan
agreement requires the monthly payment of an annualized unutilized loan fee equal to one half of one percent (.5%) of the difference between the committed available loan amount and the average outstanding loan balance. The Company has no outstanding
balance drawn on the line of credit as of the date of this Proxy Statement.</FONT></DIV>
<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>


<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Beginning November 26, 1996, the Company entered into three note agreements totaling $1,557,933 with DVI,
Inc. The loan agreements require principal and interest payments in monthly installments at varying amounts through September 2002, at annual interest rates ranging from 10.1% to 10.95%. Maturity dates of the notes range from December 1, 2001 to
September 25, 2002, and all notes are secured by equipment. Additionally, effective January 2001, the Company&#146;s U.K. subsidiary, Diametrics Medical, Ltd., entered into a capital lease agreement with DVI, Inc. in the amount of 319,500 British
pounds sterling. The capital lease agreement requires principal and interest payments in monthly installments through January 2005, at an annual interest rate of 12%. The capital lease agreement is secured by equipment.</FONT></DIV>

<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>
<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;On June 6, 1999, the Company and HP signed an exclusive worldwide Distribution Agreement to market, sell and
distribute the Company&#146;s Trendcare&reg; continuous blood-gas monitoring systems and the IRMA&reg; SL point-of-care blood analysis system. Under the terms of the Distribution Agreement, the Company transferred full responsibility for marketing,
sales and distribution for these products to HP. The initial term of the Distribution Agreement is three and a half years, with the option for extensions. Concurrently with the execution of the Distribution Agreement, HP agreed to acquire $9.5
million of the Company&#146;s Common Stock at $7.00 per share, with a warrant to purchase 452,381 shares of Common Stock at $8.40 per share. The sale of shares of Common Stock to HP for $9.5 million was completed on June 28, 1999. In addition to
HP&#146;s equity investment, the Distribution Agreement also provides for minimum purchase commitments, market development commitments, research and development funding and royalty payments over the term of the agreement.</FONT></DIV>
<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>
<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Mr. Hohmann is an executive officer of Agilent, a leading provider of test and measurement solutions and
communications components, and serves on the Board of Directors of the Company as a representative of Agilent pursuant to the Common Stock Purchase Agreement between the Company and HP. In November 1999, HP assigned the Distribution Agreement, with
all its related rights and obligations, and its equity investment with the Company to Agilent. Agilent was formed as a new company and subsidiary of HP in November 1999. HP spun-off its ownership in Agilent to HP shareholders during
2000.</FONT></DIV>
<DIV><FONT SIZE="6">&nbsp;</FONT></DIV>
<DIV ALIGN="center"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times"><B>SECTION 16(a) BENEFICIAL OWNERSHIP REPORTING COMPLIANCE</B></FONT></DIV>
<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>
<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section 16(a) of the Securities Exchange Act of 1934, as amended, requires the Company&#146;s directors and
executive officers, and persons who own more than ten percent of a registered class of the Company&#146;s equity securities, to file with the Securities and Exchange Commission initial reports of ownership and reports of changes in ownership of
common stock and other equity securities of the Company. Officers, directors and greater-than ten percent shareholders are also required by SEC regulation to furnish the Company with copies of all Section 16(a) forms they file.</FONT></DIV>
<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>
<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;To the Company&#146;s knowledge, based solely on review of the copies of such reports furnished to the
Company and written representations that no other reports were required, during the fiscal year ended December 31, 2000 all Section 16(a) filing requirements applicable to its officers, directors and greater than ten-percent beneficial owners were
complied with, except that (1) a statement of change of beneficial ownership on Form 4 was not timely filed by Mr. de Bruin to reflect the purchase of 100 shares on July 11, 2000, but such purchase was subsequently reported, and (2) an initial
statement of beneficial ownership on Form 3 was not timely filed by Dr. Goldfischer to reflect becoming a director on November 16, 2000, but such event was subsequently reported.</FONT></DIV>
<DIV><FONT SIZE="6">&nbsp;</FONT></DIV>
<DIV ALIGN="center"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times"> <B>SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT</B></FONT></DIV>
<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>
<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following table sets forth certain information regarding beneficial ownership of the Common Stock, as of
April 4, 2001 by: (i) each person who is known by the Company to beneficially own more than 5% of the Common Stock, (ii) each of the Company&#146;s directors and nominees for director, (iii) each of the officers named under the &#147;Summary
Compensation Table&#148; above and (iv) all directors, nominees and executive officers of the Company as a group:</FONT></DIV>
<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>

<TABLE ALIGN="center" WIDTH="615" CELLSPACING=0 CELLPADDING=0>
<TR>
<TH VALIGN="bottom" NOWRAP ALIGN="left"><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"><B>Name of Beneficial Owner</B></FONT><FONT SIZE="1"><HR ALIGN="left" WIDTH="100%" SIZE="1" NOSHADE></FONT></TH>
<TH><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TH>
<TH VALIGN="bottom" NOWRAP ALIGN="center"><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"><B></B><B></B><B>Number of
<BR>
Shares
<BR>
Beneficially
<BR>
Owned(1)</B></FONT><FONT SIZE="1"><HR ALIGN="center" WIDTH="100%" SIZE="1" NOSHADE></FONT></TH>
<TH><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TH>
<TH COLSPAN=2 VALIGN="bottom" NOWRAP ALIGN="center"><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"><B>Percent
<BR>
of
<BR>
Class</B></FONT><FONT SIZE="1"><HR ALIGN="center" WIDTH="100%" SIZE="1" NOSHADE></FONT></TH>
</TR>
<TR>
<TD VALIGN="bottom" NOWRAP ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">BCC Acquisition II LLC<SUP></SUP>
</FONT><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"><SUP>(2)</SUP>
</FONT><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"></FONT><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"><SUP></SUP>
</FONT><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"><SUP></SUP>
</FONT><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times"></FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">3,400,541</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">12.1</FONT></TD>
<TD VALIGN="bottom" ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">%</FONT></TD>
</TR>
<TR>
<TD VALIGN="bottom" NOWRAP ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;c/o Bay City Capital LLC</FONT></TD>
</TR>
<TR>
<TD VALIGN="bottom" NOWRAP ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;750 Battery Street, Suite 600</FONT></TD>
</TR>
<TR>
<TD VALIGN="bottom" NOWRAP ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;San Francisco, CA 94111</FONT></TD>
</TR>
<TR>
<TD VALIGN="bottom" NOWRAP ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">State of Wisconsin Investment Board<SUP></SUP>
</FONT><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"><SUP>(3)</SUP>
</FONT><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"></FONT><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"><SUP></SUP>
</FONT><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"><SUP></SUP>
</FONT><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times"></FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">2,131,800</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">8.0</FONT></TD>
<TD><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;</FONT></TD>
</TR>
<TR>
<TD VALIGN="bottom" NOWRAP ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;P.O. Box 7842</FONT></TD>
</TR>
<TR>
<TD VALIGN="bottom" NOWRAP ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Madison, WI 53707</FONT></TD>
</TR>
<TR>
<TD VALIGN="bottom" NOWRAP ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">Wellington Management Company, LLP<SUP></SUP>
</FONT><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"><SUP>(4)</SUP>
</FONT><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"></FONT><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"><SUP></SUP>
</FONT><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"><SUP></SUP>
</FONT><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times"></FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">1,871,200</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">7.0</FONT></TD>
<TD><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;</FONT></TD>
</TR>
<TR>
<TD VALIGN="bottom" NOWRAP ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;75 State Street</FONT></TD>
</TR>
<TR>
<TD VALIGN="bottom" NOWRAP ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Boston, MA 02104</FONT></TD>
</TR>
<TR>
<TD VALIGN="bottom" NOWRAP ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">Agilent Technologies, Inc.<SUP></SUP>
</FONT><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"><SUP>(5)</SUP>
</FONT><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"></FONT><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"><SUP></SUP>
</FONT><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"><SUP></SUP>
</FONT><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times"></FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">1,809,524</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">6.7</FONT></TD>
<TD><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;</FONT></TD>
</TR>
<TR>
<TD VALIGN="bottom" NOWRAP ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3000 Hanover Street</FONT></TD>
</TR>
<TR>
<TD VALIGN="bottom" NOWRAP ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;MS 20 BQ</FONT></TD>
</TR>
<TR>
<TD VALIGN="bottom" NOWRAP ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Palo Alto, CA 94304</FONT></TD>
</TR>
<TR>
<TD VALIGN="bottom" NOWRAP ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">Amarfour, L.L.C.<SUP></SUP>
</FONT><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"><SUP>(6)</SUP>
</FONT><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"></FONT><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"><SUP></SUP>
</FONT><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"><SUP></SUP>
</FONT><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times"></FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">1,789,100</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">6.7</FONT></TD>
<TD><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;</FONT></TD>
</TR>
<TR>
<TD VALIGN="bottom" NOWRAP ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;200 West Madison Street</FONT></TD>
</TR>
<TR>
<TD VALIGN="bottom" NOWRAP ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Suite 3800</FONT></TD>
</TR>
<TR>
<TD VALIGN="bottom" NOWRAP ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Chicago, IL 60606</FONT></TD>
</TR>
<TR>
<TD VALIGN="bottom" NOWRAP ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">David T. Giddings<SUP></SUP>
</FONT><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"><SUP>(7)</SUP>
</FONT><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"></FONT><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"><SUP></SUP>
</FONT><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"><SUP></SUP>
</FONT><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times"></FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">679,164</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">2.5</FONT></TD>
<TD><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;</FONT></TD>
</TR>
<TR>
<TD VALIGN="bottom" NOWRAP ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">Mark B. Knudson, Ph.D.<SUP></SUP>
</FONT><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"><SUP>(8)</SUP>
</FONT><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"></FONT><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"><SUP></SUP>
</FONT><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"><SUP></SUP>
</FONT><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times"></FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">397,621</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">1.5</FONT></TD>
<TD><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;</FONT></TD>
</TR>
<TR>
<TD VALIGN="bottom" NOWRAP ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">Gerald L. Cohn<SUP></SUP>
</FONT><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"><SUP>(9)</SUP>
</FONT><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"></FONT><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"><SUP></SUP>
</FONT><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"><SUP></SUP>
</FONT><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times"></FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">258,171</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">1.0</FONT></TD>
<TD><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;</FONT></TD>
</TR>
<TR>
<TD VALIGN="bottom" NOWRAP ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">Roy S. Johnson<SUP></SUP>
</FONT><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"><SUP>(10)</SUP>
</FONT><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"></FONT><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"><SUP></SUP>
</FONT><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"><SUP></SUP>
</FONT><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times"></FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">192,843</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">*&nbsp;</FONT></TD>
<TD><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;</FONT></TD>
</TR>
<TR>
<TD VALIGN="bottom" NOWRAP ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">Laurence L. Betterley<SUP></SUP>
</FONT><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"><SUP>(11)</SUP>
</FONT><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"></FONT><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"><SUP></SUP>
</FONT><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"><SUP></SUP>
</FONT><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times"></FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">191,056</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">*&nbsp;</FONT></TD>
<TD><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;</FONT></TD>
</TR>
<TR>
<TD VALIGN="bottom" NOWRAP ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">James R. Miller<SUP></SUP>
</FONT><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"><SUP>(12)</SUP>
</FONT><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"></FONT><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"><SUP></SUP>
</FONT><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"><SUP></SUP>
</FONT><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times"></FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">140,250</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">*&nbsp;</FONT></TD>
<TD><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;</FONT></TD>
</TR>
<TR>
<TD VALIGN="bottom" NOWRAP ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">Andr&#233; de Bruin<SUP></SUP>
</FONT><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"><SUP>(13)</SUP>
</FONT><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"></FONT><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"><SUP></SUP>
</FONT><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"><SUP></SUP>
</FONT><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times"></FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">84,893</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">*&nbsp;</FONT></TD>
<TD><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;</FONT></TD>
</TR>
<TR>
<TD VALIGN="bottom" NOWRAP ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">Hans-Guenter Hohmann</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">0</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">*&nbsp;</FONT></TD>
<TD><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;</FONT></TD>
</TR>
<TR>
<TD VALIGN="bottom" NOWRAP ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">Carl S. Goldfischer, M.D.&nbsp;</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">0</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">*&nbsp;</FONT></TD>
<TD><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;</FONT></TD>
</TR>
<TR>
<TD VALIGN="bottom" NOWRAP ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">All directors and executive officers as a group (9 persons)<SUP></SUP>
</FONT><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"><SUP>(14)</SUP>
</FONT><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"></FONT><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"><SUP></SUP>
</FONT><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times"><SUP></SUP>
</FONT><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times"></FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">1,943,999</FONT></TD>
<TD><FONT SIZE="1">&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
<TD VALIGN="bottom" NOWRAP ALIGN="right"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">6.9</FONT></TD>
<TD><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;</FONT></TD>
</TR>
</TABLE>
<DIV ALIGN="left"><HR WIDTH="10%" SIZE="1" NOSHADE></DIV>

<TABLE BORDER="0" WIDTH="100%" CELLPADDING="0" CELLSPACING="0">
<TR>
<TD WIDTH="4%" ALIGN="left" VALIGN="top"><DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;* </FONT></DIV>
</TD>
<TD WIDTH="96%" ALIGN="left" VALIGN="top"> <DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">Less than 1%.</FONT></DIV>
</TD>
</TR>
</TABLE>
<DIV><FONT SIZE="1">&nbsp;</FONT></DIV>

<TABLE BORDER="0" WIDTH="100%" CELLPADDING="0" CELLSPACING="0">
<TR>
<TD WIDTH="4%" ALIGN="left" VALIGN="top"><DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;(1) </FONT></DIV>
</TD>
<TD WIDTH="96%" ALIGN="left" VALIGN="top"> <DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">Beneficial ownership is determined in accordance with rules of the Securities and Exchange Commission, and includes generally
voting power and/or investment power with respect to securities. Shares of Common Stock subject to options, warrants or other securities currently exercisable or convertible, or exercisable or convertible within 60 days of April 4, 2001, are deemed
outstanding for computing the percentage of the person holding such options but are not deemed outstanding for computing the percentage of any other person. Except as indicated by footnote, the persons named in the table above have sole voting and
investment power with respect to all shares of Common Stock shown as beneficially owned by them.</FONT></DIV>
</TD>
</TR>
</TABLE>
<DIV><FONT SIZE="1">&nbsp;</FONT></DIV>

<TABLE BORDER="0" WIDTH="100%" CELLPADDING="0" CELLSPACING="0">
<TR>
<TD WIDTH="4%" ALIGN="left" VALIGN="top"><DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;(2) </FONT></DIV>
</TD>
<TD WIDTH="96%" ALIGN="left" VALIGN="top"> <DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">In a Schedule 13D dated as of July 15, 1999, BCC Acquisition II LLC indicated that it is the beneficial owner of 3,400,541
shares of Common Stock with shared voting and dispositive power with respect to such shares. Includes 650,731 shares of Common Stock issuable upon the exercise of outstanding warrants, and 797,619 shares of Common Stock issuable upon the conversion
of outstanding convertible notes.</FONT></DIV>
</TD>
</TR>
</TABLE>
<DIV><FONT SIZE="1">&nbsp;</FONT></DIV>

<TABLE BORDER="0" WIDTH="100%" CELLPADDING="0" CELLSPACING="0">
<TR>
<TD WIDTH="4%" ALIGN="left" VALIGN="top"><DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times"> &nbsp;(3) </FONT></DIV>
</TD>
<TD WIDTH="96%" ALIGN="left" VALIGN="top"> <DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">In a Schedule 13G dated as of February 9, 2001, the State of Wisconsin Investment Board indicated that it is the beneficial
owner of 2,131,800 shares of Common Stock with sole voting and dispositive power with respect to such shares.</FONT></DIV>
</TD>
</TR>
</TABLE>
<DIV><FONT SIZE="1">&nbsp;</FONT></DIV>

<TABLE BORDER="0" WIDTH="100%" CELLPADDING="0" CELLSPACING="0">
<TR>
<TD WIDTH="4%" ALIGN="left" VALIGN="top"><DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;(4) </FONT></DIV>
</TD>
<TD WIDTH="96%" ALIGN="left" VALIGN="top"> <DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">In a Schedule 13G dated as of February 13, 2001, Wellington Management Company, LLP indicated that it is the beneficial owner
of 1,871,200 shares of Common Stock with shared voting power with respect to 1,587,500 of such shares and shared dispositive power with respect to 1,871,200 of such shares.</FONT></DIV>
</TD>
</TR>
</TABLE>
<DIV><FONT SIZE="1">&nbsp;</FONT></DIV>

<TABLE BORDER="0" WIDTH="100%" CELLPADDING="0" CELLSPACING="0">
<TR>
<TD WIDTH="4%" ALIGN="left" VALIGN="top"><DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;(5) </FONT></DIV>
</TD>
<TD WIDTH="96%" ALIGN="left" VALIGN="top"> <DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">In a Schedule 13D dated as of December 21, 1999, Agilent Technologies, Inc. indicated that it is the beneficial owner of
1,809,524 shares of Common Stock with shared voting and dispositive power with respect to such shares. Includes 452,381 shares of Common Stock issuable upon full exercise of an outstanding warrant.</FONT></DIV>
</TD>
</TR>
</TABLE>
<DIV><FONT SIZE="1">&nbsp;</FONT></DIV>

<TABLE BORDER="0" WIDTH="100%" CELLPADDING="0" CELLSPACING="0">
<TR>
<TD WIDTH="4%" ALIGN="left" VALIGN="top"><DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;(6) </FONT></DIV>
</TD>
<TD WIDTH="96%" ALIGN="left" VALIGN="top"> <DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">In a Schedule 13G dated as of August 4, 1998, Amarfour, L.L.C. (&#147;Amarfour&#148;) indicated that it is the beneficial
owner of 1,789,100 shares of Common Stock, with sole voting and dispositive power with respect to such shares. Amarfour also indicated that an affiliate of Amarfour (the &#147;RA Trusts&#148;) directly owned 25,319 shares of Common Stock, and that
such affiliate owned indirect interests in each of BCC Acquisition II LLC, The Bay City Capital Fund I, L.P., Bay City Capital Management LLC and Bay City Capital LLC, which entities had acquired beneficial ownership of up to 3,400,541 shares of
Common Stock as of such date. Amarfour also indicated that as of August 4, 1998 certain trusts primarily for the benefit of the lineal descendants of Nicholas J. Pritzker, deceased (the &#147;Hoinfad Trusts&#148;) owned less than a 10% interest in
AEOW 96, LLC (&#147;AEOW&#148;), and that as of August 4, 1998, AEOW acquired beneficial ownership of 30,953 shares of the Company&#146;s Common Stock, and, as of such date, beneficially owned an aggregate of 91,042 shares of the Company&#146;s
Common Stock. Different individuals serve as trustees of the member trusts of Amarfour and the RA Trusts on the one hand and the Hoinfad Trusts on the other hand, and there is no overlap in trusteeships between the Hoinfad Trusts and the member
trusts of Amarfour, but there is overlap in trusteeships between the member trusts of Amarfour and the RA Trusts. Amarfour disclaims the existence of any group and beneficial ownership of such shares.</FONT></DIV>
</TD>
</TR>
</TABLE>
<DIV><FONT SIZE="1">&nbsp;</FONT></DIV>

<TABLE BORDER="0" WIDTH="100%" CELLPADDING="0" CELLSPACING="0">
<TR>
<TD WIDTH="4%" ALIGN="left" VALIGN="top"><DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;(7) </FONT></DIV>
</TD>
<TD WIDTH="96%" ALIGN="left" VALIGN="top"> <DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">Includes 668,750 shares of Common Stock issuable upon exercise of outstanding options.</FONT></DIV>
</TD>
</TR>
</TABLE>
<DIV><FONT SIZE="1">&nbsp;</FONT></DIV>

<TABLE BORDER="0" WIDTH="100%" CELLPADDING="0" CELLSPACING="0">
<TR>
<TD WIDTH="4%" ALIGN="left" VALIGN="top"><DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;(8) </FONT></DIV>
</TD>
<TD WIDTH="96%" ALIGN="left" VALIGN="top"> <DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">Includes 66,500 shares of Common Stock issuable upon the exercise of outstanding options. Includes 156,250 shares of Common
Stock beneficially owned by Medical Innovation Fund II (&#147;MIF II&#148;). Dr. Knudson is a general partner of Medical Innovation Partners II, the general partner of MIF II. Dr. Knudson disclaims beneficial ownership of these securities except to
the extent of his proportionate pecuniary interest in the partnerships. Excludes 459,254 shares of Common Stock held by Medical Innovation Fund (&#147;MIF&#148;). Medical Innovation Partners (&#147;MIP&#148;) is the general partner of MIF. Dr.
Knudson is a partner of MIP. Dr. Knudson disclaims beneficial ownership of such shares except to the extent of his proportionate pecuniary interests in such partnerships.</FONT></DIV>
</TD>
</TR>
</TABLE>
<DIV><FONT SIZE="1">&nbsp;</FONT></DIV>

<TABLE BORDER="0" WIDTH="100%" CELLPADDING="0" CELLSPACING="0">
<TR>
<TD WIDTH="4%" ALIGN="left" VALIGN="top"><DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;(9) </FONT></DIV>
</TD>
<TD WIDTH="96%" ALIGN="left" VALIGN="top"> <DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">Includes 126,899 shares of Common Stock held by the Gerald L. Cohn Revocable Trust, as well as 47,619 shares issuable to the
Gerald L. Cohn Revocable Trust upon the conversion of outstanding convertible notes. Includes 3,000 shares owned by Mr. Cohn&#146;s spouse, as well as 667 shares issuable to Mr. Cohn&#146;s spouse upon the exercise of outstanding warrants. Also
includes 46,500 shares of Common Stock issuable upon exercise of outstanding options. Excludes 3,400,541 shares beneficially owned by BCC Acquisition II LLC. On August 4, 1998, BCC Acquisition II LLC, a Delaware limited liability company, acquired
shares of Common Stock, warrants to acquire additional shares of Common Stock and notes convertible into shares of Common Stock. Mr. Cohn disclaims direct beneficial ownership in the Company&#146;s securities held by BCC Acquisition II LLC and any
transaction therein.</FONT></DIV>
</TD>
</TR>
</TABLE>
<DIV><FONT SIZE="1">&nbsp;</FONT></DIV>

<TABLE BORDER="0" WIDTH="100%" CELLPADDING="0" CELLSPACING="0">
<TR>
<TD WIDTH="4%" ALIGN="left" VALIGN="top"><DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">(10) </FONT></DIV>
</TD>
<TD WIDTH="96%" ALIGN="left" VALIGN="top"> <DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">Includes 188,750 shares of Common Stock issuable upon exercise of outstanding options.</FONT></DIV>
</TD>
</TR>
</TABLE>
<DIV><FONT SIZE="1">&nbsp;</FONT></DIV>

<TABLE BORDER="0" WIDTH="100%" CELLPADDING="0" CELLSPACING="0">
<TR>
<TD WIDTH="4%" ALIGN="left" VALIGN="top"><DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">(11) </FONT></DIV>
</TD>
<TD WIDTH="96%" ALIGN="left" VALIGN="top"> <DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">Includes 161,250 shares of Common Stock issuable upon the exercise of outstanding options.</FONT></DIV>
</TD>
</TR>
</TABLE>
<DIV><FONT SIZE="1">&nbsp;</FONT></DIV>

<TABLE BORDER="0" WIDTH="100%" CELLPADDING="0" CELLSPACING="0">
<TR>
<TD WIDTH="4%" ALIGN="left" VALIGN="top"><DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">(12) </FONT></DIV>
</TD>
<TD WIDTH="96%" ALIGN="left" VALIGN="top"> <DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">Includes 140,250 shares of Common Stock issuable upon the exercise of outstanding options.</FONT></DIV>
</TD>
</TR>
</TABLE>
<DIV><FONT SIZE="1">&nbsp;</FONT></DIV>

<TABLE BORDER="0" WIDTH="100%" CELLPADDING="0" CELLSPACING="0">
<TR>
<TD WIDTH="4%" ALIGN="left" VALIGN="top"><DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">(13) </FONT></DIV>
</TD>
<TD WIDTH="96%" ALIGN="left" VALIGN="top"> <DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">Includes 83,793 shares of Common Stock issuable upon exercise of outstanding options.</FONT></DIV>
</TD>
</TR>
</TABLE>
<DIV><FONT SIZE="1">&nbsp;</FONT></DIV>

<TABLE BORDER="0" WIDTH="100%" CELLPADDING="0" CELLSPACING="0">
<TR>
<TD WIDTH="4%" ALIGN="left" VALIGN="top"><DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">(14) </FONT></DIV>
</TD>
<TD WIDTH="96%" ALIGN="left" VALIGN="top"> <DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">See Notes (7)-(13) above.</FONT></DIV>
</TD>
</TR>
</TABLE>
<DIV ALIGN="center"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times"> <B>PROPOSAL TWO:</B></FONT></DIV>
<DIV ALIGN="center"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times"><B>AMENDMENT TO AMENDED AND RESTATED ARTICLES OF INCORPORATION</B></FONT></DIV>
<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>
<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company&#146;s Amended and Restated Articles of Incorporation currently authorize the issuance of
40,000,000 shares, consisting of 35,000,000 shares of Common Stock and 5,000,000 shares of preferred stock, par value $.01 per share (&#147;Preferred Stock&#148;). The Board of Directors has adopted a resolution proposing that the Amended and
Restated Articles of Incorporation be amended to increase the authorized number of shares to 50,000,000, with an increase in the number of authorized shares of Common Stock from 35,000,000 to 45,000,000, subject to shareholder approval. The number
of shares of Preferred Stock currently authorized by the Company&#146;s Amended and Restated Articles of Incorporation will remain at 5,000,000.</FONT></DIV>
<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>
<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As of April 4, 2001, the Company had approximately 26,734,447 shares of Common Stock outstanding and
approximately 5,136,160 shares of Common Stock reserved for future issuance under the Company&#146;s stock-based plans. There are no shares of Preferred Stock outstanding. Based on the foregoing number of outstanding and reserved shares of Common
Stock, the Company currently has approximately 3,129,393 authorized but unissued and unreserved common shares remaining available for other purposes (excluding the reduction of an additional 900,000 shares that the Company is proposing to set aside
for its stock-based plans as described in Proposals Three, Four and Five in this Proxy Statement).</FONT></DIV>
<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>
<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If approved by the Company&#146;s shareholders, the first paragraph of Article 3 of the Amended and Restated
Articles of Incorporation of the Company would be amended to read as follows:</FONT></DIV>
<DIV><FONT SIZE="1">&nbsp;</FONT></DIV>

<TABLE WIDTH="100%" BORDER="0" CELLPADDING="0" CELLSPACING="0">
<TR>
<TD WIDTH="4%" ALIGN="left" VALIGN="top"></TD>
<TD ALIGN="left" VALIGN="top"> <DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&#147;The total number of shares of capital stock which the corporation is authorized to issue shall be 50,000,000 shares, consisting of
45,000,000 shares of common stock, par value $.01 per share (&#147;Common Stock&#148;), and 5,000,000 shares of preferred stock, par value $.01 per share (&#147;Preferred Stock&#148;).&#148;</FONT></DIV>
</TD>
</TR>
</TABLE>
<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>
<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">The Board of Directors believes that the availability of additional authorized but unissued shares will provide the Company with the flexibility to issue Common Stock
for a variety of corporate purposes, such as to raise equity capital through one or more private placements and/or public offerings, to make acquisitions through the use of stock, to effect future stock splits in the form of stock dividends, to
adopt additional employee benefit plans or to reserve additional shares for issuance under such plans.</FONT></DIV>
<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>
<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Board of Directors believes that the proposed increase in the authorized Common Stock would facilitate
the Company&#146;s ability to accomplish business and financial objectives in the future without delaying such activities for further shareholder approval, except as may be required in particular cases by the Company&#146;s charter documents,
applicable law or the rules of any stock exchange or national securities association trading system on which the Company&#146;s securities may then be listed. Other than as permitted or required under the Company&#146;s employee benefit plans and
under outstanding options, warrants and other securities convertible into Common Stock, the Board of Directors has no immediate plans, understandings, agreements or commitments to issue additional Common Stock for any purposes. If the Board of
Directors elects to issue additional shares of Common Stock, such issuance could have a dilutive effect on the earnings per share, book value per share, voting power and shareholdings of current shareholders. The Company reserves the right to seek a
further increase in authorized shares from time to time in the future as considered appropriate by the Board of Directors.</FONT></DIV>
<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>
<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The proposal could have an anti-takeover effect, although that is not its intention. For example, if the
Company were the subject of a hostile takeover attempt, it could try to impede the takeover by issuing shares of Common Stock, thereby diluting the voting power of the other outstanding shares and increasing the potential cost of the takeover. The
availability of this defensive strategy to the Company could discourage unsolicited takeover attempts, thereby limiting the opportunity for the Company&#146;s shareholders to realize a higher price for their shares than is generally available in the
public markets. The Board of Directors is not aware of any attempt,
or contemplated attempt, to acquire control of the Company, and this proposal is not being presented with the intent that it be utilized as a type of anti-takeover device. No change to the Company&#146;s Preferred Stock authorization is requested by
this amendment.</FONT></DIV>
<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>
<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If the proposed amendment is adopted, it will become effective upon filing of Articles of Amendment to the
Company&#146;s Amended and Restated Articles of Incorporation with the Minnesota Secretary of State.</FONT></DIV>
<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>
<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The affirmative vote of a majority of the shares of Common Stock represented at the meeting is required for
the approval of the amendment to the Amended and Restated Articles of Incorporation.</FONT></DIV>
<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>
<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times"><B>THE BOARD OF DIRECTORS RECOMMENDS A VOTE &#147;FOR&#148; THE AMENDMENT TO THE AMENDED AND RESTATED ARTICLES OF INCORPORATION.</B></FONT></DIV>
<DIV><FONT SIZE="6">&nbsp;</FONT></DIV>
<DIV ALIGN="center"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times"><B>PROPOSAL THREE:</B></FONT></DIV>
<DIV ALIGN="center"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times"><B>AMENDMENT OF 1990 STOCK OPTION PLAN</B></FONT></DIV>
<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>
<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Board of Directors has approved, subject to shareholder approval, an amendment to the Stock Option Plan
to increase the number of shares of Common Stock available for issuance thereunder from 3,750,000 shares to 4,450,000 shares. As of December 31, 2000, the Company had remaining 319,686 shares available for option grants, pursuant to the Stock Option
Plan. The Board of Directors believes that the Stock Option Plan has been and continues to be an important incentive in attracting, retaining and motivating key employees, and that it is appropriate to increase the number of shares available for
option grants and other awards under the Stock Option Plan at this time. Approval of the proposed amendment to increase the number of authorized shares under the Stock Option Plan will assure that sufficient shares are available to enable the
Compensation Committee to achieve the objectives of the Stock Option Plan to aid in maintaining and developing personnel capable of assuring the future success of the Company, to offer such personnel additional incentives to put forth maximum effort
for the success of the business and to afford them an opportunity to acquire an interest in the Company through stock options.</FONT></DIV>
<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>
<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Stock Option Plan was approved by the Board of Directors in June 1990, amended in July 1992 and June
1993 and approved by the Company&#146;s shareholders in June 1993. The Stock Option Plan was amended by the shareholders in 1996 to increase the number of shares of Common Stock available for issuance thereunder from 1,740,000 to 3,000,000 shares.
The Stock Option Plan was amended by the Board of Directors in 1997 to allow for transferability of nonincentive stock options by optionholders to members of their immediate family or trusts for the benefit of the optionholder or members of his or
her immediate family. The Stock Option Plan was further amended by the shareholders in 1998 to increase the number of shares of Common Stock available for issuance thereunder from 3,000,000 to 3,750,000 shares.</FONT></DIV>
<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>
<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Board of Directors may amend or discontinue the Stock Option Plan at any time. Subject to certain
provisions of the Stock Option Plan, no amendment of the Stock Option Plan, however, shall without shareholder approval: (i) increase the maximum number of shares under the Stock Option Plan, (ii) decrease the minimum price, (iii) extend the maximum
term, or (iv) modify the eligibility requirements for participation in the Stock Option Plan. The Board of Directors may not alter or impair any option or award previously granted under the Stock Option Plan without the consent of the holder of the
option.</FONT></DIV>
<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>
<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to the Stock Option Plan, executive officers, other full or part-time employees, consultants or
independent contractors of the Company may receive options to purchase Common Stock. The Stock Option Plan provides for the grant of both incentive stock options (&#147;ISOs&#148;) intended to qualify for preferential tax treatment under Section 422
of the Internal Revenue Code of 1986, as amended, and nonqualified stock options that do not qualify for such treatment. The exercise price of all ISOs granted under the Stock Option Plan must equal or exceed the fair market value of the Common
Stock at the time of grant. Only full or part-time employees are eligible for the grant of ISOs. The Stock Option Plan also provides for grants of stock appreciation rights (&#147;SARs&#148;), restricted stock awards and performance awards. The
Stock Option Plan is administered by the Compensation Committee; however, the Compensation Committee may delegate to the Chief Executive Officer of the Company the right to grant awards with respect to participants who are not subject to Section
16(b) of the Securities Exchange Act of 1934.</FONT></DIV>
<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>
<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;  The following is a summary of the principal federal income tax consequences generally applicable to
options and awards under the Stock Option Plan. The grant of an option is not expected to result in any tax consequences for the recipient or the Company or any subsidiary employing such individual (the &#147;employer&#148;). The holder of an ISO
generally will have no taxable income upon exercising the ISO (except that the alternative minimum tax may apply), and the employer generally will receive no tax deduction when an ISO is exercised. Upon exercise of a stock option other than an ISO,
the optionee must recognize ordinary income equal to the excess of the fair market value of the shares acquired on the date of exercise over the option price, and the employer will then be entitled to a tax deduction for the same amount. The tax
consequences to an optionee of a disposition of shares acquired through the exercise of an option will depend on how long the shares have been held and upon whether such shares were acquired by exercising an ISO or stock option other than an ISO.
Generally, there will be no tax consequence to the employer in connection with a disposition of shares acquired under an option except that the employer may be entitled to a tax deduction in the case of a disposition of shares acquired under an ISO
before the applicable ISO holding period has been satisfied.</FONT></DIV>
<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>
<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The tax consequences of the grant of an SAR are generally governed by Section 83 of the Code. At the time an
SAR is granted, an optionholder will not recognize any taxable income. At the time of exercise of an SAR the optionholder will recognize ordinary income equal to the cash or the fair market value of the shares received at such time. Any additional
gain recognized on a subsequent sale or exchange of such shares will not be compensation income but generally will qualify as a capital gain. The Company generally will be allowed an income tax deduction in the amount that, and for its taxable year
in which, the optionholder recognizes ordinary income upon the exercise of an SAR, but only if the Company properly reports such income to the Internal Revenue Service or withholds income tax upon such amount as required under the Code.</FONT></DIV>
<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>
<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The tax consequences of restricted stock and performance awards (collectively hereinafter referred to as
&#147;deferred awards&#148;) also are governed by Section 83 of the Code. At the time a deferred award is granted, a recipient will not recognize any taxable income. At the time a deferred award matures, the recipient will recognize ordinary income
equal to the cash or fair market value of the shares received at such time. Any additional gain recognized on a subsequent sale or exchange of such shares will not be compensation income but will be treated as capital gain. Section 83(b) of the Code
provides that a recipient of a restricted stock award may elect, not later than 30 days after the date the restricted stock award is originally made, to include as ordinary income the fair market value of the stock at that time. Any future
appreciation in the fair market value of the stock will be capital gain. If the stock is subsequently forfeited under the terms of the restricted stock award, the recipient will not be allowed a tax deduction with respect to such forfeiture. The
Company generally will be allowed an income tax deduction in the amount that, and for its taxable year in which, a recipient recognizes ordinary income pursuant to a restricted stock award or performance award, but only if the Corporation properly
reports such income to the Internal Revenue Service or withholds income tax upon such amount as required under the Code.</FONT></DIV>
<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>
<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Special rules apply in the case of individuals subject to Section 16(b) of the Securities Exchange Act of
1934. In particular, under current law, shares received pursuant to the exercise of a stock option, other purchase right, or SAR may be treated as restricted as to transferability and subject to a substantial risk of forfeiture for a period of up to
six months after the date of exercise. Accordingly, unless a special tax election is made, the amount of ordinary income recognized and the amount of the employer&#146;s deduction may be determined as of such date.</FONT></DIV>
<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>
<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;As of December 31, 2000, there were outstanding options to purchase an aggregate of 2,214,568 shares of
Common Stock under the Stock Option Plan, including outstanding options granted to executive officers as follows: David T. Giddings (775,000); Roy S. Johnson (225,000); Laurence L. Betterley (195,000); and James R. Miller (174,000). Future grants of
options and awards to executive officers and other employees under the Stock Option Plan are not determinable.</FONT></DIV>
<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>
<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The affirmative vote of a majority of the shares of Common Stock represented at the meeting is required for
the approval of the amendment to the Stock Option Plan.</FONT></DIV>
<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>
<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times"> <B>THE BOARD OF DIRECTORS RECOMMENDS A VOTE &#147;FOR&#148; THE AMENDMENT TO THE 1990 STOCK OPTION PLAN.</B></FONT></DIV>
<DIV><FONT SIZE="6">&nbsp;</FONT></DIV>
<DIV ALIGN="center"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times"><B>PROPOSAL FOUR:</B></FONT></DIV>
<DIV ALIGN="center"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times"><B>AMENDMENT OF 1993 DIRECTORS&#146; STOCK OPTION PLAN</B></FONT></DIV>
<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>
<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Board of Directors has approved, subject to shareholder approval, an amendment to the Directors&#146;
Plan to increase the number of shares of Common Stock available for issuance thereunder from 367,500 shares to 467,500 shares. The purpose of the Directors&#146; Plan is to attract and retain the best available individuals for service as directors
of the Company and provide additional incentive to the non-employee Directors of the Company to serve as directors. As of December 31, 2000, the Company had remaining 91,058 shares available for automatic option grants, pursuant to the
Directors&#146; Plan. In light of the Initial and Subsequent Grants of stock options pursuant to the Directors&#146; Plan, and the ability of non-employee Directors to elect to receive stock options in lieu of annual compensation and fees, the Board
of Directors believes that approval of the proposed amendment to increase the number of authorized shares under the Directors&#146; Plan will assure that sufficient shares are available to enable the Company to achieve the objectives of the
Directors&#146; Plan.</FONT></DIV>
<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>
<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Directors&#146; Plan provides for an automatic Initial Grant of nonqualified stock options to
non-employee Directors on the date such individuals become directors of the Company, and Subsequent Grants of nonqualified stock options on each subsequent annual shareholder meeting date, subject to certain limitations. The Directors&#146; Plan was
amended by the shareholders in 1996 to increase the number of shares of Common Stock subject to the Initial Grant of options thereunder from 10,000 shares to 14,500 shares and the number of shares of Common Stock subject to the Subsequent Grants of
options thereunder from 1,500 to 4,000 shares. The Board of Directors approved an amendment to the Directors&#146; Plan, effective August 14, 1997, to increase the number of shares of Common Stock subject to the Initial Grant of options thereunder
from 14,500 shares to 18,000 shares and the number of shares of Common Stock subject to the Subsequent Grants of options thereunder from 4,000 shares to 8,000 shares. Based on a review of similar plans of other public companies and the
recommendations of an independent compensation consultant to the Company, the Board of Directors believed that an increase in the number of shares subject to the Initial Grant of options and the Subsequent Grants of options under the Directors&#146;
Plan was consistent with the plans of other public companies and was desirable in order to attract qualified individuals to serve as the Company&#146;s directors. The Directors&#146; Plan was also amended to provide for transferability of options by
optionholders to members of their immediate family or trusts for the benefit of the optionholder or members of his or her immediate family. The Directors&#146; Plan was further amended by the shareholders in 1998 to increase the number of shares of
Common Stock available for issuance thereunder from 217,500 shares to 367,500 shares.</FONT></DIV>
<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>
<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Directors&#146; Plan is designed to operate automatically and not to require administration; however, to
the extent administration is necessary, it will be provided by the Board of Directors. Only non-employee Directors are eligible to participate in the Directors&#146; Plan. In the event of a merger in which the Company is not the surviving
corporation, a transfer of all of the Company&#146;s stock, a sale of substantially all of the Company&#146;s assets or a dissolution or liquidation of the Company, all outstanding options will become exercisable in full at least ten days prior to
such event on such conditions as the Board shall determine, unless the successor corporation assumes the outstanding options or substitutes substantially equivalent options.</FONT></DIV>
<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>
<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Board may at any time amend, alter, suspend, or discontinue the Directors&#146; Plan, but no amendment,
alteration, suspension or discontinuance may be made that would impair the rights of any optionholder under any grant previously made, without his or her consent. In addition, to the extent necessary and desirable to comply with Rule 16b-3 under the
Securities Exchange Act of 1934, the Company will obtain shareholder approval of any amendment in such a manner and to such a degree as required.</FONT></DIV>
<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>
<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The following is a summary of the principal federal income tax consequences generally applicable to options
and awards under the Directors&#146; Plan. The grant of an option under the Directors&#146; Plan is not expected to result in any taxable income for the recipient. Upon exercising a non-qualified stock option, the optionee must recognize ordinary
income equal to the excess of the fair market value of the shares of Common Stock acquired
on the date of exercise over the exercise price, and the Company will be entitled at that time to a tax deduction for the same amount. The tax consequence to a director upon a disposition of shares acquired through the exercise of a non-qualified
option granted under the Directors&#146; Plan will depend upon how long the shares have been held. Generally, there will be no tax consequence to the Company in connection with the disposition of shares acquired pursuant to such an
option.</FONT></DIV>
<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>
<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Special rules apply to directors under Section 16(b) of the Securities Exchange Act of 1934. Under certain
circumstances, shares received pursuant to the exercise of a stock option may be deemed restricted under the Internal Revenue Code of 1986, as amended, for a period of up to six months after the date of exercise resulting in the amount of any
ordinary income recognized, and the amount of the Company&#146;s tax deduction, being determined as of the end of such period instead of on the date of exercise.</FONT></DIV>
<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>
<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The affirmative vote of a majority of the shares of Common Stock represented at the meeting is required for
the approval of the amendment to the Directors&#146; Plan.</FONT></DIV>
<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>
<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times"><B>THE BOARD OF DIRECTORS RECOMMENDS A VOTE &#147;FOR&#148; THE AMENDMENT TO THE 1993 DIRECTORS&#146; STOCK OPTION PLAN.</B></FONT></DIV>
<DIV><FONT SIZE="6">&nbsp;</FONT></DIV>
<DIV ALIGN="center"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times"><B>PROPOSAL FIVE:</B></FONT></DIV>
<DIV ALIGN="center"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times"><B>AMENDMENT OF 1995 EMPLOYEE STOCK PURCHASE PLAN</B></FONT></DIV>
<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>
<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Board of Directors has approved, subject to shareholder approval, an amendment to the Employee Stock
Purchase Plan (the &#147;Stock Purchase Plan&#148;) to increase the number of shares of Common Stock available for issuance thereunder from 300,000 to 400,000 shares. Of the 300,000 shares currently authorized for issuance pursuant to the Stock
Purchase Plan, 38,842 shares are available to the Company for future issuance. The Board of Directors believes that an increase in the authorized shares under the Stock Purchase Plan is desirable to allow continued employee ownership participation
in the Company for the next several years.</FONT></DIV>
<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>
<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Stock Purchase Plan was originally approved by the Board of Directors in April 1995 and by the
shareholders of the Company in June 1995. The purpose of the Stock Purchase Plan is to provide employees of the Company with an opportunity to share in the ownership of the Company by providing them with a convenient means for regular and systematic
purchases of Common Stock, and, thus, to develop a stronger incentive to work for the continued success of the Company. The Stock Purchase Plan is intended to qualify under Section 423 of the Code.</FONT></DIV>
<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>
<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Under the Stock Purchase Plan, an eligible employee (including executive officers of the Company) may
purchase shares of Common Stock from the Company through payroll deductions of up to 10% of their base compensation at a price per share equal to 85% of the lesser of the fair market value (based on the Nasdaq Stock Market closing price) of the
Company&#146;s Common Stock as of the first day or the last day of each three-month offering period under the Stock Purchase Plan. The offering periods commence on January 1, April 1, July 1 and October 1 of each year. The first purchase period
commenced on July 1, 1995.</FONT></DIV>
<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>
<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Stock Purchase Plan is administered by the Company&#146;s Compensation Committee. All questions of
interpretation of the Stock Purchase Plan will be determined by the Committee. Any employee who is customarily employed for at least 20 hours per week by the Company, and who does not own five percent or more of the total combined voting power or
value of all classes of the Company&#146;s outstanding capital stock, is eligible to participate in the Stock Purchase Plan, provided that the employee has been employed for at least 90 days prior to the commencement date of an offering
period.</FONT></DIV>
<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>
<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The maximum number of shares that a participant may purchase on the last day of any offering period is
determined by dividing the participant&#146;s payroll deductions accumulated during the offering period by the purchase price. However, no person may purchase shares under this or any other employee stock purchase plan of the Company to the extent
that purchases pursuant to such employee stock purchase plans accrue a right to purchase shares at a rate that exceeds $25,000 worth of stock (determined based on fair market value of the shares on the first day of the offering period) for any
calendar year and no more than 2,000 shares may be purchase under the Stock Purchase Plan by any participant during any purchase period.</FONT></DIV>
<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>
<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;  Payroll deductions under the Stock Purchase Plan will be reportable by a participant as a part of the
participant&#146;s income for the year in which such amounts would otherwise have been paid. The participant will not have any additional taxable income at the time shares are purchased under the Stock Purchase Plan, even though the purchase will be
made for less than fair market value. A participant may have taxable income in the year in which a sale or other disposition of the purchased shares is made, depending upon the circumstances. If the shares have been held by the participant for more
than two years after the offering date and more than one year after the purchase date, the lesser of: (a) the excess of the fair market value of the shares at the time of such disposition over the purchase price, or (b) the excess of the fair market
value of the shares at the time the option was granted over the purchase price (which purchase price will be computed as of the grant date) will be treated as ordinary income, and any further gain will be treated as long-term capital gain. If the
shares are disposed of before the expiration of these holding periods, the excess of the fair market value of the shares on the purchase date over the purchase price generally will be treated as ordinary income, and any further gain or any loss on
such disposition will be long-term or short-term capital gain or loss, depending on the holding period. Generally, there will be no tax consequences to the Company in connection with the issuance of shares under the Stock Purchase Plan, except that
the Company may be entitled to a tax deduction in the case of a participant&#146;s disposition of shares acquired under the Stock Purchase Plan before the applicable holding period for tax purposes has been satisfied.</FONT></DIV>
<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>
<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Board of Directors may amend or discontinue the Stock Purchase Plan at any time. Subject to certain
provisions of the Stock Purchase Plan, no amendment of the Stock Purchase Plan, however, shall without shareholder approval: (i) cause Rule 16b-3 under the Securities Exchange Act of 1934 to become available with respect to the Stock Purchase Plan,
(ii) require shareholder approval under any rules or regulation of the National Association of Securities Dealers, Inc. or any securities exchange that are applicable to the Company, or (iii) permit the issuance of Common Stock before payment
therefore in full.</FONT></DIV>
<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>
<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;An aggregate of 31,066 shares have been issued under the Stock Purchase Plan to the executive officers of
the Company as follows: David T. Giddings (7,164); Roy S. Johnson (4,093); Laurence L. Betterley (15,066); and James R. Miller (4,743). The number of shares which may be purchased in the future under the Stock Purchase Plan is not
determinable.</FONT></DIV>
<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>
<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The affirmative vote of a majority of the shares of Common Stock represented at the meeting is required for
the approval of the amendment to the Stock Purchase Plan.</FONT></DIV>
<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>
<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times"><B>THE BOARD OF DIRECTORS RECOMMENDS A VOTE &#147;FOR&#148; THE AMENDMENT TO THE 1995 EMPLOYEE STOCK PURCHASE PLAN.</B></FONT></DIV>
<DIV><FONT SIZE="6">&nbsp;</FONT></DIV>
<DIV ALIGN="center"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times"><B>AUDIT COMMITTEE REPORT</B></FONT></DIV>
<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>


<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Audit Committee of the Company&#146;s Board of Directors is composed of the following nonemployee
directors: Gerald L. Cohn, Andr&#233; de Bruin and Carl S. Goldfischer. All of the members of the Audit Committee meet the independence requirements of the applicable Nasdaq listing standards. The Audit Committee operates under a written charter
adopted by the Board of Directors, a copy of which is attached to this Proxy Statement as <I>Exhibit A</I>. The Audit Committee recommends to the Board of Directors the selection of the Company&#146;s independent certified public
accountants.</FONT></DIV>

<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>


<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Management is responsible for the Company&#146;s internal controls and the financial reporting process. The
Company&#146;s independent certified public accountants are responsible for performing an independent audit of the Company&#146;s financial statements in accordance with auditing standards generally accepted in the United States of America and to
issue a report thereon. The Audit Committee&#146;s responsibility is to monitor and oversee these processes.</FONT></DIV>

<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>


<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;  In this context, the Audit Committee has met and held discussions with management and the independent
certified public accountants. Management represented to the Audit Committee that the Company&#146;s consolidated financial statements were prepared in accordance with accounting principles generally accepted in the United States of America, and the
Audit Committee has reviewed and discussed the consolidated financial statements with management and the independent certified public accountants. The Audit Committee discussed with the independent certified public accountants matters required to be
discussed by <I>Statement on Auditing Standards No. 61 (Communications with Audit Committees</I>).</FONT></DIV>

<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>


<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company&#146;s independent certified public accountants also provided to the Audit Committee the written
disclosures required by <I>Independence Standards Board Standard No. 1 (Independence Discussions with Audit Committees</I>), and the Audit Committee discussed with the independent certified public accountants that firm&#146;s independence. The Audit
Committee also considered whether the provision of any nonaudit services was compatible with maintaining the independence of KPMG LLP as the Company&#146;s independent certified public accountants.</FONT></DIV>

<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>


<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Based upon the Audit Committee&#146;s discussion with management and the independent certified public
accountants and the Audit Committee&#146;s review of the representation of management and the report of the independent certified public accountants to the Audit Committee, the Audit Committee recommended that the Board of Directors include the
audited consolidated financial statements in the Company&#146;s Annual Report on Form 10-K for the year ended December 31, 2000 filed with the Securities and Exchange Commission.</FONT></DIV>

<DIV><FONT SIZE="5">&nbsp;</FONT></DIV>

<TABLE WIDTH="100%" BORDER="0" CELLPADDING="0" CELLSPACING="0">
<TR>
<TD WIDTH="52%" ALIGN="left" VALIGN="top"></TD>
<TD ALIGN="left" VALIGN="top"> <DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">GERALD L. COHN</FONT></DIV>
</TD>
</TR>
</TABLE>

<TABLE WIDTH="100%" BORDER="0" CELLPADDING="0" CELLSPACING="0">
<TR>
<TD WIDTH="52%" ALIGN="left" VALIGN="top"></TD>
<TD ALIGN="left" VALIGN="top"> <DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">ANDRE DE BRUIN</FONT></DIV>
</TD>
</TR>
</TABLE>

<TABLE WIDTH="100%" BORDER="0" CELLPADDING="0" CELLSPACING="0">
<TR>
<TD WIDTH="52%" ALIGN="left" VALIGN="top"></TD>
<TD ALIGN="left" VALIGN="top"> <DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">CARL S. GOLDFISCHER</FONT></DIV>
</TD>
</TR>
</TABLE>

<TABLE WIDTH="100%" BORDER="0" CELLPADDING="0" CELLSPACING="0">
<TR>
<TD WIDTH="52%" ALIGN="left" VALIGN="top"></TD>
<TD ALIGN="left" VALIGN="top"> <DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">The Members of the Audit Committee</FONT></DIV>
</TD>
</TR>
</TABLE>

<TABLE WIDTH="100%" BORDER="0" CELLPADDING="0" CELLSPACING="0">
<TR>
<TD WIDTH="52%" ALIGN="left" VALIGN="top"></TD>
<TD ALIGN="left" VALIGN="top"> <DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">of the Board of Directors</FONT></DIV>
</TD>
</TR>
</TABLE>
<DIV><FONT SIZE="6">&nbsp;</FONT></DIV>
<DIV ALIGN="center"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times"><B>APPOINTMENT OF INDEPENDENT AUDITORS</B></FONT></DIV>
<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>
<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Board of Directors has appointed KPMG LLP as independent auditors for the Company for the fiscal year
ending December 31, 2001. KPMG LLP has served as the Company&#146;s independent auditors since 1990 and has no relationship with the Company other than that arising from its employment as independent auditors. Representatives of KPMG LLP are
expected to be present at the Annual Meeting, will have an opportunity to make a statement if they desire to do so, and will be available to respond to appropriate questions from shareholders.</FONT></DIV>
<DIV><FONT SIZE="5">&nbsp;</FONT></DIV>

<TABLE BORDER="0" WIDTH="100%" CELLPADDING="0" CELLSPACING="0">
<TR>
<TD WIDTH="4%" ALIGN="left" VALIGN="top"></TD>
<TD WIDTH="96%" ALIGN="left" VALIGN="top"> <DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times"><I>Audit Fees</I></FONT></DIV>
</TD>
</TR>
</TABLE>
<DIV><FONT SIZE="1">&nbsp;</FONT></DIV>


<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Audit fees billed to the Company by KPMG LLP for review of the Company&#146;s financial statements for the
fiscal year ended December 31, 2000 and the financial statements included in the Company&#146;s quarterly reports on Form 10-Q for the last fiscal year totaled $89,500.</FONT></DIV>

<DIV><FONT SIZE="5">&nbsp;</FONT></DIV>

<TABLE BORDER="0" WIDTH="100%" CELLPADDING="0" CELLSPACING="0">
<TR>
<TD WIDTH="4%" ALIGN="left" VALIGN="top"></TD>
<TD WIDTH="96%" ALIGN="left" VALIGN="top"> <DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times"><I>Financial Information Systems Design and Implementation Fees</I></FONT></DIV>
</TD>
</TR>
</TABLE>
<DIV><FONT SIZE="1">&nbsp;</FONT></DIV>
<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Company did not engage KPMG LLP to provide advice to the Company regarding financial information systems
design and implementation during 2000.</FONT></DIV>
<DIV><FONT SIZE="5">&nbsp;</FONT></DIV>

<TABLE BORDER="0" WIDTH="100%" CELLPADDING="0" CELLSPACING="0">
<TR>
<TD WIDTH="4%" ALIGN="left" VALIGN="top"></TD>
<TD WIDTH="96%" ALIGN="left" VALIGN="top"> <DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times"><I>All Other Fees</I></FONT></DIV>
</TD>
</TR>
</TABLE>
<DIV><FONT SIZE="1">&nbsp;</FONT></DIV>


<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Fees billed to the Company by KPMG LLP for all other nonaudit services rendered to the Company during 2000,
including tax services, totaled $28,783.</FONT></DIV>

<DIV><FONT SIZE="1">&nbsp;</FONT></DIV>
<DIV ALIGN="center"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times"> <B>PROPOSALS FOR THE NEXT ANNUAL MEETING</B></FONT></DIV>
<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>


<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Pursuant to federal securities laws, any proposal by a shareholder to be presented at the 2002 Annual
Meeting of Shareholders and to be included in the Company&#146;s proxy statement and form of proxy must be received at the Company&#146;s executive offices, 2658 Patton Road, Roseville, Minnesota 55113, no later than the close of business on
December 26, 2001. Proposals should be sent to the attention of the Secretary. Pursuant to the Company&#146;s Bylaws, in order for business to be properly brought before the next annual meeting by a shareholder, the shareholder must give written
notice of such shareholder&#146;s intent to bring a matter before the annual meeting no later than February 23, 2002. Each such notice should be sent to the attention of the Secretary, and must set forth certain information with respect to the
shareholder who intends to bring such matter before the meeting and the business desired to be conducted, as set forth in greater detail in the Company&#146;s Bylaws. The Company intends to exercise its discretionary authority with respect to any
matter not properly presented by such date in accordance with the proxy rules adopted under the Securities Exchange Act of 1934.</FONT></DIV>

<DIV><FONT SIZE="5">&nbsp;</FONT></DIV>

<TABLE WIDTH="100%" BORDER="0" CELLPADDING="0" CELLSPACING="0">
<TR>
<TD WIDTH="52%" ALIGN="left" VALIGN="top"></TD>
<TD ALIGN="left" VALIGN="top"> <DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">BY ORDER OF THE BOARD OF DIRECTORS</FONT></DIV>
</TD>
</TR>
</TABLE>
<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>

<TABLE WIDTH="100%" BORDER="0" CELLPADDING="0" CELLSPACING="0">
<TR>
<TD WIDTH="52%" ALIGN="left" VALIGN="top"></TD>
<TD ALIGN="left" VALIGN="top"> <DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times"> </FONT></DIV>
</TD>
</TR>
</TABLE>

<TABLE WIDTH="100%" BORDER="0" CELLPADDING="0" CELLSPACING="0">
<TR>
<TD WIDTH="52%" ALIGN="left" VALIGN="top"></TD>
<TD ALIGN="left" WIDTH="48%" VALIGN="top"> <DIV ALIGN="left"><FONT SIZE="1" COLOR="#000000" FACE="'Times New Roman', Times">/s/&nbsp;&nbsp;&nbsp;&nbsp; Kenneth L. Cutler</FONT></DIV>
</TD>
</TR>
</TABLE>

<TABLE WIDTH="100%" BORDER="0" CELLPADDING="0" CELLSPACING="0">
<TR>
<TD WIDTH="52%" ALIGN="left" VALIGN="top"></TD>
<TD ALIGN="left" VALIGN="top"> <DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">Kenneth L. Cutler</FONT></DIV>
</TD>
</TR>
</TABLE>

<TABLE WIDTH="100%" BORDER="0" CELLPADDING="0" CELLSPACING="0">
<TR>
<TD WIDTH="52%" ALIGN="left" VALIGN="top"></TD>
<TD ALIGN="left" VALIGN="top"> <DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times"><I>Secretary</I></FONT></DIV>
</TD>
</TR>
</TABLE>
<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>


<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">April 24, 2001</FONT></DIV>

<DIV><FONT SIZE="1">&nbsp;</FONT></DIV>
<DIV ALIGN="center"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times"> <B>EXHIBIT A</B></FONT></DIV>
<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>
<DIV ALIGN="center"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times"><B>AUDIT COMMITTEE CHARTER</B></FONT></DIV>
<DIV><FONT SIZE="5">&nbsp;</FONT></DIV>
<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times"><B>Mission Statement</B></FONT></DIV>
<DIV><FONT SIZE="1">&nbsp;</FONT></DIV>
<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Audit Committee (&#147;the Committee&#148;) will assist the Board of Directors in achieving its
oversight and monitoring responsibilities to the stockholders relating to corporate accounting, financial controls and financial reporting practices of the Company.</FONT></DIV>
<DIV><FONT SIZE="5">&nbsp;</FONT></DIV>
<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times"><B>Organization</B></FONT></DIV>
<DIV><FONT SIZE="1">&nbsp;</FONT></DIV>
<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The members of the Committee and its Chairperson shall be elected by the Board of Directors. The Committee
shall be composed of at least three directors. The members of the Committee shall meet the independence and financial literacy and experience requirements set forth in the corporate governance standards of The Nasdaq Stock Market, Inc., (Nasdaq) as
from time to time amended or supplemented, or similar requirements of such other securities exchange or quotation system as may from time to time apply to the Company. A director who does not meet these requirements may be appointed to the
Committee, if the Board, under exceptional and limited circumstances, determines that the individual&#146;s membership on the Committee is in the best interests of the Company and its stockholders, if permitted under applicable Nasdaq
rules.</FONT></DIV>
<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>


<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Committee should meet with management and the independent certified public accountants in separate
executive sessions, as necessary or appropriate, to discuss any matters that the Committee or any of these groups believe should be discussed privately. The Committee may ask members of management or others to attend the meetings and provide
pertinent information as necessary.</FONT></DIV>

<DIV><FONT SIZE="5">&nbsp;</FONT></DIV>
<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times"><B>Responsibilities</B></FONT></DIV>
<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>


<TABLE WIDTH="100%" BORDER="0" CELLPADDING="0" CELLSPACING="0">
<TR>
<TD WIDTH="4%" ALIGN="left" VALIGN="top"></TD>
<TD WIDTH="4%" ALIGN="left" VALIGN="top"><DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times"></FONT><FONT SIZE="2" COLOR="#000000" FACE="Wingdings">&#159;</FONT><FONT SIZE="2" COLOR="#000000"
FACE="'Times New Roman', Times"> </FONT></DIV>
</TD>
<TD WIDTH="92%" ALIGN="left" VALIGN="top"> <DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">Review the performance and independence of the independent certified public accountants and annually recommend to the Board
of Directors the appointment of the independent certified public accountants, and, when appropriate, recommend their replacement. Also, approve the fees and other significant compensation to be paid to the independent certified public accountants.
The Committee and the Board of Directors have the ultimate authority and responsibility with respect to these matters, as representatives of the stockholders of the Company. The independent certified public accountants shall be ultimately
accountable to the Board of Directors and the Committee.</FONT></DIV>
</TD>
</TR>
</TABLE>

<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>


<TABLE WIDTH="100%" BORDER="0" CELLPADDING="0" CELLSPACING="0">
<TR>
<TD WIDTH="4%" ALIGN="left" VALIGN="top"></TD>
<TD WIDTH="4%" ALIGN="left" VALIGN="top"><DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times"></FONT><FONT SIZE="2" COLOR="#000000" FACE="Wingdings">&#159;</FONT><FONT SIZE="2" COLOR="#000000"
FACE="'Times New Roman', Times"> </FONT></DIV>
</TD>
<TD WIDTH="92%" ALIGN="left" VALIGN="top"> <DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">Ensure receipt from the independent certified public accountants of a formal written statement delineating all relationships
between the certified public accountants and the Company, consistent with Independence Standards Board Standard No. 1.</FONT></DIV>
</TD>
</TR>
</TABLE>

<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>


<TABLE WIDTH="100%" BORDER="0" CELLPADDING="0" CELLSPACING="0">
<TR>
<TD WIDTH="4%" ALIGN="left" VALIGN="top"></TD>
<TD WIDTH="4%" ALIGN="left" VALIGN="top"><DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times"></FONT><FONT SIZE="2" COLOR="#000000" FACE="Wingdings">&#159;</FONT><FONT SIZE="2" COLOR="#000000"
FACE="'Times New Roman', Times"> </FONT></DIV>
</TD>
<TD WIDTH="92%" ALIGN="left" VALIGN="top"> <DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">Actively engage in dialogue with the independent certified public accountants with respect to any disclosed relationships or
services that may impact the objectivity and independence of the certified public accountants and take, or recommend that the full Board of Directors take, appropriate action to oversee the independence of the certified public
accountants.</FONT></DIV>
</TD>
</TR>
</TABLE>

<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>


<TABLE WIDTH="100%" BORDER="0" CELLPADDING="0" CELLSPACING="0">
<TR>
<TD WIDTH="4%" ALIGN="left" VALIGN="top"></TD>
<TD WIDTH="4%" ALIGN="left" VALIGN="top"><DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times"></FONT><FONT SIZE="2" COLOR="#000000" FACE="Wingdings">&#159;</FONT><FONT SIZE="2" COLOR="#000000"
FACE="'Times New Roman', Times"> </FONT></DIV>
</TD>
<TD WIDTH="92%" ALIGN="left" VALIGN="top"> <DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">Meet with the independent certified public accountants and financial management to review the scope of the proposed
independent audit for the current year and the audit procedures to be utilized, and, at the conclusion thereof, review the results of such audit.</FONT></DIV>
</TD>
</TR>
</TABLE>

<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>


<TABLE WIDTH="100%" BORDER="0" CELLPADDING="0" CELLSPACING="0">
<TR>
<TD WIDTH="4%" ALIGN="left" VALIGN="top"></TD>
<TD WIDTH="4%" ALIGN="left" VALIGN="top"><DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times"></FONT><FONT SIZE="2" COLOR="#000000" FACE="Wingdings">&#159;</FONT><FONT SIZE="2" COLOR="#000000"
FACE="'Times New Roman', Times"> </FONT></DIV>
</TD>
<TD WIDTH="92%" ALIGN="left" VALIGN="top"> <DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">Review with management and the independent certified public accountants, as appropriate:</FONT></DIV>
</TD>
</TR>
</TABLE>

<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>


<TABLE WIDTH="100%" BORDER="0" CELLPADDING="0" CELLSPACING="0">
<TR>
<TD WIDTH="8%" ALIGN="left" VALIGN="top"></TD>
<TD WIDTH="4%" ALIGN="left" VALIGN="top"><DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times"></FONT><FONT SIZE="2" COLOR="#000000" FACE="Wingdings">&#159;</FONT><FONT SIZE="2" COLOR="#000000"
FACE="'Times New Roman', Times"> </FONT></DIV>
</TD>
<TD WIDTH="88%" ALIGN="left" VALIGN="top"> <DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">Financial statements and related footnotes and the independent certified public accountants&#146; report thereon, including
their report on the adequacy and quality of systems of internal control and any significant recommendations they may offer to improve controls.</FONT></DIV>
</TD>
</TR>
</TABLE>

<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>


<TABLE WIDTH="100%" BORDER="0" CELLPADDING="0" CELLSPACING="0">
<TR>
<TD WIDTH="8%" ALIGN="left" VALIGN="top"></TD>
<TD WIDTH="4%" ALIGN="left" VALIGN="top"><DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times"></FONT><FONT SIZE="2" COLOR="#000000" FACE="Wingdings">&#159;</FONT><FONT SIZE="2" COLOR="#000000"
FACE="'Times New Roman', Times"> </FONT></DIV>
</TD>
<TD WIDTH="88%" ALIGN="left" VALIGN="top"> <DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">The independent certified public accountants&#146; judgments about the quality and appropriateness of the Company&#146;s
accounting principles as applied in financial reporting.</FONT></DIV>
</TD>
</TR>
</TABLE>

<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>

<TABLE WIDTH="100%" BORDER="0" CELLPADDING="0" CELLSPACING="0">
<TR>
<TD WIDTH="8%" ALIGN="left" VALIGN="top"></TD>
<TD WIDTH="4%" ALIGN="left" VALIGN="top"><DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times"></FONT><FONT SIZE="2" COLOR="#000000" FACE="Wingdings">&#159;</FONT><FONT SIZE="2" COLOR="#000000"
FACE="'Times New Roman', Times"> </FONT></DIV>
</TD>
<TD WIDTH="88%" ALIGN="left" VALIGN="top"> <DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">The adequacy of system internal controls over financial reporting and the safeguarding of assets and compliance with laws and
regulations.</FONT></DIV>
</TD>
</TR>
</TABLE>
<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>


<TABLE WIDTH="100%" BORDER="0" CELLPADDING="0" CELLSPACING="0">
<TR>
<TD WIDTH="8%" ALIGN="left" VALIGN="top"></TD>
<TD WIDTH="4%" ALIGN="left" VALIGN="top"><DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times"> </FONT><FONT SIZE="2" COLOR="#000000" FACE="Wingdings">&#159;</FONT><FONT SIZE="2" COLOR="#000000"
FACE="'Times New Roman', Times"> </FONT></DIV>
</TD>
<TD WIDTH="88%" ALIGN="left" VALIGN="top"> <DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">Any serious difficulties or disputes with management encountered by the independent certified public accountants during the
course of the audit and any instances of second opinions sought by management.</FONT></DIV>
</TD>
</TR>
</TABLE>

<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>

<TABLE WIDTH="100%" BORDER="0" CELLPADDING="0" CELLSPACING="0">
<TR>
<TD WIDTH="8%" ALIGN="left" VALIGN="top"></TD>
<TD WIDTH="4%" ALIGN="left" VALIGN="top"><DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times"></FONT><FONT SIZE="2" COLOR="#000000" FACE="Wingdings">&#159;</FONT><FONT SIZE="2" COLOR="#000000"
FACE="'Times New Roman', Times"> </FONT></DIV>
</TD>
<TD WIDTH="88%" ALIGN="left" VALIGN="top"> <DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">Other matters related to the conduct of the external audit which are communicated to the Committee under generally accepted
auditing standards.</FONT></DIV>
</TD>
</TR>
</TABLE>
<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>


<TABLE WIDTH="100%" BORDER="0" CELLPADDING="0" CELLSPACING="0">
<TR>
<TD WIDTH="8%" ALIGN="left" VALIGN="top"></TD>
<TD WIDTH="4%" ALIGN="left" VALIGN="top"><DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times"></FONT><FONT SIZE="2" COLOR="#000000" FACE="Wingdings">&#159;</FONT><FONT SIZE="2" COLOR="#000000"
FACE="'Times New Roman', Times"> </FONT></DIV>
</TD>
<TD WIDTH="88%" ALIGN="left" VALIGN="top"> <DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">Any significant matters that are identified during the certified public accountants&#146; interim review of quarterly
financial statements.</FONT></DIV>
</TD>
</TR>
</TABLE>

<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>

<TABLE WIDTH="100%" BORDER="0" CELLPADDING="0" CELLSPACING="0">
<TR>
<TD WIDTH="4%" ALIGN="left" VALIGN="top"></TD>
<TD WIDTH="4%" ALIGN="left" VALIGN="top"><DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times"></FONT><FONT SIZE="2" COLOR="#000000" FACE="Wingdings">&#159;</FONT><FONT SIZE="2" COLOR="#000000"
FACE="'Times New Roman', Times"> </FONT></DIV>
</TD>
<TD WIDTH="92%" ALIGN="left" VALIGN="top"> <DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">Prepare a report to stockholders as required by the Securities and Exchange Commission to be included in the Company&#146;s
annual proxy statement.</FONT></DIV>
</TD>
</TR>
</TABLE>
<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>

<TABLE WIDTH="100%" BORDER="0" CELLPADDING="0" CELLSPACING="0">
<TR>
<TD WIDTH="4%" ALIGN="left" VALIGN="top"></TD>
<TD WIDTH="4%" ALIGN="left" VALIGN="top"><DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times"></FONT><FONT SIZE="2" COLOR="#000000" FACE="Wingdings">&#159;</FONT><FONT SIZE="2" COLOR="#000000"
FACE="'Times New Roman', Times"> </FONT></DIV>
</TD>
<TD WIDTH="92%" ALIGN="left" VALIGN="top"> <DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">Maintain minutes or other records of meetings and activities of the Committee.</FONT></DIV>
</TD>
</TR>
</TABLE>
<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>

<TABLE WIDTH="100%" BORDER="0" CELLPADDING="0" CELLSPACING="0">
<TR>
<TD WIDTH="4%" ALIGN="left" VALIGN="top"></TD>
<TD WIDTH="4%" ALIGN="left" VALIGN="top"><DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times"></FONT><FONT SIZE="2" COLOR="#000000" FACE="Wingdings">&#159;</FONT><FONT SIZE="2" COLOR="#000000"
FACE="'Times New Roman', Times"> </FONT></DIV>
</TD>
<TD WIDTH="92%" ALIGN="left" VALIGN="top"> <DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">Report Committee actions to the Board of Directors with such recommendations as the Committee may deem
appropriate.</FONT></DIV>
</TD>
</TR>
</TABLE>
<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>

<TABLE WIDTH="100%" BORDER="0" CELLPADDING="0" CELLSPACING="0">
<TR>
<TD WIDTH="4%" ALIGN="left" VALIGN="top"></TD>
<TD WIDTH="4%" ALIGN="left" VALIGN="top"><DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times"></FONT><FONT SIZE="2" COLOR="#000000" FACE="Wingdings">&#159;</FONT><FONT SIZE="2" COLOR="#000000"
FACE="'Times New Roman', Times"> </FONT></DIV>
</TD>
<TD WIDTH="92%" ALIGN="left" VALIGN="top"> <DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">Review the Committee&#146;s charter on an annual basis and update as necessary.</FONT></DIV>
</TD>
</TR>
</TABLE>
<DIV><FONT SIZE="2">&nbsp;</FONT></DIV>


<DIV ALIGN="left"><FONT SIZE="2" COLOR="#000000" FACE="'Times New Roman', Times">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The responsibilities of a member of the Committee are in addition to those for a member of the Board of
Directors. While the Committee has the responsibility and powers set forth in this charter, it is not the duty of the Committee to plan or conduct audits or to determine that the Company&#146;s financial statements are complete and accurate and are
in compliance with generally accepted accounting principles. This is the responsibility of management and the independent certified public accountants. Also, it is not the duty of the Committee to conduct investigations, to resolve disagreements, if
any, between management and the independent certified public accountants or to assure compliance with laws and regulations or the Company&#146;s corporate policies.</FONT></DIV>

<DIV><FONT SIZE="3">&nbsp;</FONT></DIV>
<P> </P>
<P ALIGN="right"><FONT FACE="Times New Roman, Times, serif" SIZE="2"><I>Appendix A</I> </FONT></P>
<P ALIGN="center"> <FONT FACE="Times New Roman, Times, serif" SIZE="2"><B>DIAMETRICS MEDICAL, INC.
<BR>
AMENDED AND RESTATED</B>
<BR>
<B>1990 STOCK OPTION PLAN</B>
<BR>
(<B>as amended May 23, 2001)</B></FONT> </P>
<P> <FONT FACE="Times New Roman, Times, serif" SIZE="2">1.&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Purpose of Plan.</U></FONT> </P>
<P> <FONT FACE="Times New Roman, Times, serif" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;This Plan shall be known as the &#147;<B>DIAMETRICS MEDICAL, INC. 1990 STOCK OPTION PLAN</B>&#148; and is
hereinafter referred to as the &#147;Plan.&#148; The purpose of the Plan is to aid in maintaining and developing personnel capable of assuring the future success of Diametrics Medical, Inc., a Minnesota corporation (the &#147;Company&#148;), to
offer such personnel additional incentives to put forth maximum efforts for the success of the business, and to afford them an opportunity to acquire a proprietary interest in the Company through stock options and other long-term incentive awards as
provided herein. Options granted under this Plan may be either incentive stock options (&#147;Incentive Stock Options&#148;) within the meaning of Section 422 of the Internal Revenue Code of 1986 (the &#147;Code&#148;), or options which do not
qualify as Incentive Stock Options. Awards granted under this Plan shall be<B> </B>SARs,<B> </B>restricted stock or performance awards as hereinafter described.</FONT> </P>
<P> <FONT FACE="Times New Roman, Times, serif" SIZE="2">2.&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Stock Subject to Plan.</U></FONT> </P>
<P> <FONT FACE="Times New Roman, Times, serif" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Subject to the provisions of Section 15 hereof, the stock to be subject to options or other awards under the Plan
shall be the Company's authorized but unissued shares of Common Stock, par value $.01 per share. Such shares may be either authorized but unissued shares, or issued shares which have been reacquired by the Company. Subject to adjustment as provided
in Section 15 hereof, the maximum number of shares on which options may be exercised or other awards issued under this Plan shall be 4,450,000 shares. If an option or award under the Plan expires, or for any reason is terminated or unexercised with
respect to any shares, such shares shall again be available for options or awards thereafter granted during the term of the Plan.</FONT> </P>
<P> <FONT FACE="Times New Roman, Times, serif" SIZE="2">3&nbsp;. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Administration of Plan.</U></FONT> </P>
<P> <FONT FACE="Times New Roman, Times, serif" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The Plan shall be administered by a committee (the
&#147;Committee&#148;) of two or more members of the Board of Directors of the Company, none of whom shall be officers or employees of the Company and all of whom shall be &#147;disinterested persons&#148; with respect to the Plan within the meaning
of Rule 16b-3 under the Securities Exchange Act of 1934, as amended (the &#147;Exchange Act&#148;), or any successor rule or regulation thereto. The members of any such committee shall be appointed by and serve at the pleasure of the Board of
Directors.</FONT> </P>
<P> <FONT FACE="Times New Roman, Times, serif" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The Committee shall have plenary authority in its discretion,
but subject to the express provisions of the Plan: (i) to determine the purchase price of the Common Stock covered by each option or award, (ii) to determine the employees to whom and the time or times at which such options</FONT> <FONT
FACE="Times New Roman, Times, serif" SIZE="2">and awards shall be granted and the number of shares to be subject to each, (iii) to </FONT></P>
<P ALIGN="center"><FONT FACE="Times New Roman, Times, serif" SIZE="2">-1-</FONT></P>

<P ALIGN="left"></P>
<P><FONT FACE="Times New Roman, Times, serif" SIZE="2">determine the form of payment to be made upon the exercise of an SAR or in connection with performance awards, either cash, Common Stock of the Company or a combination thereof, (iv) to
determine the terms of exercise of each option and award, (v) to accelerate the time at which all or any part of an option or award may be exercised, (vi) to amend or modify the terms of any option or award with the consent of the optionee, (vii) to
interpret the Plan, (viii) to prescribe, amend and rescind rules and regulations relating to the Plan, (ix) to determine the terms and provisions of each option and award agreement under the Plan (which agreements need not be identical), including
the designation of those options intended to be Incentive Stock Options, and (x) to make all other determinations necessary or advisable for the administration of the Plan, subject to the exclusive authority of the Board of Directors under Section
16 herein to amend or terminate the Plan.</FONT> </P>
<P> <FONT FACE="Times New Roman, Times, serif" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Committee shall select one of its members as its Chairman
and shall hold its meetings at such times and places as it may determine. A majority of its members shall constitute a quorum, provided that if the Committee is comprised of no more than two members, all of its members must be present to constitute
a quorum. All determinations of the Committee shall be made by not less than a majority of its members, provided that if the Committee is comprised of no more than two members, such determinations may not be made by less than all of its members. Any
decision or determination reduced to writing and signed by all of the members of the Committee shall be fully effective as if it had been made by a majority vote at a meeting duly called and held. The grant of an option or award shall be effective
only if a written agreement shall have been duly executed and delivered by and on behalf of the Company following such grant. The Committee may appoint a Secretary and may make such rules and regulations for the conduct of business as it shall deem
advisable.</FONT> </P>
<P> <FONT FACE="Times New Roman, Times, serif" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Chief Executive Officer of the Company shall have the
authority, as granted by the Committee pursuant to clause (ix) of subsection (b) of this Section 3, to grant, pursuant to the Plan, options or other awards to eligible persons who are not considered by the Company as its officers or directors for
purposes of Section 16 of the Securities Exchange Act of 1934, as amended. The Chief Executive Officer of the Company shall provide information as to any grants made pursuant to this subsection to the Committee at their next meeting.</FONT> </P>
<P> <FONT FACE="Times New Roman, Times, serif" SIZE="2">4.&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Eligibility.</U></FONT> </P>
<P> <FONT FACE="Times New Roman, Times, serif" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Incentive Stock Options may only be granted under this Plan to any full or part-time employee (which term as used
herein includes, but is not limited to, officers and directors who are also employees) of the Company and of its present and future subsidiary corporations within the meaning of Section 424(f) of the Code (herein called &#147;subsidiaries&#148;).
Full or part-time employees, consultants or independent contractors to the Company or one of its subsidiaries shall be eligible to receive options which do not qualify as Incentive Stock Options and awards. In determining the persons to whom options
and awards shall be granted and the number of shares subject to each, the Committee may take into account the nature of services rendered by the respective employees or consultant their present and</FONT> <FONT FACE="Times New Roman, Times, serif"
SIZE="2">potential contributions to the success of the Company and such other factors as the Committee in its discretion shall deem relevant. A person</FONT></P>
<P ALIGN="center"><FONT SIZE="2" FACE="Times New Roman, Times, serif">-2-</FONT></P>

<P ALIGN="left"></P>
<P><FONT FACE="Times New Roman, Times, serif" SIZE="2"> who has been granted an option or award under this Plan may be granted additional options or awards under the Plan if the Committee shall so determine; provided, however, that for Incentive
Stock Options granted after December 31, 1986, to the extent the aggregate fair market value (determined at the time the Incentive Stock Option is granted) of the Common Stock with respect to which all Incentive Stock Options are exercisable for the
first time by an employee during any calendar year (under all plans described in subsection (d) of Section 422 of the Code of his employer corporation and its parent and subsidiary corporations) exceeds $100,000, such options shall be treated as
options which do not qualify as Incentive Stock Options. Nothing in the Plan or in any agreement thereunder shall confer on any employee any right to continue in the employ of the Company or any of its subsidiaries or affect, in any way, the right
of the Company or any of its subsidiaries to terminate his or her employment at any time.</FONT> </P>
<P> <FONT FACE="Times New Roman, Times, serif" SIZE="2">5.&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Price.</U></FONT> </P>
<P> <FONT FACE="Times New Roman, Times, serif" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The option price for all Incentive Stock Options granted under the Plan shall be determined by the Committee but
shall not be less than 100% of the fair market value of the Common Stock at the date of grant of such option. The option price for options granted under the Plan which do not qualify as Incentive Stock Options and, if applicable, the price for all
awards shall also be determined by the Committee. For purposes of the preceding sentence and for all other valuation purposes under the Plan, the fair market value of shares of Common Stock shall be (i) the closing price of the Common Stock as
reported for composite transactions if the Common Stock is then traded on a national securities exchange, (ii) the last sale price if the Common Stock is then quoted on the NASDAQ National Market System, or (iii) the average of the closing
representative bid and asked prices of the Common Stock as reported on NASDAQ on the date as of which the fair market value is being determined. If on the date of grant of any option or award hereunder the Common Stock is not traded on an
established securities market, the Committee shall make a good faith attempt to satisfy the requirements of this Section 5 and in connection therewith shall take such action as it deems necessary or advisable.</FONT> </P>
<P> <FONT FACE="Times New Roman, Times, serif" SIZE="2">6.&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Term.</U></FONT> </P>
<P> <FONT FACE="Times New Roman, Times, serif" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each option and award and all rights and obligations thereunder shall expire on the date determined by the
Committee and specified in the option or award agreement. The Committee shall be under no duty to provide terms of like duration for options or awards granted under the Plan, but the term of an Incentive Stock Option may not extend more than ten
(10) years from the date of grant of such option and the term of options granted under the Plan which do not qualify as Incentive Stock Options may not extend more than fifteen (15) years from the date of granting of such option.</FONT> </P>
<P> <FONT FACE="Times New Roman, Times, serif" SIZE="2">7.&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Exercise of Option or Award.</U></FONT> </P>
<P> <FONT FACE="Times New Roman, Times, serif" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The Committee shall have full and complete authority to
determine whether an option or award will be exercisable in full at any time or from time to time during the term thereof, or to provide</FONT> <FONT FACE="Times New Roman, Times, serif" SIZE="2">for the exercise thereof in such installments, upon
the occurrence of such</FONT></P>
<P ALIGN="center"><FONT SIZE="2" FACE="Times New Roman, Times, serif">-3-</FONT></P>

<P ALIGN="left"></P>
<P><FONT FACE="Times New Roman, Times, serif" SIZE="2">events (such as termination of employment for any reason) and at such times during the term of the option as the Committee may determine and specify in the option or award agreement.</FONT> </P>
<P> <FONT FACE="Times New Roman, Times, serif" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The exercise of any option or award granted hereunder shall
only be effective at such time that the sale of Common Stock pursuant to such exercise will not violate any state or federal securities or other laws. Only to the extent required in order to comply with Rule 16b-3 under the Exchange Act, in the case
of an option or other award granted to a person considered by the Company as one of its officers or directors for purposes of Section 16 of the Exchange Act, the terms of the option or other award will require that such shares are not disposed of by
such officer or director for a period of at least six months from the date of grant.</FONT> </P>
<P> <FONT FACE="Times New Roman, Times, serif" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; An optionee or grantee electing to exercise an option or award
shall give written notice to the Company of such election and of the number of shares subject to such exercise. The full purchase price of such shares shall be tendered with such notice of exercise. Payment shall he made to the Company in cash
(including bank check, certified check, personal check, or money order), or, at the discretion of the Committee and as specified by the Committee, (i) by delivering certificates for the Company's Common Stock already owned by the optionee or grantee
having a fair market value as of the date of grant equal to the full purchase price of the shares, or (ii) by delivering the optionee&#146;s or grantee's promissory note, which shall provide for interest at a rate not less than the minimum rate
required to avoid the imputation of income, original issue discount or a below-market-rate loan pursuant to Sections 483, 1274 or 7872 of the Code or any successor provisions thereto, or (iii) a combination of cash, the optionee&#146;s or grantee
promissory note and such shares. The fair market value of such tendered shares shall be determined as provided in Section 5 herein. The optionee&#146;s or grantee's promissory note shall be a full recourse liability of the optionee and may, at the
discretion of the Committee, be secured by a pledge of the shares being purchased. Until such person has been issued the shares subject to such exercise, he or she shall possess no rights as a shareholder with respect to such shares.</FONT> </P>
<P> <FONT FACE="Times New Roman, Times, serif" SIZE="2">8.&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Stock Appreciation Rights.</U></FONT> </P>
<P> <FONT FACE="Times New Roman, Times, serif" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <U>Grant</U>. At the time of grant of an option or award under
the Plan (or at any other time), the Committee, in its discretion, may grant a Stock Appreciation Right (&#147;SAR&#148;) evidenced by an agreement in such form as the Committee shall from time to time approve. Any such SAR may be subject to
restrictions on the exercise thereof as may be set forth in the agreement representing such SAR, which agreement shall comply with and be subject to the following terms and conditions and any additional terms and conditions established by the
Committee that are consistent with the terms of the Plan.</FONT> </P>
<P> <FONT FACE="Times New Roman, Times, serif" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <U>Exercise</U>. An SAR shall be exercised by the delivery to
the Company of a written notice which shall state that the holder thereof elects to exercise his or her SAR as to the number of shares specified in the notice and which shall further state what portion, if any, of the SAR exercise</FONT> <FONT
FACE="Times New Roman, Times, serif" SIZE="2">amount (hereinafter defined) the holder thereof requests be paid to in cash and what portion, if any, is to be paid in Common Stock of the Company. The Committee promptly shall cause to be paid to such
holder the SAR exercise amount either in cash, in Common Stock of the </FONT></P>
<P ALIGN="center"><FONT SIZE="2" FACE="Times New Roman, Times, serif">-4-</FONT></P>

<P ALIGN="left"></P>
<P><FONT FACE="Times New Roman, Times, serif" SIZE="2">Company, or any combination of cash and shares as the Committee may determine. Such determination may be either in accordance with the request made by the holder of the SAR or in the sole and
absolute discretion of the Committee. The SAR exercise amount is the excess of the fair market value of one share of the Company's Common Stock on the date of exercise over the per share exercise price in respect of which the SAR was granted,
multiplied by the number of shares as to which the SAR is exercised. For the purposes hereof, the fair market value of the Company&#146;s shares of Common Stock shall be determined as provided in Section 5 herein.</FONT> </P>
<P> <FONT FACE="Times New Roman, Times, serif" SIZE="2">9.&nbsp; &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Restricted Stock Awards.</U></FONT> </P>
<P> <FONT FACE="Times New Roman, Times, serif" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Awards of Common Stock subject to forfeiture and transfer restrictions may be granted by the Committee. Any
restricted stock award shall be evidenced by an agreement in such form as the Committee shall from time to time approve, which agreement shall comply with and be subject to the following terms and conditions and any additional terms and conditions
established by the Committee that are consistent with the terms of the Plan:</FONT> </P>
<P> <FONT FACE="Times New Roman, Times, serif" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <U>Grant of Restricted Stock Awards. </U>Each restricted stock
award made under the Plan shall be for such number of shares of Common Stock as shall be determined by the Committee and set forth in the agreement containing the terms of such restricted stock award. Such agreement shall set forth a period of time
during which the grantee must remain in the continuous employment of the Company in order for the forfeiture and transfer restrictions to lapse. If the Committee so determines, the restrictions may lapse during such restricted period in installments
with respect to specified portions of the shares covered by the restricted stock award. The agreement may also, in the discretion of the Committee, set forth performance or other conditions that will subject the Common Stock to forfeiture and
transfer restrictions. The Committee may, at its discretion, waive all or any part of the restrictions applicable to any or all outstanding restricted stock awards.</FONT> </P>
<P> <FONT FACE="Times New Roman, Times, serif" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <U>Delivery of Common Stock and Restrictions</U>. At the time
of a restricted stock award, a certificate representing the number of shares of Common Stock awarded thereunder shall be registered in the name of the grantee. Such certificate shall be held by the Company or any custodian appointed by the Company
for the account of the grantee subject to the terms and conditions of the Plan, and shall bear such a legend setting forth the restrictions imposed thereon as the Committee, in its discretion, may determine. The grantee shall have all rights of a
shareholder with respect to the Common Stock, including the right to receive dividends and the right to vote such shares, subject to the following restrictions: (i) the grantee shall not be entitled to delivery of the stock certificate until the
expiration of the restricted period and the fulfillment of any other restrictive conditions set forth in the restricted stock agreement with respect to such Common Stock; (ii) none of the shares of Common Stock may be sold, assigned, transferred,
pledged, hypothecated or otherwise encumbered or disposed of during such restricted period or until after the fulfillment of any such other restrictive conditions; and (iii) except as</FONT> <FONT FACE="Times New Roman, Times, serif"
SIZE="2">otherwise determined by the Committee, all of the Common Stock shall be forfeited and all rights of the grantee to such Common Stock shall terminate, without further obligation on the part of the Company, unless the grantee remains in the
continuous employment of the Company for the </FONT></P>
<P ALIGN="center"><FONT FACE="Times New Roman, Times, serif" SIZE="2">-5-</FONT></P>

<P ALIGN="left"></P>
<P><FONT FACE="Times New Roman, Times, serif" SIZE="2">entire restricted period in relation to which such shares of Common Stock were granted and unless any other restrictive conditions relating to the restricted stock award are met. Any Common
Stock, any other securities of the Company and any other property (except for cash dividends) distributed with respect to the Common Stock subject to restricted stock awards shall be subject to the same restrictions, terms and conditions as such
restricted Common Stock.</FONT> </P>
<P> <FONT FACE="Times New Roman, Times, serif" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <U>Termination of Restrictions</U>. At the end of the
restricted period and provided that any other restrictive conditions of the restricted stock award are met, or at such earlier time as otherwise determined by the Committee, all restrictions set forth in the agreement relating to the restricted
stock award or in the Plan shall lapse as to the restricted Common Stock subject thereto, and a stock certificate for the appropriate number of shares of Common Stock, free of the restrictions and the restricted stock legend, shall be delivered to
the grantee or his beneficiary or estate, as the case may be.</FONT> </P>
<P> <FONT FACE="Times New Roman, Times, serif" SIZE="2">10. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Performance Awards.</U></FONT> </P>
<P> <FONT FACE="Times New Roman, Times, serif" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The Committee is further authorized to grant performance awards (&#147;Performance Award&#148;). Subject to the
terms of this Plan and any applicable award agreement, Performance Awards granted under the Plan (i) may be denominated or payable in cash, Common Stock (including, without limitation, restricted stock), other securities, other awards, or other
property and (ii) shall confer on the holder thereof rights valued as determined by the Committee, in its discretion, and payable to, or exercisable by, the holder of the Performance Awards, in whole or in part, upon the achievement of such
performance goals during such performance periods as the Committee, in its discretion, shall establish. Subject to the terms of this Plan and any applicable award agreement, the performance goals to be achieved during any performance period, the
length of any performance period, the amount of any Performance Awards granted, and the amount of any payment or transfer to be made by the grantee and by the Company under any Performance Awards shall be determined by the Committee.</FONT> </P>
<P> <FONT FACE="Times New Roman, Times, serif" SIZE="2">11.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <U>Income Tax Withholding and Tax Bonuses.</U></FONT> </P>
<P> <FONT FACE="Times New Roman, Times, serif" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In order to comply with all applicable federal or state income
tax laws or regulations, the Company may take such action as it deems appropriate to ensure that all applicable federal or state payroll, withholding, income or other taxes, which are the sole and absolute responsibility of an optionee or grantee
under the Plan, are withheld or collected from such optionee or grantee. In order to assist an optionee or grantee in paying all federal and state taxes to be withheld or collected upon exercise of an option or award which does not qualify as an
Incentive Stock Option hereunder, the Committee, in its absolute discretion and subject to such additional terms and conditions as it may adopt, shall permit the optionee or grantee to satisfy such tax obligation by (i) electing to have the Company
withhold a portion of the shares otherwise to be delivered upon exercise of such option or award with a fair market value, determined in accordance with Section 5 herein, equal to such taxes or (ii) delivering to the Company</FONT> <FONT
FACE="Times New Roman, Times, serif" SIZE="2">Common Stock other than the shares issuable upon exercise of such option or award with a fair market value, determined in accordance with Section 5, equal to such taxes.</FONT> </P>
<P ALIGN="center"><FONT SIZE="2" FACE="Times New Roman, Times, serif">-6-</FONT></P>

<P ALIGN="left"></P>
<P> <FONT FACE="Times New Roman, Times, serif" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (b) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Committee shall have the authority, at the time of grant
of an option under the Plan or at any time thereafter, to approve tax bonuses to designated optionees or grantees to be paid upon their exercise of options or awards granted hereunder. The amount of any such payments shall be determined by the
Committee. The Committee shall have full authority in its absolute discretion to determine the amount of any such tax bonus and the terms and conditions affecting the vesting and payment thereafter.</FONT> </P>
<P> <FONT FACE="Times New Roman, Times, serif" SIZE="2">12. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Additional Restrictions.</U></FONT> </P>
<P> <FONT FACE="Times New Roman, Times, serif" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Committee shall have full and complete authority to determine whether all or any part of the Common Stock of
the Company acquired upon exercise of any of the options or awards granted under the Plan shall be subject to restrictions on the transferability thereof or any other restrictions affecting in any manner the optionee&#146;s or grantee's rights with
respect thereto, but any such restriction shall be contained in the agreement relating to such options or awards.</FONT> </P>
<P> <FONT FACE="Times New Roman, Times, serif" SIZE="2">13. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Ten Percent Shareholder Rule.</U></FONT> </P>
<P> <FONT FACE="Times New Roman, Times, serif" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Notwithstanding any other provision in the Plan, if at the time an option is otherwise to be granted pursuant to
the Plan the optionee owns directly or indirectly (within the meaning of Section 424(d) of the Code) Common Stock of the Company possessing more than ten percent (10%) of the total combined voting power of all classes of stock of the Company or its
parent or subsidiary corporations, if any (within the meaning of Section 422(b)(6) of the Code), then any Incentive Stock Option to be granted to such optionee pursuant to the Plan shall satisfy the requirements of Section 422(c)(5) of the Code, and
the option price shall be not less than 110% of the fair market value of the Common Stock of the Company determined as described herein, and such option by its terms shall not be exercisable after the expiration of five (5) years from the date such
option is granted.</FONT> </P>
<P> <FONT FACE="Times New Roman, Times, serif" SIZE="2">14.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <U>Non-Transferability.</U></FONT> </P>
<P> <FONT FACE="Times New Roman, Times, serif" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; No option may be sold, pledged, assigned, hypothecated, transferred, or disposed of in any manner other than (i)
by will or by the laws of descent or distribution, or (ii) in the case of options that are not Incentive Stock Options, to members of the optionee&#146;s immediate family or to one or more trusts for the benefit of the optionee or members of his or
her immediate family, and the option may be exercised, during the lifetime of the Optionee, only by the optionee or a permitted transferee.</FONT> </P>
<P> <FONT FACE="Times New Roman, Times, serif" SIZE="2">15.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <U>Dilution or Other Adjustments.</U></FONT> </P>
<P> <FONT FACE="Times New Roman, Times, serif" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; If there shall be any change in the Common Stock through merger, consolidation, reorganization, recapitalization,
dividend in the form of stock (of whatever amount), stock split or other change in the corporate structure, appropriate adjustments in the Plan and outstanding options and</FONT> <FONT FACE="Times New Roman, Times, serif" SIZE="2">awards shall be
made by the Committee. In the event of any such changes, adjustments shall include, where appropriate, changes in the aggregate number of shares subject to the Plan, the number of shares and the price per share subject to outstanding options and
</FONT></P>
<P ALIGN="center"><FONT SIZE="2" FACE="Times New Roman, Times, serif">-7-</FONT></P>

<P ALIGN="left"></P>
<P><FONT FACE="Times New Roman, Times, serif" SIZE="2">awards and the amount payable upon exercise of outstanding awards, in order to prevent dilution or enlargement of option or award rights.</FONT> </P>
<P> <FONT FACE="Times New Roman, Times, serif" SIZE="2">16. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Amendment or Discontinuance of Plan.</U></FONT> </P>
<P> <FONT FACE="Times New Roman, Times, serif" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The Board of Directors may amend or discontinue the Plan at any time. Subject to the provisions of Section 15 no
amendment of the Plan, however, shall without shareholder approval: (i) increase the maximum number of shares under the Plan as provided in Section 2 herein, (ii) decrease the minimum price provided in Section 5 herein, (iii) extend the maximum term
under Section 6, or (iv) modify the eligibility requirements for participation in the Plan. The Board of Directors shall not alter or impair any option or award theretofore granted under the Plan without the consent of the holder of the
option.</FONT> </P>
<P> <FONT FACE="Times New Roman, Times, serif" SIZE="2">17. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Time of Granting.</U></FONT> </P>
<P> <FONT FACE="Times New Roman, Times, serif" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Nothing contained in the Plan or in any resolution adopted or to be adopted by the Board of Directors or by the
shareholders of the Company, and no action taken by the Committee or the Board of Directors (other than the execution and delivery of an option or award agreement), shall constitute the granting of an option or award hereunder.</FONT> </P>
<P> <FONT FACE="Times New Roman, Times, serif" SIZE="2">18. &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Effective Date and Termination of Plan.</U></FONT> </P>
<P> <FONT FACE="Times New Roman, Times, serif" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The Plan was approved by the Board of Directors on June 29,
1990 and shall be approved by the shareholders of the Company within twelve (12) months thereof.</FONT> </P>
<P> <FONT FACE="Times New Roman, Times, serif" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Unless the Plan shall have been discontinued as provided in
Section 16 hereof, the Plan shall terminate June 29, 2005. No option or award may be granted after such termination, but termination of the Plan shall not, without the consent of the optionee or grantee, alter or impair any rights or obligations
under any option or award theretofore granted.</FONT> </P>
<DIV ALIGN="center"><FONT FACE="Times New Roman, Times, serif" SIZE="2">-8- </FONT> </DIV>
<FONT SIZE="2" FACE="Times New Roman, Times, serif"><I></I></FONT>
<P ALIGN="right"> <FONT SIZE="2" FACE="Times New Roman, Times, serif"><I>Appendix B</I> </FONT></P>
<P ALIGN="center"> <FONT SIZE="2" FACE="Times New Roman, Times, serif"><B>DIAMETRICS MEDICAL, INC.
<BR>
AMENDED AND RESTATED</B>
<BR>
</FONT><FONT SIZE="2" FACE="Times New Roman, Times, serif"><B>1993 DIRECTORS&#146; STOCK OPTION PLAN</B>
<BR>
</FONT><FONT FACE="Times New Roman, Times, serif" SIZE="2">(as amended May 23, 2001)</FONT> </P>
<P> <FONT FACE="Times New Roman, Times, serif" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <U>Purpose of the Plan</U>. The purpose of this Diametrics Medical, Inc. 1993</FONT>
<FONT FACE="Times New Roman, Times, serif" SIZE="2">Directors&#146; Stock Option Plan is to attract and retain the best available individuals for service as Directors of the Company and provide additional incentive to the Outside Directors of the
Company to serve as Directors.</FONT> </P>
<P> <FONT SIZE="2" FACE="Times New Roman, Times, serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;None of the options granted hereunder shall be &#147;incentive stock options&#148; within the meaning of Section 422 of the Code (as hereinafter
defined).</FONT> </P>
<P> <FONT FACE="Times New Roman, Times, serif" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <U></U><U>Definitions</U>. As used herein, the following definitions shall
apply:</FONT></P>
<P><FONT FACE="Times New Roman, Times, serif" SIZE="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <U></U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <U></U>&nbsp;(a) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&#147;<U>Board</U>&#148; shall mean the Board of Directors of the Company.</FONT> </P>
<P> <FONT FACE="Times New Roman, Times, serif" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <U></U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <U></U>&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&#147;<U>Code</U>&#148; shall mean the Internal Revenue Code of 1986, as amended.</FONT> </P>
<P> <FONT FACE="Times New Roman, Times, serif" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <U></U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <U></U>&nbsp;(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&#147;<U>Common Stock</U>&#148; shall mean the Common Stock of the Company.</FONT> </P>
<P> <FONT SIZE="2" FACE="Times New Roman, Times, serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <U></U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <U></U>&nbsp;(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&#147;<U>Company</U>&#148; shall mean Diametrics Medical, Inc., a Minnesota corporation.</FONT> </P>
<P> <FONT SIZE="2" FACE="Times New Roman, Times, serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <U></U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <U></U>&nbsp;(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&#147;<U>Continuous Status as a Director</U>&#148; shall mean the absence of any interruption or termination of service as a Director.</FONT> </P>
<P> <FONT FACE="Times New Roman, Times, serif" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <U></U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <U></U>&nbsp;(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&#147;<U>Director</U>&#148; shall mean a member of the Board.</FONT> </P>
<P> <FONT SIZE="2" FACE="Times New Roman, Times, serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <U></U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <U></U>&nbsp;(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&#147;<U>Employee</U>&#148; shall mean any person, including officers and Directors, employed by the Company or any parent or Subsidiary of the Company. The payment of a Director&#146;s fee by the Company shall not be sufficient in and of
itself to constitute &#147;employment&#148; by the Company.</FONT> </P>
<P> <FONT SIZE="2" FACE="Times New Roman, Times, serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <U></U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <U></U>&nbsp;(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&#147;<U>Exchange Act</U>&#148; shall mean the Securities Exchange Act of 1934, as amended.</FONT> </P>
<P> <FONT FACE="Times New Roman, Times, serif" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <U></U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <U></U>&nbsp;(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&#147;<U>Option</U>&#148; shall mean a stock option granted pursuant to the Plan.</FONT> </P>
<P> <FONT SIZE="2" FACE="Times New Roman, Times, serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <U></U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <U></U>&nbsp;(j)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&#147;<U>Option Value</U>&#148; shall mean, with respect to an option described in Section 4(b)(iv) of the Plan, the value of such option determined on the date of grant using the same methodology as was used by the Company&#146;s independent
public accountants to value stock options for the purposes of the Company&#146;s most recent annual audited financial statements.</FONT> </P>
<P> <FONT FACE="Times New Roman, Times, serif" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <U></U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <U></U>&nbsp;(k)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&#147;<U>Optioned Stock</U>&#148; shall mean the Common Stock subject to an Option.</FONT> </P>
<P ALIGN="center"><FONT SIZE="2" FACE="Times New Roman, Times, serif">-1-</FONT></P>
<FONT SIZE="2" FACE="Times New Roman, Times, serif"></FONT>
<P></P>
<P><FONT FACE="Times New Roman, Times, serif" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;(l)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&#147;<U>Optionee</U>&#148; shall mean an Outside Director who receives an Option.</FONT></P>
<P><FONT FACE="Times New Roman, Times, serif" SIZE="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;(m)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#147;<U>Outside
Director</U>&#148; shall mean a Director who is not an Employee.</FONT></P>
<P><FONT FACE="Times New Roman, Times, serif" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;(n)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#147;<U>Parent</U>&#148;
shall mean a &#147;parent corporation,&#148; whether now or hereafter existing, as defined in Section 425(e) of the Code.</FONT></P>
<P><FONT FACE="Times New Roman, Times, serif" SIZE="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;(o)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &#147;<U>Plan</U>&#148;
shall mean this 1993 Directors&#146; Stock Option Plan.</FONT></P>
<P><FONT FACE="Times New Roman, Times, serif" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;(p)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT SIZE="2"
FACE="Times New Roman, Times, serif">&#147;<U>Shares</U>&#148; shall mean shares of the Common Stock, as adjusted in accordance with Section 11 of the Plan.</FONT></P>
<P><FONT FACE="Times New Roman, Times, serif" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;(q)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT SIZE="2"
FACE="Times New Roman, Times, serif">&#147;<U>Subsidiary</U>&#148; shall mean a &#147;subsidiary corporation,&#148; whether now or hereafter existing, as defined in Section 425(f) of the Code.</FONT></P>
<TABLE WIDTH="100%" BORDER="0" CELLSPACING="0" CELLPADDING="0">
<TR>
<TD COLSPAN="5"><FONT FACE="Times New Roman, Times, serif" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Stock Subject to the Plan</U>. Subject to the provisions of Section 10 of
the Plan, the maximum aggregate number of Shares which may be optioned and sold under the Plan is 467,500 Shares of Common Stock. The Shares may be authorized, but unissued, or reacquired Common Stock.</FONT></TD>
</TR>
<TR>
<TD COLSPAN="5">&nbsp;</TD>
</TR>
<TR>
<TD COLSPAN="5"><FONT SIZE="2" FACE="Times New Roman, Times, serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If an Option should expire or become unexercisable for any reason without having been exercised in full, the
unpurchased Shares which were subject thereto shall, unless the Plan shall have been terminated, become available for future grant under the Plan. If Shares which were acquired upon exercise of an Option are subsequently repurchased by the Company,
such Shares shall not in any event be returned to the Plan and shall not become available for future grant under the Plan.</FONT></TD>
</TR>
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="89%" COLSPAN="2">&nbsp;</TD>
</TR>
<TR>
<TD COLSPAN="5"><FONT FACE="Times New Roman, Times, serif" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4</FONT>.<FONT SIZE="2" FACE="Times New Roman, Times, serif">&nbsp;&nbsp;&nbsp;</FONT><FONT
FACE="Times New Roman, Times, serif" SIZE="2">Administration of and Grants of Options under the Plan.</FONT></TD>
</TR>
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="89%" COLSPAN="2">&nbsp;</TD>
</TR>
<TR>
<TD COLSPAN="5"><FONT SIZE="2" FACE="Times New Roman, Times, serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;<FONT SIZE="2" FACE="Times New Roman, Times, serif"><U>Administrator</U>. Except as otherwise required herein, the Plan shall be administered by the Board.</FONT></FONT></TD>
</TR>
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="89%" COLSPAN="2">&nbsp;</TD>
</TR>
<TR>
<TD COLSPAN="5"><FONT SIZE="2" FACE="Times New Roman, Times, serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </FONT><FONT SIZE="2"
FACE="Times New Roman, Times, serif"> &nbsp;&nbsp;</FONT><FONT SIZE="2" FACE="Times New Roman, Times, serif"><U>Procedure for Grants</U>. The provisions set forth in this Section 4(b) shall not be amended more than once every six months, other than
to comport with changes in the Code, the Employee Retirement Income Security Act of 1974, as amended, or the rules thereunder. All grants of Options hereunder shall be made in accordance with the following provisions:</FONT> <FONT SIZE="2"
FACE="Times New Roman, Times, serif"><U></U></FONT></TD>
</TR>
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="89%" COLSPAN="2">&nbsp;</TD>
</TR>
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD COLSPAN="4"><FONT SIZE="2" FACE="Times New Roman, Times, serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i)&nbsp;&nbsp;&nbsp;&nbsp; The Board shall
have discretion to grant options to Outside Directors in addition to the Options described in Sections 4(b)(ii), (iii) and (iv) and to determine the number of Shares to be covered by such Options. </FONT></TD>
</TR>
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="89%" COLSPAN="2">&nbsp;</TD>
</TR>
<TR>
<TD WIDTH="5%">&nbsp;</TD>
<TD COLSPAN="4"><FONT SIZE="2" FACE="Times New Roman, Times, serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii)&nbsp;&nbsp;&nbsp;&nbsp; Effective
August 14, 1997, each Outside Director shall be automatically granted an Option (an &#147;Initial Grant&#148;) to purchase 18,000 Shares on the date on which such person first becomes a Director, whether through election by the shareholders of the
Company or appointment by the Board of Directors to fill a vacancy. </FONT></TD>
</TR>
</TABLE>
<P></P>
<DIV ALIGN="center"><FONT FACE="Times New Roman, Times, serif" SIZE="2">-2- </FONT> </DIV>
<FONT FACE="Times New Roman, Times, serif" SIZE="2"></FONT>
<P> </P>
<TABLE WIDTH="100%" BORDER="0" CELLSPACING="0" CELLPADDING="0">
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD COLSPAN="5"><FONT FACE="Times New Roman, Times, serif" SIZE="2">Options granted under this section 4(b)(ii) shall become vested and thereby exercisable with respect to 50% of such Initial Grant on the twelve month anniversary date of such
Initial Grant and with respect to 25% at each successive anniversary date; provided, however, an unvested portion of an Initial Grant shall only vest so long as the Outside Director remains a Director on the date such portion vests.</FONT> </TD>
</TR>
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="6%">&nbsp;</TD>
<TD WIDTH="84%" COLSPAN="2">&nbsp;</TD>
</TR>
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD COLSPAN="5"><FONT SIZE="2" FACE="Times New Roman, Times, serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Effective August 14, 1997, each
Outside Director shall automatically receive, on the date of each Annual Meeting of Shareholders, an Option to purchase 8,000 Shares of the Company&#146;s Common Stock, such Option to become exercisable six months subsequent to the date of grant;
<U>provided</U> however, that such Option shall only be granted to Outside Directors who have served since the date of the last Annual Meeting of Shareholders and will continue to serve after the date of grant of such Option.</FONT> </TD>
</TR>
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="6%">&nbsp;</TD>
<TD WIDTH="84%" COLSPAN="2">&nbsp;</TD>
</TR>
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD COLSPAN="5"><FONT SIZE="2" FACE="Times New Roman, Times, serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Each Outside Director may elect,
not later than the last day of the Company&#146;s fiscal year, to be granted Options in lieu of the compensation and fees otherwise payable to such Outside Director for the next fiscal year. Such Options shall be granted quarterly on the last day of
each fiscal quarter in which such compensation and fees are earned, to be exercisable immediately. The number of Shares covered by each such Option shall be the number determined by dividing the total amount of compensation and fees payable at the
end of such quarter by the Option Value of one such Share on the date of grant.</FONT> </TD>
</TR>
<TR>
<TD COLSPAN="6"><FONT FACE="Times New Roman, Times, serif" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>
</TR>
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%">&nbsp;</TD>
<TD COLSPAN="4"><FONT FACE="Times New Roman, Times, serif" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(v)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The terms of an Option granted hereunder shall be as
follows:</FONT> </TD>
</TR>
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="6%">&nbsp;</TD>
<TD WIDTH="84%" COLSPAN="2">&nbsp;</TD>
</TR>
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="3%">&nbsp;</TD>
<TD COLSPAN="3"><FONT FACE="Times New Roman, Times, serif" SIZE="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(A)</FONT><FONT FACE="Times New Roman, Times, serif" SIZE="2"> &nbsp;the term
of the Option shall be ten (10) years.</FONT> </TD>
</TR>
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="6%">&nbsp;</TD>
<TD WIDTH="84%" COLSPAN="2">&nbsp;</TD>
</TR>
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%">&nbsp;</TD>
<TD COLSPAN="4"><FONT SIZE="2" FACE="Times New Roman, Times, serif"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(B)</FONT><FONT SIZE="2"
FACE="Times New Roman, Times, serif"> &nbsp;the Option shall be exercisable only while the Outside Director remains a Director of the Company, except as set forth in Section 8 hereof.</FONT> </TD>
</TR>
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="6%">&nbsp;</TD>
<TD WIDTH="84%" COLSPAN="2">&nbsp;</TD>
</TR>
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%">&nbsp;</TD>
<TD COLSPAN="4"><FONT SIZE="2" FACE="Times New Roman, Times, serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (C)&nbsp; </FONT><FONT SIZE="2"
FACE="Times New Roman, Times, serif">the exercise price per Share shall be 100% of the fair value per Share on the date of grant of the Option.</FONT> </TD>
</TR>
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="6%">&nbsp;</TD>
<TD WIDTH="84%" COLSPAN="2">&nbsp;</TD>
</TR>
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%">&nbsp;</TD>
<TD COLSPAN="4"><FONT SIZE="2" FACE="Times New Roman, Times, serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (D)&nbsp; </FONT><FONT SIZE="2"
FACE="Times New Roman, Times, serif">to the extent necessary to comply with the applicable provisions of Rule 16b-3 promulgated under the Exchange Act (&#147;Rule 16b-3&#148;), no Option will be exercisable until a date more than six months
subsequent to the date of the grant of that Option.</FONT> </TD>
</TR>
<TR>
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="3%">&nbsp;</TD>
<TD WIDTH="6%">&nbsp;</TD>
<TD WIDTH="84%" COLSPAN="2">&nbsp;</TD>
</TR>
<TR>
<TD COLSPAN="6"><FONT SIZE="2" FACE="Times New Roman, Times, serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;&nbsp; </FONT><FONT SIZE="2" FACE="Times New Roman, Times, serif"><U>Powers of the Board</U>.
Subject to the provisions and restrictions of the Plan, the Board shall have the authority, in its discretion: (i) to determine, upon review of relevant information and in accordance with Section 7(b) of the Plan, the fair market value of the Common
Stock; (ii) to determine the exercise price per share of Options to be granted, which exercise price shall be determined in accordance with Section 7(a) of the Plan; (iii) to interpret the Plan; (iv) to prescribe, amend and rescind rules and
regulations relating to the Plan; (v) to authorize any person to execute on behalf of the Company any instrument required to effectuate</FONT> </TD>
</TR>
</TABLE>

<P ALIGN="center"><FONT SIZE="2" FACE="Times New Roman, Times, serif">-3- </FONT> </P>
<FONT SIZE="2" FACE="Times New Roman, Times, serif"></FONT>
<P><FONT SIZE="2" FACE="Times New Roman, Times, serif"> </FONT></P>
<TABLE WIDTH="100%" BORDER="0" CELLSPACING="0" CELLPADDING="0">
<TR>
<TD COLSPAN="2"><FONT FACE="Times New Roman, Times, serif" SIZE="2">the grant of an Option previously granted hereunder; and (vi) to make all other determinations deemed necessary or advisable for the administration of the Plan.</FONT> </TD>
</TR>
<TR>
<TD WIDTH="12%">&nbsp;</TD>
<TD WIDTH="88%">&nbsp;</TD>
</TR>
<TR>
<TD COLSPAN="2"><FONT SIZE="2" FACE="Times New Roman, Times, serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp; <U></U><U>Effect of Board&#146;s Decision</U>. All
decisions, determinations and interpretations of the Board shall be final and binding on all Optionees and any other holders of any Options granted under the Plan.</FONT> </TD>
</TR>
</TABLE>
<P> <FONT SIZE="2" FACE="Times New Roman, Times, serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Eligibility</U>. Options may be granted only to Outside Directors. All Options shall be
automatically granted in accordance with the terms set forth in Section 4(b) hereof.</FONT> </P>
<P> <FONT SIZE="2" FACE="Times New Roman, Times, serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Plan shall not confer upon any Optionee any right with respect to continuation of service as a Director or nomination to serve as a Director,
nor shall it interfere in any way with any rights which the Director or the Company may have to terminate his directorship at any time.</FONT> </P>
<P> <FONT SIZE="2" FACE="Times New Roman, Times, serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;6.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Term of Plan</U>. The Plan shall become effective upon the earlier of (i) its adoption by
the Board or (ii) its approval by the shareholders of the Company as described in Section 16 of the Plan. It shall continue in effect for a term of ten (10) years unless sooner terminated under Section 12 of the Plan.</FONT> </P>
<P> <FONT FACE="Times New Roman, Times, serif" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;7.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Exercise Price and Consideration.</FONT> </P>
<P> <FONT SIZE="2" FACE="Times New Roman, Times, serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <U>Exercise Price</U>. The
per Share exercise price for the Shares to be issued pursuant to exercise of an Option shall be 100% of the fair market value per Share on the date of grant of the Option.</FONT> </P>
<P> <FONT SIZE="2" FACE="Times New Roman, Times, serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;(b) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Fair Market Value.</U>
The fair market value (&#147;Fair Market Value&#148;) of a Share shall be determined by the Board in its discretion; <U>provided</U> however, that where there is a public market for the Common Stock, the fair market value per Share shall be the
closing price of the Common Stock in the over-the-counter market on the date of grant, as reported in <U>The Wall Street Journal</U> (or, if not so reported, as otherwise reported by the National Association of Securities Dealers Automated Quotation
(&#147;NASDAQ&#148;) System) or, in the event the Common Stock is traded on the NASDAQ National Market System or listed on a stock exchange, the fair market value per Share shall be the closing price on such system or exchange on the date of grant
of the Option, as reported in <U>The Wall Street Journal</U>.</FONT> </P>
<P> <FONT SIZE="2" FACE="Times New Roman, Times, serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <U>Form of
Consideration</U>. Subject to compliance with applicable provisions of Section 16(b) of the Exchange Act, (or other applicable law), the consideration to be paid for the Shares to be issued upon exercise of an Option, including the method of
payment, shall be determined by the Board and may consist entirely of (i) cash, (ii) check, (iii) other Shares which (X) in the case of Shares acquired upon exercise of an Option, have been owned by the Optionee for more than six months on the date
of surrender, and (Y) have a Fair Market Value on the date of exercise equal to the aggregate exercise price of the Shares as to which said Option shall be exercised, (iv) authorization for the Company to retain from the total number of Shares as to
which the Option is exercised that number of Shares having a Fair Market Value on the date of exercise equal to the exercise price for the total number of Shares as to which the Option is exercised, (v) delivery of a properly executed exercise
notice together with irrevocable</FONT> </P>
<P ALIGN="center"><FONT SIZE="2" FACE="Times New Roman, Times, serif">-4-</FONT></P>
<FONT SIZE="2" FACE="Times New Roman, Times, serif"></FONT> </FONT>
<P> <FONT FACE="Times New Roman, Times, serif" SIZE="2">instructions to a broker to promptly deliver to the Company the amount of sale or loan proceeds required to pay the exercise price, (vi) by delivering an irrevocable subscription agreement for
the Shares which irrevocably obligates the option holder to take and pay for the Shares not more than twelve months after the date of delivery of the subscription agreement, (vii) any combination of the foregoing methods of payment or (viii) such
other consideration and method of payment for the issuance of Shares as may be permitted under applicable laws. In making its determination as to the type of consideration to accept, the Board shall consider whether acceptance of such consideration
may be reasonably expected to benefit the Company.</FONT> </P>
<P> <FONT FACE="Times New Roman, Times, serif" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;8.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Exercise of Option.</FONT> </P>
<P> <FONT SIZE="2" FACE="Times New Roman, Times, serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <U></U><U>Procedure for
Exercise; Rights as a Shareholder</U>. Any Option granted hereunder shall be exercisable at such times as are set forth in Section 4(b) hereof; <U>provided </U>however, that no Options shall be exercisable until shareholder approval of the Plan in
accordance with Section 16 hereof has been obtained.</FONT> </P>
<P> <FONT FACE="Times New Roman, Times, serif" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;An Option may not be exercised for a fraction of a Share.</FONT> </P>
<P> <FONT SIZE="2" FACE="Times New Roman, Times, serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;An Option shall be deemed to be exercised when written notice of such exercise has been given to the Company in accordance with the terms of the
Option by the person entitled to exercise the Option and full payment for the Shares with respect to which the Option is exercised has been received by the Company. Full payment may consist of any consideration and method of payment allowable under
Section 7(c) of the Plan. Until the issuance (as evidenced by the appropriate entry on the books of the Company or of a duly authorized transfer agent of the Company) of the stock certificate evidencing such Shares, no right to vote or receive
dividends or any other rights as a shareholder shall exist with respect to the Optioned Stock, notwithstanding the exercise of the Option. A share certificate for the number of Shares so acquired shall be issued to the Optionee as soon as
practicable after exercise of the Option. No adjustment will be made for a dividend or other right for which the record date is prior to the date the stock certificate is issued, except as provided in Section 10 of the Plan.</FONT> </P>
<P> <FONT SIZE="2" FACE="Times New Roman, Times, serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Exercise of an Option in any manner shall result in a decrease in the number of Shares which thereafter may be available, both for purposes of
the Plan and for sale under the Option, by the number of Shares as to which the Option is exercised.</FONT> </P>
<P> <FONT SIZE="2" FACE="Times New Roman, Times, serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <U></U><U>Termination of
Status as a Director</U>. If an Outside Director ceases to serve as a Director, he may, but only within seven (7) months after the date he ceases to be a Director of the Company, exercise his Option to the extent that he was entitled to exercise it
at the date of such termination. To the extent that he was not entitled to exercise an Option at the date of such termination, or if he does not exercise such Option (which he was entitled to exercise) within the time specified herein, the Option
shall terminate.</FONT> </P>
<P> <FONT SIZE="2" FACE="Times New Roman, Times, serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <U></U><U>Disability of
Optionee</U>. Notwithstanding the provisions of Section 8(b) above, in the event an Optionee is unable to continue his service as a Director with the Company as a result of his total and permanent disability (as defined in Section 22(e)(3) of the
Code) he</FONT> </P>
<P ALIGN="center"><FONT SIZE="2" FACE="Times New Roman, Times, serif">-5-</FONT></P>
<FONT SIZE="2" FACE="Times New Roman, Times, serif"> <FONT FACE="Times New Roman, Times, serif" SIZE="2"></FONT>
<P><FONT FACE="Times New Roman, Times, serif" SIZE="2">may, but only within seven (7) months from the date of termination, exercise his Option to the extent he was entitled to exercise it at the date of such termination. To the extent that he was
not entitled to exercise the Option at the date of termination, or if he does not exercise such Option (which he was entitled to exercise) within the time specified herein, the Option shall terminate.</FONT></P>
<P>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<FONT SIZE="2" FACE="Times New Roman, Times, serif">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <U>Death of Optionee</U>.
Notwithstanding the provisions of Section 4(b), in the event of the death of an Optionee:</FONT> </P>
<BLOCKQUOTE>
<P><FONT SIZE="2" FACE="Times New Roman, Times, serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) </FONT><FONT SIZE="2"
FACE="Times New Roman, Times, serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;during the term of the Option who is at the time of his death a Director of the Company and who has been in Continuous Status as a Director since the date of grant
of the Option, the Option may be exercised, at any time within seven (7) months following the date of death, by the Optionee&#146;s estate or by a person who acquired the right to exercise the Option by bequest or inheritance, but only to the extent
of the right to exercise that would have accrued had the Optionee continued living and remained in Continuous Status as a Director for six (6) months after the date of death; or</FONT> </P>

<P><FONT SIZE="2" FACE="Times New Roman, Times, serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;within thirty (30) days after the termination of Continuous Status as a Director, the Option may be exercised, at any time within seven (7) months following the date of death, by the Optionee&#146;s estate or by a person who acquired the right
to exercise the Option by bequest or inheritance, but only to the extent of the right to exercise that had accrued at the date of termination.</FONT> </P>
</BLOCKQUOTE>
<P><FONT SIZE="2" FACE="Times New Roman, Times, serif"> <U></U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;9.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <U>Non-Transferability of Options</U>. The Option may not be sold,
pledged, assigned, hypothecated, transferred, or disposed of in any manner other than (i) by will, (ii) by the laws of descent or distribution, (iii) to members of the Optionee&#146;s immediate family or (iv) to one or more trusts for the benefit of
the Optionee or members of his or her immediate family, and the Option may be exercised, during the lifetime of the Optionee, only by the Optionee or a permitted transferee.</FONT> </P>

<P> <FONT FACE="Times New Roman, Times, serif" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;10.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Adjustments Upon Changes in Capitalization, Dissolution or Merger</U>.</FONT>
</P>
<P> <FONT SIZE="2" FACE="Times New Roman, Times, serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) &nbsp;&nbsp;&nbsp;&nbsp;In the event that the
number of outstanding shares of Common Stock of the Company is changed by a stock dividend, stock split, reverse stock split, combination, reclassification or similar change in the capital structure of the Company without consideration, the number
of Shares available under this Plan and the number of Shares subject to outstanding Options and the exercise price per share of such Options shall be proportionately adjusted, subject to any required action by the Board or shareholders of the
Company and compliance with applicable securities laws; <U>provided</U> however, that no certificate or scrip representing fractional shares shall be issued upon exercise of any Option and any resulting fractions of a Share shall be ignored. Such
adjustment shall be made by the Board, whose determination in that respect shall be final, binding and conclusive.</FONT> </P>
<P> <FONT SIZE="2" FACE="Times New Roman, Times, serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; In the event of a
dissolution or liquidation of the Company, a merger in which the Company is not the surviving corporation, a transaction or series of related transactions in which 100% of the then outstanding voting stock is sold or otherwise transferred,</FONT>
</P>
<P ALIGN="center"><FONT SIZE="2" FACE="Times New Roman, Times, serif">-6-</FONT></P>
<FONT SIZE="2" FACE="Times New Roman, Times, serif"></FONT>
<P> <FONT FACE="Times New Roman, Times, serif" SIZE="2">or the sale of substantially all of the assets of the Company, any or all outstanding Options shall, notwithstanding any contrary terms of the written agreement governing such Option,
accelerate and become exercisable in full at least ten days prior to (and shall expire on) the consummation of such dissolution, liquidation, merger or sale of stock or sale of assets on such conditions as the Board shall determine unless the
successor corporation assumes the outstanding Options or substitutes substantially equivalent options.</FONT> </P>
<P> <FONT SIZE="2" FACE="Times New Roman, Times, serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <U></U>11.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Time of Granting Options</U>. The date of grant of an Option shall, for all purposes, be
the date determined in accordance with Section 4(b) hereof. Notice of the determination shall be given to each Outside Director to whom an Option is so granted within a reasonable time after the date of such grant.</FONT> </P>
<P> <FONT FACE="Times New Roman, Times, serif" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <U></U>12.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Amendment and Termination of the Plan</U>.</FONT> </P>
<P> <FONT SIZE="2" FACE="Times New Roman, Times, serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Amendment and
Termination</U>. The Board may at any time amend, alter, suspend, or discontinue the Plan, but no amendment, alteration, suspension, or discontinuance shall be made which would impair the rights of any Optionee under any grant theretofore made,
without his or her consent. In addition, to the extent necessary and desirable to comply with Rule 16b-3 under the Exchange Act (or any other applicable law or regulation), the Company shall obtain shareholder approval of any Plan amendment in such
a manner and to such a degree as required.</FONT> </P>
<P> <FONT SIZE="2" FACE="Times New Roman, Times, serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Effect of
Amendment or Termination</U>. Any such amendment or termination of the Plan shall not affect Options already granted and such Options shall remain in full force and effect as if this Plan had not been amended or terminated, unless mutually agreed
otherwise between the Optionee and the Board, which agreement must be in writing and signed by the Optionee and the Company.</FONT> </P>
<P> <FONT SIZE="2" FACE="Times New Roman, Times, serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <U></U>13.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Conditions Upon Issuance of Shares</U>. Shares shall not be issued pursuant to the
exercise of an Option unless the exercise of such Option and the issuance and delivery of such Shares pursuant thereto shall comply with all relevant provisions of law, including, without limitation, the Securities Act of 1933, as amended, the
Exchange Act, the rules and regulations promulgated thereunder, state securities laws, and the requirements of any stock exchange upon which the Shares may then be listed, and shall be further subject to the approval of counsel for the Company with
respect to such compliance.</FONT> </P>
<P> <FONT SIZE="2" FACE="Times New Roman, Times, serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <U></U>As a condition to the exercise of an Option, the Company may require the person exercising such Option to represent and warrant at the
time of any such exercise that the Shares are being purchased only for investment and without any present intention to sell or distribute such Shares, if, in the opinion of counsel for the Company, such a representation is required by any of the
aforementioned relevant provisions of law.</FONT> </P>
<P> <FONT SIZE="2" FACE="Times New Roman, Times, serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <U></U>Inability of the Company to obtain authority from any regulatory body having jurisdiction, which authority is deemed by the
Company&#146;s counsel to be necessary to the lawful issuance and sale of any Shares hereunder, shall relieve the Company of any liability in respect</FONT> </P>
<P ALIGN="center"><FONT FACE="Times New Roman, Times, serif" SIZE="2">-7-</FONT></P>
<FONT SIZE="2" FACE="Times New Roman, Times, serif"></FONT> </FONT>
<P> <FONT FACE="Times New Roman, Times, serif" SIZE="2">of the failure to issue or sell such Shares as to which such requisite authority shall not have been obtained.</FONT> </P>
<P> <FONT SIZE="2" FACE="Times New Roman, Times, serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <U></U>14.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Reservation of Shares</U>. The Company, during the term of this Plan, will at all
times reserve and keep available such number of the Shares available for issuance pursuant to this Plan as shall be sufficient to satisfy the requirements of the Plan.</FONT> </P>
<P> <FONT SIZE="2" FACE="Times New Roman, Times, serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <U></U>15.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Option Agreement</U>. Options shall be evidenced by written option agreements in
such form as the Board shall approve.</FONT> </P>
<P> <FONT FACE="Times New Roman, Times, serif" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <U></U>16.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Shareholder Approval</U>.</FONT> </P>
<P> <FONT SIZE="2" FACE="Times New Roman, Times, serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The Plan shall
be subject to approval by the shareholders of the Company within twelve (12) months of its adoption by the Board. If such shareholder approval is obtained at a duly held shareholders&#146; meeting, it may be obtained by the affirmative vote of the
holders of a majority of the outstanding shares of the Company present or represented and entitled to vote thereon. If such shareholder approval is obtained by written consent, it may be obtained by the written consent of the holders of a majority
of the outstanding shares of the Company.</FONT> </P>
<P> <FONT SIZE="2" FACE="Times New Roman, Times, serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Any required
approval of the shareholders of the Company shall be substantially in accordance with Section 14(a) of the Exchange Act and the rules and regulations promulgated thereunder.</FONT> </P>
<P> <FONT SIZE="2" FACE="Times New Roman, Times, serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <U></U>17.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Information to Optionees</U>. The Company shall provide to each Optionee, during the
period for which such Optionee has one or more Options outstanding, copies of all annual reports to shareholders, proxy statements and other information provided to all shareholders of the Company.</FONT> </P>
<P ALIGN="center"><FONT FACE="Times New Roman, Times, serif" SIZE="2">-8-</FONT></P>
<FONT SIZE="2" FACE="Times New Roman, Times, serif"> </FONT>
<P ALIGN=left><FONT SIZE="2"><I><FONT SIZE="2"><I><FONT FACE="Times Roman"></FONT></I></FONT></I></FONT></P>
<P ALIGN=right><FONT SIZE="2"><I><FONT FACE="Times Roman">Appendix C</FONT></I></FONT></P>
<P ALIGN=CENTER><FONT SIZE="2"><B><FONT FACE="Times Roman">DIAMETRICS MEDICAL, INC.
<BR>
1995 EMPLOYEE STOCK PURCHASE PLAN
<BR>
</FONT></B></FONT><FONT FACE="Times Roman" SIZE="2"><B>(as amended May 23, 2001)</B></FONT></P>
<P ALIGN=CENTER><FONT FACE="Times Roman" SIZE="2">ARTICLE I. &nbsp;&nbsp;INTRODUCTION</FONT></P>

<P><FONT SIZE="2"><FONT FACE="Times Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section 1.01. &nbsp;&nbsp;<U>Purpose</U></FONT><U><FONT FACE="Times Roman" SIZE="2">.</FONT></U></FONT><FONT FACE="Times Roman" SIZE="2">
&nbsp;&nbsp;The purpose of the Diametrics Medical, Inc. 1995 Employee Stock Purchase Plan (the &quot;Plan&quot;) is to provide employees of Diametrics Medical, Inc., a Minnesota corporation (the &quot;Company&quot;), and certain related corporations
with an opportunity to share in the ownership of the Company by providing them with a convenient means for regular and systematic purchases of the Company's Common Stock, par value $.01 per share, and, thus, to develop a stronger incentive to work
for the continued success of the Company.</FONT></P>
<P><FONT SIZE="2"><FONT FACE="Times Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section 1.02. &nbsp;&nbsp;<U>Rules of Interpretation</U></FONT><U><FONT FACE="Times Roman" SIZE="2">.</FONT></U></FONT><FONT
FACE="Times Roman" SIZE="2"> &nbsp;&nbsp;It is intended that the Plan be an &quot;employee stock purchase plan&quot; as defined in Section 423(b) of the Internal Revenue Code of 1986, as amended (the &quot;Code&quot;), and Treasury Regulations
promulgated thereunder. Accordingly, the Plan shall be interpreted and administered in a manner consistent therewith if so approved. All Participants in the Plan will have the same rights and privileges consistent with the provisions of the
Plan.</FONT></P>
<P><FONT SIZE="2"><FONT FACE="Times Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section 1.03. &nbsp;&nbsp;<U>Definitions</U></FONT></FONT><U><FONT FACE="Times Roman" SIZE="2">.</FONT></U><FONT FACE="Times Roman"
SIZE="2">&nbsp;&nbsp;&nbsp;For purposes of the Plan, the following terms will have the meanings set forth below:</FONT></P>
<BLOCKQUOTE>
<P><FONT FACE="Times Roman" SIZE="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&quot;<U>Acceleration Date</U>&quot; means the earlier of the
date of shareholder approval or approval by the Company's Board of Directors of (i) any consolidation or merger of the Company in which the Company is not the continuing or surviving corporation or pursuant to which shares of Company Common Stock
would be converted into cash, securities or other property, other than a merger of the Company in which shareholders of the Company immediately prior to the merger have the same proportionate ownership of stock in the surviving corporation
immediately after the merger; (ii) any sale, exchange or other transfer (in one transaction or a series of related transactions) of all or substantially all of the assets of the Company; or (iii) any plan of liquidation or dissolution of the
Company.</FONT></P>

<P><FONT FACE="Times Roman" SIZE="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &quot;<U>Affiliate</U>&quot; means any subsidiary corporation
of the Company, as defined in Section 424(f) of the Code, whether now or hereafter acquired or established.</FONT></P>

<P><FONT FACE="Times Roman" SIZE="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&quot;<U>Committee</U>&quot; means the committee described in
Section 10.01.</FONT></P>

<P><FONT FACE="Times Roman" SIZE="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&quot;<U>Company</U>&quot; means Diametrics Medical, Inc., a
Minnesota corporation, and its successors by merger or consolidation as contemplated by Article XI herein.</FONT></P>

<P><FONT FACE="Times Roman" SIZE="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&quot;<U>Current Compensation</U>&quot; means all regular base
wage or salary payments paid by the Company to a Participant in accordance with the terms of his or her employment, but excluding annual bonus payments and all other forms of special compensation.</FONT></P>

<P><FONT FACE="Times Roman" SIZE="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(f) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&quot;<U>Fair Market Value</U>&quot; as of a given date means
such value of the Common Stock as reasonably determined by the Committee, but shall not be less than (i) the closing price of the Common Stock as reported for composite transactions if the Common Stock is then traded on a national securities
exchange, (ii) the last sale price if the Common Stock is then quoted on the NASDAQ National Market System, or (iii) the average of the closing representative bid and asked prices of the Common Stock as reported on NASDAQ on the date as of which the
fair market value is being determined. If on a given date the Common Stock are not traded on an established securities market, the Committee shall make a good faith attempt to satisfy the requirements of this Section 1.03 and in connection therewith
shall take such action as it deems necessary or advisable.</FONT></P>

<P ALIGN="left"></P>

<P ALIGN="left"></P>

<P ALIGN="left"></P>

<P ALIGN="left"></P>
</BLOCKQUOTE>

<P></P>
<BLOCKQUOTE>
<P><FONT FACE="Times Roman" SIZE="2">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(g) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&quot;<U>Full-Time Employee</U>&quot; means an employee of the
Company or a Participating Affiliate as of the first day of a Purchase Period who has worked for the company for at least 90 days, including an officer or director who is also an employee, but excluding an employee whose customary employment is less
than 20 hours per week, provided, however, that for the initial Purchase Period, all employees whose customary employment exceeds 20 hours per week shall be eligible to participate regardless of the number of days they have been employed by the
Company.</FONT></P>

<P><FONT FACE="Times Roman" SIZE="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(h) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&quot;<U>Participant</U>&quot; means a Full-Time Employee who
is eligible to participate in the Plan under Section 2.01 and who has elected to participate in the Plan.</FONT></P>

<P><FONT FACE="Times Roman" SIZE="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &quot;<U>Participating Affiliate</U>&quot; means an Affiliate
which has been designated by the Committee in advance of the Purchase Period in question as a corporation whose eligible Full-Time Employees may participate in the Plan.</FONT></P>

<P><FONT FACE="Times Roman" SIZE="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(j) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; &quot;<U>Plan</U>&quot; means the Diametrics Medical, Inc.
1995 Employee Stock Purchase Plan, as amended, the provisions of which are set forth herein.</FONT></P>

<P><FONT FACE="Times Roman" SIZE="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(k) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&quot;<U>Purchase Period</U>&quot; means the approximate
3-month periods beginning on the first business day in January, April, July and October of each year and ending on the last business day in the following March, June, September and December, respectively; provided that the initial Purchase Period
will commence on July 3, 1995 and will terminate on September 29, 1995.</FONT></P>

<P><FONT FACE="Times Roman" SIZE="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(l) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&quot;<U>Common Stock</U>&quot; means the Company's Common
Stock, $.01 par value, as such stock may be adjusted for changes in the Company as contemplated by Article XI herein.</FONT></P>

<P><FONT FACE="Times Roman" SIZE="2"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(m) &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&quot;<U>Stock Purchase Account</U>&quot; means the account
maintained on the books and records of the Company recording the amount received from each Participant through payroll deductions made under the Plan.</FONT></P>
</BLOCKQUOTE>
<P ALIGN=CENTER><FONT FACE="Times Roman" SIZE="2">ARTICLE II.&nbsp;&nbsp; ELIGIBILITY AND PARTICIPATION</FONT></P>

<P><FONT SIZE="2"><FONT FACE="Times Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section 2.01.&nbsp;&nbsp; <U>Eligible Employees</U></FONT><U><FONT FACE="Times Roman" SIZE="2">.</FONT></U></FONT><FONT FACE="Times Roman"
SIZE="2"> &nbsp;&nbsp;All Full-Time Employees shall be eligible to participate in the plan beginning on the first day of the first Purchase Period to commence after such person becomes a Full-Time Employee. Subject to the provisions of Article VI,
each such employee will continue to be eligible to participate in the Plan so long as he or she remains a Full-Time Employee.</FONT></P>
<P><FONT SIZE="2"><FONT FACE="Times Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section 2.02.&nbsp;&nbsp; <U>Election to Participate</U></FONT><U><FONT FACE="Times Roman" SIZE="2">.</FONT></U></FONT><FONT
FACE="Times Roman" SIZE="2"> &nbsp;&nbsp;An eligible Full-Time Employee may elect to participate in the Plan for a given Purchase Period by filing with the Company, in advance of that Purchase Period and in accordance with such terms and conditions
as the Committee in its sole discretion may impose, a form provided by the Company for such purpose which authorizes regular payroll deductions from Current Compensation beginning with the first payday in that Purchase Period and continuing until
the employee withdraws from the Plan or ceases to be eligible to participate in the Plan.</FONT></P>
<P><FONT SIZE="2"><FONT FACE="Times Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section 2.03.&nbsp;&nbsp; <U>Limits on Stock Purchase</U></FONT><U><FONT FACE="Times Roman" SIZE="2">.</FONT></U></FONT><FONT
FACE="Times Roman" SIZE="2"> &nbsp;&nbsp;No employee shall be granted any right to purchase Common Stock hereunder if such employee, immediately after such right to purchase is granted, would own, directly or indirectly, within the meaning of
Section 423(b)(3) and Section 424(d) of the Code, Common Stock possessing 5% or more of the total combined voting power or value of all the classes of the capital stock of the Company or all Affiliates.</FONT></P>
<P><FONT SIZE="2"><FONT FACE="Times Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section 2.04.&nbsp;&nbsp; <U>Voluntary Participation</U></FONT><U><FONT FACE="Times Roman" SIZE="2">.</FONT></U> &nbsp;&nbsp; </FONT><FONT
FACE="Times Roman" SIZE="2">Participation in the Plan on the part of a Participant is voluntary and such participation is not a condition of employment nor does participation in the Plan entitle a Participant to be retained as an employee.
</FONT></P>
<P ALIGN="center"><FONT FACE="Times Roman" SIZE="2">-2-</FONT></P>

<P ALIGN="left"></P>
<P ALIGN=CENTER><FONT FACE="Times Roman" SIZE="2">ARTICLE III. PAYROLL DEDUCTIONS, COMPANY
<BR>
</FONT><FONT FACE="Times Roman" SIZE="2">CONTRIBUTIONS AND STOCK PURCHASE ACCOUNT</FONT></P>

<P><FONT SIZE="2"><FONT FACE="Times Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section 3.01. &nbsp;&nbsp;<U>Deduction from Pay</U></FONT></FONT><U><FONT FACE="Times Roman" SIZE="2">.</FONT></U><FONT FACE="Times Roman"
SIZE="2"> &nbsp;&nbsp;The form described in Section 2.02 will permit a Participant to elect payroll deductions of any multiple of 1% but not less than 1% or more than 10% of such Participant's Current Compensation for each pay period, subject to
such other limitations as the Committee in its sole discretion may impose. A Participant may cease making payroll deductions at any time, subject to such limitations as the Committee in its sole discretion may impose. </FONT></P>
<P><FONT SIZE="2"><FONT FACE="Times Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section 3.02.&nbsp;&nbsp; <U>Credit to Account</U></FONT></FONT><U><FONT FACE="Times Roman" SIZE="2">.</FONT></U><FONT FACE="Times Roman"
SIZE="2"> &nbsp;&nbsp;Pay</FONT><FONT FACE="Times Roman" SIZE="2">roll deductions will be credited to the Participant's Stock Purchase Account on each payday, and Company contributions will be credited to the Participant's Stock Purchase Account on
the last business day of the Purchase Period at the time of and in connection with the purchase of shares of Common Stock in accordance with Article IV and V hereof. </FONT></P>
<P><FONT SIZE="2"><FONT FACE="Times Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section 3.03. &nbsp;&nbsp;<U>Interest</U></FONT></FONT><U><FONT FACE="Times Roman" SIZE="2">.</FONT></U><FONT FACE="Times Roman"
SIZE="2">&nbsp; No interest will be paid upon payroll deductions, Company contributions or on any amount credited to, or on deposit in, a Participant's Stock Purchase Account. </FONT></P>
<P><FONT SIZE="2"><FONT FACE="Times Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section 3.04. &nbsp;&nbsp;<U>Nature of Account</U></FONT></FONT><U><FONT FACE="Times Roman" SIZE="2">.</FONT></U><FONT FACE="Times Roman"
SIZE="2"> &nbsp;&nbsp;The Stock Purchase Account is established solely for accounting purposes, and all amounts credited to the Stock Purchase Account will remain part of the general assets of the Company or the Participating Affiliate (as the case
may be).</FONT></P>
<P><FONT SIZE="2"><FONT FACE="Times Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section 3.05.&nbsp;&nbsp; <U>No Additional Contributions</U></FONT></FONT><U><FONT FACE="Times Roman" SIZE="2">.</FONT></U><FONT
FACE="Times Roman" SIZE="2">&nbsp;&nbsp; A Participant may not make any payment into the Stock Purchase Account other than the payroll deductions made pursuant to the Plan.</FONT></P>

<P ALIGN=CENTER><FONT FACE="Times Roman" SIZE="2">ARTICLE IV. &nbsp;&nbsp;RIGHT TO PURCHASE SHARES</FONT></P>

<P><FONT SIZE="2"><FONT FACE="Times Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section 4.01.&nbsp;&nbsp; <U>Number of Shares</U></FONT></FONT><U><FONT FACE="Times Roman" SIZE="2">.</FONT></U><FONT FACE="Times Roman"
SIZE="2"> &nbsp;&nbsp;Each Participant will have the right to purchase on the last business day of the Purchase Period all, but not less than all, of the largest number of whole shares of Common Stock that can be purchased at the price specified in
Section 4.02 with the entire credit balance in the Participant's Stock Purchase Account, subject to the limitations that (a) no more than 2,000 shares of Common Stock may be purchased under the Plan by any one Participant for a given Purchase Period
and (b) in accordance with Section 423 (b)(8) of the Code, no more than $25,000 in Fair Market Value (determined at the beginning of each Purchase Period) of Common Stock and other stock may be purchased under the Plan and all other employee stock
purchase plans (if any) of the Company and the Affiliates by any one Participant for any calendar year. If the purchases for all Participants would otherwise cause the aggregate number of shares of Common Stock to be sold under the Plan to exceed
the number specified in Section 10.03, each Participant shall be allocated a pro rata portion of the Common Stock to be sold.</FONT></P>

<P><FONT SIZE="2"><FONT FACE="Times Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section 4.02. &nbsp;&nbsp;<U>Purchase Price</U></FONT></FONT><U><FONT FACE="Times Roman" SIZE="2">.</FONT></U><FONT FACE="Times Roman"
SIZE="2">&nbsp;&nbsp; The purchase price for any Purchase Period shall be the lesser of (a) 85% of the Fair Market Value of the Common Stock on the first business day of that Purchase Period or (b) 85% of the Fair Market Value of the Common Stock on
the last business day of that Purchase Period, in each case rounded up to the next higher full cent.</FONT></P>

<P ALIGN=CENTER><FONT FACE="Times Roman" SIZE="2">ARTICLE V. &nbsp;&nbsp;EXERCISE OF RIGHT</FONT></P>
<P><FONT SIZE="2"><FONT FACE="Times Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section 5.01. &nbsp;&nbsp;<U>Purchase of Stock</U></FONT></FONT><U><FONT FACE="Times Roman" SIZE="2">.</FONT></U><FONT FACE="Times Roman"
SIZE="2"> </FONT><FONT FACE="Times Roman" SIZE="2">&nbsp;&nbsp;On the last business day of a Purchase Period, the entire credit balance in each Participant's Stock Purchase Account will be used to purchase the largest number of whole shares of
Common Stock purchasable with such amount (subject to the limitations of Section 4.01), unless the Participant has filed with the Company, in advance of that date and subject to such terms and conditions as the Committee in its sole discretion may
impose, a form provided by the Company which requests the distribution of the entire credit balance in cash.</FONT></P>

<P><FONT SIZE="2"><FONT FACE="Times Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section 5.02.&nbsp;&nbsp; <U>Cash Contributions</U></FONT></FONT><U><FONT FACE="Times Roman" SIZE="2">.</FONT></U><FONT FACE="Times Roman"
SIZE="2"> &nbsp;&nbsp;A</FONT><FONT FACE="Times Roman" SIZE="2">ny amount remaining in a Participant's Stock Purchase Account after the last business day of a Purchase Period will be paid to the Participant in cash within 30 days after the end of
that Purchase Period.</FONT></P>
<P ALIGN="center"><FONT FACE="Times Roman" SIZE="2">-3-</FONT></P>

<P ALIGN="left"></P>
<P><FONT SIZE="2"><FONT FACE="Times Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section 5.03. &nbsp;&nbsp;<U>Notice of Acceleration Date</U></FONT></FONT><U><FONT FACE="Times Roman" SIZE="2">.</FONT></U><FONT
FACE="Times Roman" SIZE="2"> &nbsp;&nbsp;The Co</FONT><FONT FACE="Times Roman" SIZE="2">mpany shall use its best efforts to notify each Participant in writing at least ten days prior to any Acceleration Date that the then current Purchase Period
will end on such Acceleration Date.</FONT></P>

<P ALIGN=CENTER><FONT FACE="Times Roman" SIZE="2">ARTICLE VI. &nbsp;&nbsp;WITHDRAWAL FROM PLAN: SALE OF STOCK</FONT></P>

<P><FONT SIZE="2"><FONT FACE="Times Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section 6.01.&nbsp;&nbsp; <U>Voluntary Withdrawal</U></FONT></FONT><U><FONT FACE="Times Roman" SIZE="2">.</FONT></U><FONT FACE="Times Roman"
SIZE="2"> &nbsp;&nbsp;A Participant may, in accordance with such terms and conditions as the Committee in its sole discretion may impose, withdraw from the Plan and cease making a payroll deductions by filing with the Company a form provided for
this purpose. In such event, the entire credit balance in the Participant's Stock Purchase Account will be paid to the Participant in cash within 30 days. A Participant who withdraws from the Plan will not be eligible to reenter the Plan until the
beginning of the next Purchase Period following the date of such withdrawal.</FONT></P>
<P><FONT SIZE="2"><FONT FACE="Times Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section 6.02.&nbsp;&nbsp; <U>Death</U></FONT></FONT><U><FONT FACE="Times Roman" SIZE="2">.</FONT></U><FONT FACE="Times Roman" SIZE="2">&nbsp;
&nbsp;Subject to such terms and conditions as the Committee in its sole discretion may impose, upon the death of a Participant, no further amounts shall be credited to the Participant's Stock Purchase Account. Thereafter, on the last business day of
the Purchase Period during which such Participant's death occurred and in accordance with Section 5.01, the entire credit balance in such Participant's Stock Purchase Account will be used to purchase Common Stock, unless such Participant's estate
has filed with the Company, in advance of that day and subject to such terms and conditions as the Committee in its sole discretion may impose, a form provided by the Company which elects to have the entire credit balance in such Participant's Stock
Account distributed in cash within 30 days after the end of that Purchase Period or at such earlier time as the Committee in its sole discretion may decide. Each Participant, however, may designate one or more beneficiaries who, upon death, are to
receive the Common Stock or the amount that otherwise would have been distributed or paid to the Participant's estate and may change or revoke any such designation form time to time. No such designation, change or revocation will be effective unless
made by the Participant in writing and filed with the Company during the Participant's lifetime. Unless the Participant has otherwise specified the beneficiary designation, the beneficiary or beneficiaries so designated will become fixed as of the
date of the death of the Participant so that, if a beneficiary survives the Participant but dies before the receipt of the payment due such beneficiary, the payment will be made to such beneficiary's estate.</FONT></P>

<P><FONT SIZE="2"><FONT FACE="Times Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section 6.03. &nbsp;&nbsp;<U>Termination of Employment</U></FONT></FONT><U><FONT FACE="Times Roman" SIZE="2">.</FONT></U><FONT FACE="Times Roman"
SIZE="2"> &nbsp;&nbsp;Subject such terms and conditions as the Committee in its sole discretion may impose, upon a Participant's normal or early retirement with the consent of the Company under any pension or retirement plan of the Company or
Participating Affiliate, no further amounts shall be credited to the Participant's Stock Purchase Account. Thereafter, on the last business day of the Purchase Period during which such Participant's approved retirement occurred and in accordance
with Section 5.01, the entire credit balance in such Participant's Stock Purchase Account will be used to purchase Common Stock, unless such Participant has filed with Company, in advance of that day and subject to such terms and conditions as the
committee in its sole discretion may impose, a form provided by the Company which elects to receive the entire credit balance in such Participant's Stock Purchase Account in cash within 30 days after the end of that Purchase Period, provided that
such Participant shall have no right to purchase Common Stock in the event that the last day of such a Purchase Period occurs more than three months following the termination of such Participates employment with Company by reason of such an approved
retirement. In the event of any other termination of employment (other than death) with the Company or a participating Affiliate, participation the Plan will cease on the date the Participant ceases to be a Full-Time Employee for any reason. In such
event, the entire credit balance in such Participant's Stock Purchase Account will be paid to the Participant in cash within 30 days. For purposes of this Section 6.03, a transfer of employment to any Affiliate, or a leave of absence which has been
approved by the Committee, will not be deemed a termination of employment as a Full-Time Employee.</FONT></P>

<P ALIGN=CENTER><FONT FACE="Times Roman" SIZE="2">ARTICLE VII. &nbsp;&nbsp;NON-TRANSFERABILITY</FONT></P>
<P><FONT SIZE="2"><FONT FACE="Times Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section 7.01. &nbsp;&nbsp;<U>Nontransferable Right to Purchase</U></FONT></FONT><U><FONT FACE="Times Roman" SIZE="2">.</FONT></U><FONT
FACE="Times Roman" SIZE="2"> &nbsp;&nbsp;The right to purchase Common Stock hereunder may not be assigned, transferred, pledged or hypothecated (whether by operation of law or otherwise), except as provided in Section 6.02, and will not be subject
to execution, attachment or similar process. Any attempted assignment, transfer, pledge, hypothecation or other disposition or levy of attachment or similar process upon the right to purchase will be null and void and without effect.</FONT></P>
<P ALIGN="center"><FONT FACE="Times Roman" SIZE="2">-4-</FONT></P>

<P ALIGN="left"></P>
<P><FONT SIZE="2"><FONT FACE="Times Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section 7.02. &nbsp;&nbsp;<U>Nontransferable Account</U></FONT></FONT><U><FONT FACE="Times Roman" SIZE="2">. </FONT></U><FONT FACE="Times Roman"
SIZE="2">&nbsp;&nbsp;as provided in Section 6.02, the amounts credited to a Stock Purchase Account may not be assigned, transferred, pledged or hypothecated in any way, and any attempted assignment, transfer, pledge, hypothecation or other
disposition of such amounts will be null and void and without effect.</FONT></P>
<P ALIGN=CENTER><FONT FACE="Times Roman" SIZE="2">ARTICLE VIII. &nbsp;&nbsp;STOCK CERTIFICATES</FONT></P>

<P><FONT SIZE="2"><FONT FACE="Times Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section 8.01.&nbsp;&nbsp; <U>Delivery</U></FONT></FONT><U><FONT FACE="Times Roman" SIZE="2">.</FONT></U><FONT FACE="Times Roman" SIZE="2">
&nbsp;&nbsp;Promptly after the last day of each Purchase Period and subject to such terms and conditions as the Committee in its sole discretion may impose, the Company will cause to be delivered to or for the benefit of the Participant a
certificate representing the Common Stock purchased on the last business day of such Purchase Period.</FONT></P>

<P><FONT SIZE="2"><FONT FACE="Times Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section 8.02. &nbsp;&nbsp;<U>Securities Laws</U></FONT></FONT><U><FONT FACE="Times Roman" SIZE="2">.</FONT></U><FONT FACE="Times Roman"
SIZE="2">&nbsp;&nbsp; The Company shall not be required to issue or deliver any certificate representing Common Stock prior to registration under the Securities Act of 1933, as amended, or registration or qualification under any state law if such
registrations required. The Company shall use its best efforts to accomplish such registration (if and to the extent required) not later than a reasonable time following the Purchase Period, and delivery of certificates may be deferred until such
registration is accomplished.</FONT></P>
<P><FONT SIZE="2"><FONT FACE="Times Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section 8.03. &nbsp;&nbsp;<U>Completion of Purchase</U></FONT></FONT><U><FONT FACE="Times Roman" SIZE="2">.</FONT></U><FONT FACE="Times Roman"
SIZE="2"> &nbsp;&nbsp;A Participant shall have no interest in the Common Stock purchased until a certificate representing the same is issued to or for the benefit of the Participant.</FONT></P>

<P><FONT SIZE="2"><FONT FACE="Times Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section 8.04. &nbsp;&nbsp;<U>Form of Ownership</U></FONT></FONT><U><FONT FACE="Times Roman" SIZE="2">.</FONT></U><FONT FACE="Times Roman"
SIZE="2">&nbsp;&nbsp; The certificates representing Common Stock issued under the Plan will be registered in the name of the Participant or jointly in the name of the Participant and another person, as the Participant may direct on a form provided
by the Company.</FONT></P>
<P ALIGN=CENTER><FONT FACE="Times Roman" SIZE="2">ARTICLE IX. &nbsp;&nbsp;EFFECTIVE DATE AMENDMENT AND TERMINATION OF PLAN</FONT></P>

<P><FONT SIZE="2"><FONT FACE="Times Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section 9.01. &nbsp;&nbsp;<U>Effective Date</U></FONT></FONT><U><FONT FACE="Times Roman" SIZE="2">.</FONT></U><FONT FACE="Times Roman" SIZE="2">
&nbsp;&nbsp;The Plan was approved by the Board of Directors of the Company on April 19, 1995, and will be approved by the shareholders within 12 months of such date.</FONT></P>
<P><FONT SIZE="2"><FONT FACE="Times Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section 9.02. &nbsp;&nbsp;<U>Plan Commencement</U></FONT></FONT><U><FONT FACE="Times Roman" SIZE="2">.</FONT></U><FONT FACE="Times Roman"
SIZE="2"> &nbsp;&nbsp;The initial Purchase Period under the Plan will commence on July 3, 1995. Thereafter each succeeding Purchase Period will commence and terminate in accordance with Section 1.03(k).</FONT></P>

<P><FONT SIZE="2"><FONT FACE="Times Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section 9.03.&nbsp;&nbsp; <U>Powers of Board</U></FONT></FONT><U><FONT FACE="Times Roman" SIZE="2">.</FONT></U><FONT FACE="Times Roman" SIZE="2">
&nbsp;&nbsp;The Board of Directors may amend or discontinue the Plan at any time. No amendment or discontinuation of the Plan, however, shall without shareholder approval be made that (i) absent such shareholder approval, would cause Rule 16b-3
under the Securities Exchange Act of 1934, as amended (the &quot;Act&quot;) to become unavailable with respect to the Plan, (ii) requires shareholder approval under any rules or regulations of the National Association of Securities Dealers, Inc. or
any securities exchange that are applicable to the Company, or (iii) permit the issuance of Common Stock before payment therefor in full.</FONT></P>

<P><FONT SIZE="2"><FONT FACE="Times Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section 9.04.&nbsp;&nbsp; <U>Automatic Termination</U></FONT></FONT><U><FONT FACE="Times Roman" SIZE="2">.</FONT></U><FONT FACE="Times Roman"
SIZE="2"> &nbsp;&nbsp;The Plan shall automatically terminate when all of the shares of Common Stock provided for in Section 10.03 have been sold.</FONT></P>

<P ALIGN=CENTER><FONT FACE="Times Roman" SIZE="2">ARTICLE X.&nbsp;&nbsp; ADMINISTRATION</FONT></P>

<P><FONT SIZE="2"><FONT FACE="Times Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section 10.01. &nbsp;&nbsp;&nbsp;&nbsp;<U>The Committee</U></FONT></FONT><U><FONT FACE="Times Roman" SIZE="2">.</FONT></U><FONT FACE="Times Roman"
SIZE="2"> &nbsp;&nbsp;The Plan shall be administered by a committee (the &quot;Committee&quot;) of two or more directors of the none of whom shall be officers or employees of the Company and all of whom shall be &quot;disinterested persons&quot;
with respect to the Plan within the meaning of Rule 16b-3 under the Act. The members of the committee shall be appointed by and serve at the pleasure of the Board of Directors.</FONT></P>
<P><FONT SIZE="2"><FONT FACE="Times Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section 10.02. &nbsp;&nbsp;&nbsp;&nbsp;<U>Powers of Committee</U></FONT></FONT><U><FONT FACE="Times Roman" SIZE="2">.</FONT></U><FONT
FACE="Times Roman" SIZE="2"> &nbsp;&nbsp;Subject to the provisions of the Plan, the Committee shall have full authority to administer the plan, including authority to interpret and construe any provision of the Plan, to establish deadlines by which
the various administrative forms must be received in order to be effective, and to adopt such other rules and regulations for administrating the Plan as it may deem appropriate. The Committee shall have full </FONT></P>
<P ALIGN="center"><FONT SIZE="2" FACE="Times New Roman, Times, serif">-5-</FONT></P>

<P ALIGN="left"></P>
<P><FONT FACE="Times Roman" SIZE="2">and complete authority to determine whether all or any part of the Common Stock acquired pursuant to the Plan shall be subject to restriction on the transferability thereof or any other restrictions affecting in
any manner a Participant's rights with respect thereto but any such restrictions shall be contained in the form by which a Participant elects to participate in the Plan pursuant to Section 2.02. Decisions of the Committee will be final and binding
on all parties who have an interest in the Plan.</FONT></P>
<P><FONT SIZE="2"><FONT FACE="Times Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section &nbsp;10.03.&nbsp;&nbsp; <U>Stock to be Sold</U></FONT></FONT><U><FONT FACE="Times Roman" SIZE="2">.</FONT></U><FONT
FACE="Times Roman" SIZE="2"> &nbsp;&nbsp;The Common Stock to be issued and sold under the Plan may be treasury shares or authorized but unissued shares, or the Company may purchase Common Stock in the market for sale under the Plan. Except as
provided in Section 11.01, the aggregate number of shares of Common Stock to be sold under the Plan will not exceed 400,000 shares.</FONT></P>

<P><FONT SIZE="2"><FONT FACE="Times Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section 10.04. &nbsp;&nbsp;<U>Notices</U></FONT></FONT><U><FONT FACE="Times Roman" SIZE="2">.</FONT></U><FONT FACE="Times Roman" SIZE="2">
&nbsp;&nbsp;Notices to the Committee should be addressed as follows:</FONT></P>
<BLOCKQUOTE>
<P><FONT FACE="Times Roman" SIZE="2">Compensation Committee</FONT></P>

<P><FONT FACE="Times Roman" SIZE="2">Diametrics Medical, Inc.</FONT></P>

<P><FONT FACE="Times Roman" SIZE="2">2658 Patton Road</FONT></P>

<P><FONT FACE="Times Roman" SIZE="2">Roseville, Minnesota 55113</FONT></P>
</BLOCKQUOTE>
<P ALIGN=CENTER><FONT FACE="Times Roman" SIZE="2">ARTICLE XI. &nbsp;&nbsp;ADJUSTMENT FOR CHANGES IN STOCK OR COMPANY</FONT></P>
<P><FONT SIZE="2"><FONT FACE="Times Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section 11.01. &nbsp;&nbsp;<U>Stock dividend or Reclassification</U></FONT></FONT><U><FONT FACE="Times Roman" SIZE="2">.</FONT></U><FONT
FACE="Times Roman" SIZE="2"> &nbsp;&nbsp;If the outstanding shares of Common Stock are increased, decreased, changed into or exchanged for a different number or kind of securities of the Company, or shares of a different par value or without par
value, through reorganization, recapitalization, reclassification, stock dividend, stock split, amendment to the Company's certificate of Incorporation, reverse stock split or otherwise, and appropriate adjustment shall be made in the maximum
numbers and kind of securities to be purchased under the Plan with a corresponding adjustment in the purchase price to be paid therefor.</FONT></P>

<P><FONT SIZE="2"><FONT FACE="Times Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Section 11.02. &nbsp;&nbsp;<U>Merger or Consolidation</U></FONT></FONT><U><FONT FACE="Times Roman" SIZE="2">.</FONT></U><FONT
FACE="Times Roman" SIZE="2"> &nbsp;&nbsp;If the Company is merged into or consolidated with one or more corporations during the term of the Plan, appropriate adjustments will be made to give effect thereto on an equitable basis in terms of issuance
of shares of the corporation surviving the merger or of the consolidated corporation, as the case may be.</FONT></P>

<P ALIGN=CENTER><FONT FACE="Times Roman" SIZE="2">ARTICLE XII. APPLICABLE LAW</FONT></P>
<P><FONT FACE="Times Roman" SIZE="2">Rights to purchase Common Stock granted under the Plan shall be construed and shall take effect in accordance with the laws of the State of Minnesota.</FONT></P>
<P ALIGN="center"><FONT SIZE="2" FACE="Times New Roman, Times, serif">-6-</FONT></P>
<FONT SIZE="2"> </FONT>
<P ALIGN="center"> <FONT SIZE="2" FACE="Times New Roman, Times, serif">DIAMETRICS MEDICAL, INC.</FONT>
<BR>
<FONT SIZE="2" FACE="Times New Roman, Times, serif">2658 Patton Road
<BR>
Roseville, Minnesota 55113</FONT> </P>
<P ALIGN="center"> <FONT SIZE="2" FACE="Times New Roman, Times, serif">Annual Meeting of Shareholders May 23, 2001
<BR>
</FONT> <FONT SIZE="2" FACE="Times New Roman, Times, serif">This Proxy is Solicited on Behalf of the Board of Directors</FONT> </P>
<P> <FONT SIZE="2" FACE="Times New Roman, Times, serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;The undersigned appoints David T. Giddings and Laurence L. Betterley, and each of them, with power to act without the other and with all the right of substitution
in each, the proxies of the undersigned to vote all shares of Diametrics Medical, Inc. (the "Company") held by the undersigned on April 4, 2001, at the Annual Meeting of Shareholders of the Company to be held on Wednesday, May 23, 2001 at 3:30 p.m.,
at the Minneapolis Marriott City Center, 30 South Seventh Street, Minneapolis, Minnesota, and at all adjournments thereof, with all the powers the undersigned would possess if present in person. All previous proxies given with respect to the meeting
are revoked.</FONT> </P>
<P> <FONT SIZE="2" FACE="Times New Roman, Times, serif">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Receipt of Notice of Annual Meeting of Shareholders and Proxy Statement is acknowledged by your execution of this proxy. Complete, sign, date and return the proxy
in the addressed envelope -- no postage required. Please mail promptly to save further solicitation expenses.</FONT> </P>
<P ALIGN="center"> <FONT SIZE="2" FACE="Times New Roman, Times, serif">(To be Signed on Reverse Side)</FONT> </P>
<FONT SIZE="2" FACE="Times New Roman, Times, serif"> </FONT>
<P ALIGN="center"> <FONT SIZE="2" FACE="Times New Roman, Times, serif"> &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<B>Please date, sign and mail your
<BR>
proxy card back as soon as possible! </B></FONT></P>
<P ALIGN="center"> <B><FONT SIZE="2" FACE="Times New Roman, Times, serif">Annual Meeting of Shareholders
<BR>
DIAMETRICS MEDICAL, INC. </FONT></B></P>
<P ALIGN="center"> <B><FONT SIZE="2" FACE="Times New Roman, Times, serif">May 23, 2001</FONT></B></P>
<P ALIGN="center"> <FONT SIZE="2" FACE="Times New Roman, Times, serif">
<BR>

<BR>
<FONT FACE="wingdings">&ecirc;</FONT>&nbsp;Please Detach and Mail in the Envelope Provided<FONT FACE="wingdings">&ecirc;</FONT></FONT><FONT SIZE="2" FACE="Times New Roman, Times, serif"> </FONT></P>
<TABLE BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD COLSPAN="8"><FONT SIZE="2"></FONT> <HR NOSHADE ALIGN="left" WIDTH="100%" SIZE="1"> </TD>
</TR>
<TR>
<TD WIDTH="1%">&nbsp;</TD>
<TD VALIGN="top" WIDTH="5%"><FONT FACE="wingdings">x</FONT><FONT SIZE="2"></FONT></TD>
<TD NOWRAP WIDTH="22%"> <DIV ALIGN="center"><FONT SIZE="2" FACE="Times New Roman, Times, serif">Please mark your votes as in this example</FONT></DIV>
</TD>
<TD VALIGN="bottom" NOWRAP WIDTH="20%">&nbsp;</TD>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="17%">&nbsp;</TD>
<TD WIDTH="12%">&nbsp;</TD>
<TD WIDTH="16%">&nbsp;</TD>
</TR>
<TR>
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="22%">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP WIDTH="20%">&nbsp;</TD>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="17%">&nbsp;</TD>
<TD WIDTH="12%">&nbsp;</TD>
<TD WIDTH="16%">&nbsp;</TD>
</TR>
<TR>
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="22%">&nbsp;</TD>
<TD ALIGN="center" VALIGN="bottom" NOWRAP WIDTH="20%"><FONT SIZE="2" FACE="Times New Roman, Times, serif">FOR all nominees
<BR>
(except as marked to
<BR>
the contrary below) </FONT></TD>
<TD ALIGN="center" WIDTH="8%">&nbsp;</TD>
<TD ALIGN="center" WIDTH="17%"><FONT SIZE="2" FACE="Times New Roman, Times, serif">WITHHOLD AUTHORITY
<BR>
to vote for all nominees </FONT></TD>
<TD WIDTH="12%">&nbsp;</TD>
<TD WIDTH="16%">&nbsp;</TD>
</TR>
<TR VALIGN="top">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="22%">&nbsp;</TD>
<TD VALIGN="top" NOWRAP WIDTH="20%">&nbsp;</TD>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="17%">&nbsp;</TD>
<TD WIDTH="12%">&nbsp;</TD>
<TD NOWRAP WIDTH="16%">&nbsp;</TD>
</TR>
<TR VALIGN="top">
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="5%"><FONT SIZE="2" FACE="Times New Roman, Times, serif">(1)</FONT></TD>
<TD WIDTH="22%"><FONT SIZE="2" FACE="Times New Roman, Times, serif">Election of
<BR>
Directors: </FONT></TD>
<TD VALIGN="top" NOWRAP WIDTH="20%"> <DIV ALIGN="center"><FONT FACE="wingdings" SIZE="2">o</FONT></DIV>
</TD>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="17%"> <DIV ALIGN="center"><FONT FACE="wingdings" SIZE="2">o</FONT></DIV>
</TD>
<TD WIDTH="12%"> <DIV ALIGN="left"><FONT SIZE="2" FACE="Times New Roman, Times, serif">Nominees:</FONT></DIV>
</TD>
<TD NOWRAP WIDTH="16%">
<P><FONT SIZE="2" FACE="Times New Roman, Times, serif">Gerald L. Cohn
<BR>
Carl S. Goldfischer, M.D
<BR>
Mark B. Knudson, Ph. D.</FONT></P>
</TD>
</TR>
<TR>
<TD VALIGN="top" WIDTH="1%">&nbsp;</TD>
<TD VALIGN="top" WIDTH="5%">&nbsp;</TD>
<TD WIDTH="22%">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP WIDTH="20%">&nbsp;</TD>
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="17%">&nbsp;</TD>
<TD WIDTH="12%">&nbsp;</TD>
<TD WIDTH="16%">&nbsp;</TD>
</TR>
<TR>
<TD VALIGN="top" WIDTH="1%">&nbsp;</TD>
<TD VALIGN="top" WIDTH="5%">&nbsp;</TD>
<TD COLSPAN="6"><FONT SIZE="2" FACE="Times New Roman, Times, serif">To withhold authority to vote for a specific nominee, place a line through such nominee's name at right.</FONT></TD>
</TR>
<TR>
<TD VALIGN="top" WIDTH="1%">&nbsp;</TD>
<TD VALIGN="top" WIDTH="5%">&nbsp;</TD>
<TD COLSPAN="6" VALIGN="top">&nbsp;</TD>
</TR>
<TR>
<TD VALIGN="top" WIDTH="1%">&nbsp;</TD>
<TD VALIGN="top" WIDTH="5%"> <FONT SIZE="2">(2)</FONT></TD>
<TD COLSPAN="6" VALIGN="top"><FONT SIZE="2">Approval of amendment to the Company&#146;s Amended and Restated Articles of Incorporation to increase the number of authorized shares.</FONT></TD>
</TR>
<TR>
<TD VALIGN="top" WIDTH="1%">&nbsp;</TD>
<TD VALIGN="top" WIDTH="5%">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="6">&nbsp;</TD>
</TR>
<TR>
<TD VALIGN="top" WIDTH="1%">&nbsp;</TD>
<TD VALIGN="top" WIDTH="5%">&nbsp;</TD>
<TD WIDTH="22%"> <DIV ALIGN="center"><FONT FACE="Times New Roman, Times, serif" SIZE="2">FOR</FONT><FONT FACE="wingdings" SIZE="2">
<BR>
o</FONT></DIV>
</TD>
<TD WIDTH="20%"> <DIV ALIGN="center"><FONT SIZE="2">AGAINST<FONT FACE="wingdings">
<BR>
o</FONT></FONT></DIV>
</TD>
<TD WIDTH="8%"> <DIV ALIGN="center"><FONT SIZE="2"></FONT></DIV>
</TD>
<TD WIDTH="17%"> <DIV ALIGN="center"><FONT SIZE="2">ABSTAIN<FONT FACE="wingdings">
<BR>
o</FONT></FONT></DIV>
</TD>
<TD WIDTH="12%"> <DIV ALIGN="center"><FONT SIZE="2"></FONT></DIV>
</TD>
<TD WIDTH="16%">&nbsp;</TD>
</TR>
<TR>
<TD VALIGN="top" WIDTH="1%">&nbsp;</TD>
<TD VALIGN="top" WIDTH="5%">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="6">&nbsp;</TD>
</TR>
<TR>
<TD VALIGN="top" WIDTH="1%">&nbsp;</TD>
<TD VALIGN="top" WIDTH="5%"><FONT SIZE="2">(3)</FONT></TD>
<TD VALIGN="top" COLSPAN="6"><FONT SIZE="2">Approval of amendment to the Company&#146;s 1990 Stock Option Plan to increase the number of authorized shares.</FONT></TD>
</TR>
<TR>
<TD VALIGN="top" WIDTH="1%">&nbsp;</TD>
<TD VALIGN="top" WIDTH="5%"><FONT SIZE="2"></FONT></TD>
<TD VALIGN="top" WIDTH="22%"> <DIV ALIGN="center"><FONT FACE="Times New Roman, Times, serif" SIZE="2">FOR</FONT><FONT FACE="wingdings" SIZE="2">
<BR>
o</FONT></DIV>
</TD>
<TD VALIGN="bottom" WIDTH="20%"> <DIV ALIGN="center"><FONT SIZE="2"><FONT SIZE="2">AGAINST<FONT FACE="wingdings">
<BR>
o</FONT></FONT></FONT></DIV>
</TD>
<TD WIDTH="8%"> <DIV ALIGN="center"><FONT SIZE="2"></FONT></DIV>
</TD>
<TD VALIGN="top" WIDTH="17%"> <DIV ALIGN="center"><FONT SIZE="2">ABSTAIN<FONT FACE="wingdings">
<BR>
o</FONT></FONT></DIV>
</TD>
<TD WIDTH="12%"> <DIV ALIGN="center"><FONT SIZE="2"></FONT></DIV>
</TD>
<TD WIDTH="16%">&nbsp;</TD>
</TR>
<TR>
<TD VALIGN="top" WIDTH="1%">&nbsp;</TD>
<TD VALIGN="top" WIDTH="5%">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="6">&nbsp;</TD>
</TR>
<TR>
<TD VALIGN="top" WIDTH="1%">&nbsp;</TD>
<TD VALIGN="top" WIDTH="5%"><FONT SIZE="2">(4)</FONT></TD>
<TD VALIGN="top" COLSPAN="6"><FONT SIZE="2">Approval of amendment to the Company&#146;s 1993 Directors&#146; Stock Option Plan to increase the number of authorized shares. </FONT></TD>
</TR>
<TR>
<TD VALIGN="top" WIDTH="1%">&nbsp;</TD>
<TD VALIGN="top" WIDTH="5%">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="6">&nbsp;</TD>
</TR>
<TR>
<TD VALIGN="top" WIDTH="1%">&nbsp;</TD>
<TD VALIGN="top" WIDTH="5%"><FONT SIZE="2"></FONT></TD>
<TD WIDTH="22%"> <DIV ALIGN="center"><FONT FACE="Times New Roman, Times, serif" SIZE="2">FOR</FONT><FONT FACE="wingdings" SIZE="2">
<BR>
o</FONT></DIV>
</TD>
<TD WIDTH="20%"> <DIV ALIGN="center"><FONT SIZE="2">AGAINST<FONT FACE="wingdings">
<BR>
o</FONT></FONT></DIV>
</TD>
<TD WIDTH="8%"> <DIV ALIGN="center"><FONT SIZE="2"></FONT></DIV>
</TD>
<TD WIDTH="17%"> <DIV ALIGN="center"><FONT SIZE="2">ABSTAIN<FONT FACE="wingdings">
<BR>
o</FONT></FONT></DIV>
</TD>
<TD WIDTH="12%"> <DIV ALIGN="center"><FONT SIZE="2"></FONT></DIV>
</TD>
<TD WIDTH="16%"><FONT SIZE="2"></FONT></TD>
</TR>
<TR>
<TD VALIGN="top" WIDTH="1%">&nbsp;</TD>
<TD VALIGN="top" WIDTH="5%">&nbsp;</TD>
<TD VALIGN="top" COLSPAN="6">&nbsp;</TD>
</TR>
<TR>
<TD VALIGN="top" WIDTH="1%">&nbsp;</TD>
<TD VALIGN="top" WIDTH="5%"><FONT SIZE="2">(5)</FONT></TD>
<TD VALIGN="top" COLSPAN="6"><FONT SIZE="2">Approval of amendment to the Company&#146;s 1995 Employee Stock Purchase Plan to increase the number of authorized shares.</FONT></TD>
</TR>
<TR>
<TD WIDTH="1%">&nbsp;</TD>
<TD WIDTH="5%">&nbsp;</TD>
<TD VALIGN="top" WIDTH="22%"> <DIV ALIGN="center"><FONT FACE="Times New Roman, Times, serif" SIZE="2">FOR</FONT><FONT FACE="wingdings" SIZE="2">
<BR>
o</FONT></DIV>
</TD>
<TD VALIGN="bottom" NOWRAP WIDTH="20%"> <DIV ALIGN="center"><FONT SIZE="2"><FONT SIZE="2">AGAINST<FONT FACE="wingdings">
<BR>
o</FONT></FONT></FONT></DIV>
</TD>
<TD WIDTH="8%"> <DIV ALIGN="center"><FONT SIZE="2"></FONT></DIV>
</TD>
<TD VALIGN="top" WIDTH="17%"> <DIV ALIGN="center"><FONT SIZE="2">ABSTAIN<FONT FACE="wingdings">
<BR>
o</FONT></FONT></DIV>
</TD>
<TD WIDTH="12%"> <DIV ALIGN="center"><FONT SIZE="2"></FONT></DIV>
</TD>
<TD WIDTH="16%">&nbsp;</TD>
</TR>
<TR>
<TD WIDTH="1%">&nbsp;</TD>
<TD VALIGN="top" WIDTH="5%"><FONT SIZE="2">(6)</FONT></TD>
<TD VALIGN="top" COLSPAN="6"><FONT SIZE="2" FACE="Times New Roman, Times, serif">To vote with discretionary authority on such other matters as may properly come before the meeting. </FONT></TD>
</TR>
<TR>
<TD WIDTH="1%">&nbsp;</TD>
<TD COLSPAN="6" VALIGN="top">&nbsp;</TD>
<TD WIDTH="16%">&nbsp;</TD>
</TR>
<TR>
<TD WIDTH="1%">&nbsp;</TD>
<TD COLSPAN="7" VALIGN="top"><FONT SIZE="2" FACE="Times New Roman, Times, serif"><B>THIS PROXY, WHEN PROPERLY EXECUTED, WILL BE VOTED IN THE MANNER DIRECTED HEREIN BY THE UNDERSIGNED SHAREHOLDER. IF NO DIRECTION IS PROVIDED BY THE UNDERSIGNED
SHAREHOLDER, THE PROXY WILL BE VOTED &quot;FOR&quot; ITEMS 1 THROUGH 5 LISTED HEREIN, ON ALL OTHER MATTERS THE PROXIES SHALL VOTE AS THEY DEEM IN THE BEST INTEREST OF THE COMPANY.</B></FONT></TD>
</TR>
</TABLE>
<P><FONT SIZE="2" FACE="Times New Roman, Times, serif">SIGNATURE(S) ______________________________ &nbsp;&nbsp;_________________________________ &nbsp;&nbsp;Dated&nbsp;&nbsp;______________&nbsp;&nbsp;, 2001
<BR>
</FONT><FONT SIZE="2" FACE="Times New Roman, Times, serif">INSTRUCTIONS: When shares are held by joint tenants, all joint tenants should sign. When signing as attorney, executor, administrator, custodian or guardian, please give full title as such.
If shares are held by a corporation, this proxy should be signed in full corporate name by its president or other authorized officer. If a partnership holds the shares subject to this proxy, an authorized person should sign in the name of such
partnership.
<BR>
</FONT></P>
 </BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g3344733447palan01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>

begin 644 g3344733447palan01.jpg
M_]C_X``02D9)1@`!`@$`E@"6``#_[0R*4&AO=&]S:&]P(#,N,``X0DE-`^D`
M`````'@``P```$@`2``````"V`(H_^'_X@+Y`D8#1P4H`_P``@```$@`2```
M```"V`(H``$```!D`````0`#`P,````!)P\``0`!````````````````8`@`
M&0&0```````````````````````````````````````````X0DE-`^T`````
M`!``E@````$``0"6`````0`!.$))300-```````$````>#A"24T$&0``````
M!````!XX0DE-`_,```````D```````````$`.$))300*```````!```X0DE-
M)Q````````H``0`````````".$))30/T```````2`#4````!`"T````&````
M```!.$))30/W```````<``#_____________________________`^@``#A"
M24T$"```````$`````$```)````"0``````X0DE-!!X```````0`````.$))
M300:``````!O````!@`````````````!J````FP````'`#,`,P`T`#0`-P!P
M`&$````!``````````````````````````$``````````````FP```&H````
M`````````````````````````````````````````#A"24T$%```````!```
M``(X0DE-!`P`````"?\````!````<````$T```%0``!E$```">,`&``!_]C_
MX``02D9)1@`!`@$`2`!(``#_[@`.061O8F4`9(`````!_]L`A``,"`@("0@,
M"0D,$0L*"Q$5#PP,#Q48$Q,5$Q,8$0P,#`P,#!$,#`P,#`P,#`P,#`P,#`P,
M#`P,#`P,#`P,#`P,`0T+"PT.#1`.#A`4#@X.%!0.#@X.%!$,#`P,#!$1#`P,
M#`P,$0P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`S_P``1"`!-`'`#`2(`
M`A$!`Q$!_]T`!``'_\0!/P```04!`0$!`0$``````````P`!`@0%!@<("0H+
M`0`!!0$!`0$!`0`````````!``(#!`4&!P@)"@L0``$$`0,"!`(%!P8(!0,,
M,P$``A$#!"$2,05!46$3(G&!,@84D:&Q0B,D%5+!8C,T<H+10P<EDE/PX?%C
M<S46HK*#)D235&1%PJ-T-A?25>)E\K.$P]-UX_-&)Y2DA;25Q-3D]*6UQ=7E
M]59F=H:6IK;&UN;V-T=79W>'EZ>WQ]?G]Q$``@(!`@0$`P0%!@<'!@4U`0`"
M$0,A,1($05%A<2(3!3*!D12AL4(CP5+1\#,D8N%R@I)#4Q5C<S3Q)086HK*#
M!R8UPM)$DU2C%V1%539T9>+RLX3#TW7C\T:4I(6TE<34Y/2EM<75Y?569G:&
MEJ:VQM;F]B<W1U=G=X>7I[?'_]H`#`,!``(1`Q$`/P#T;,QJZ,=YI+ZS=92U
MY:]X@&QC"VKW?H?8_;^BV*MG,;BND'*>SVC;4[(N?+O4.YS:;F[:_P!'])6,
M[%HKI>]@+777T&PASM2+J^/=[.?S$6YKW9#BQI>YOIN@/-?'J_2+?IM_X-R2
MG+JN%I<`W.;M&X[Z\MNDAOMW9'N^E]!J*&M(<0_*]H)C9E@F/W=U[4>^JT40
M66,#8`<,IP.KP_Z3_:YW]?\`,_0_05.+75M8U][B]]@'ZXT.X]K6.;]/Z/\`
MUC\Q)22&["_=EP-2-F7,2UGT?7W.^G^;^9O5L=->1/KV:_R[_P#WI5.`7O<V
MVXMMW$-&8WDG8[8)]FUOZ1FQ_L1\?+LQP:6M=>206FS(K<\[@-/<YOY_J,24
MR?A&JVAKK;'-N>6&+;VD>RRR1^L/_P!&K'[-H_TE_P#V_;_Z44;'VOLQ3;6:
MB+R`TD.D>E=[O8KJ2FI^S:/])?\`]OV_^E$OV;1_I+_^W[?_`$HK:22FI^S:
M/])?_P!OV_\`I119@XMF[9=>[8[:Z,BW1P_-=^D5B^QPVUUF++##202`![GN
M='\G_P`$V(;VLPV,LK&RBIH98W<0UE;03O:SW-W5_P#GO_BZTE,?V;1_I+_^
MW[?_`$HHV8==.RQEEVYMC/I76.!!<UC@YCWN8[VN5Q"ROYMO_&5_]6Q)3__0
M]&SL6BNI]E;-K[KJ#803J1=7'?S5IU)-AL;8YA<`T@!I&F[]YKOWE4S<3%KJ
M?;56UEE]U!M<W0N+;F1N+?ZSEH)*:]N)ZS=EKS8R9VN:QPD>3JT/]F8^_P!2
M&[R02[TZYD<>[TU<224TCTK%)DM82=9].K_TFG_9F/+3#9;]']'7I_5_1JXD
MDI`<8NLK>^U[O2=O:(:!):ZO7:S]VQ'2224I))5\C]-8W%$@&'W$;A[`?:T/
M:-OZ2QNUS-W\SZJ2E\:;)R7"#:!Z8((+:^6M>UQ^FYWO?[&?Z/\`P2.DDDI!
M4XU6_9W?1<"ZEQ))(GWL<8_P>[]'[_YO_BGI\K^;;_QE?_5L4[:_49MD@@AP
M([%IW-0'6NLQVEX#;6V5MM8)(#P^O<UKGMK<YG[C]GO8DI__T?1<W&Q65665
M,:VRVZCUG-T+B+J]N]S?=[96@J&=1CBISZV-%EEU'JN;HXQ=7MWN;[O;N<KZ
M2E))))*4DDDDI222'9>RMS6&7/?.QC1),`N_JL^C].SV)*966,J87O.UH[_'
M0#^TH8]98S<\198=]@DN`<0!M:3^:V-J9K+7O;98=H;#FUM)$$M+7"US7;;?
MI?1^@C)*4DDDDI2J9M;PZNVO6;*V6M)(&W>TM<W1WZ1C_P#H;_Y"MH.5_-M_
MXRO_`*MB2G__TO1L['Q14]U=;!9;=CFXM`#G$75[?4+?<[^TKZS\ZC#-5GIU
MU^K9=CF_:&[G$6U[/6V^YW]M7++ZJRT/=JYP8``2=SN/:V4E)$D'UWGZ%+W#
M;N#C#1,[=GZ1S;-WYW\VE&6_<"65#<0TB7DMCZ7N]-M=F[_CDE)D.S(IJ^F[
M6"0P>YQVZNV5LW/?_80GUTU,]3)O=M:T!SWOV-T,[G;/2KW.5.GKG06FVG!M
M9=Z,NM;BMWL#B9<U]M+?09:YWTM]B2F]NR+20T>C7J"YP!>X$?2K$_H_^N_]
MM*=5%54EC0'.C>_ESBT!C76/^E8[:W\]4*NOX5C"[TLMNUNYP&+>\1_(MQZK
MJ+G?\1;:H5?6;I5]GIU6$.'+;8QW#R=1FG&R/_`DE.LDLW(ZNVNKUV^D*`0U
MSW6;G;G':QE5.,V]U]K_`/!4L=ZEK_8@C$ZGU1Q=G6'$Z>1#<.H;+K![';\R
M]K[/2K<YKV_8\=W\U_2<C])9BUI26[J5V4ZS'Z3M<ZMQ9=FV`FBH@>[;!9]L
MN9_HJG^DSW^ODTV_HD%YMPAZN-U1EQ`<7T9KV[;'G4.;?2UMF)Q_@Z;L:O\`
MP>&K[.F8+65U^BU[*0!4U\O#(^CZ;;-S:]O\A6DE.0SZS=-:YM>6XXMKCM:3
M[ZGN@>VC+IWT6.=_@ZG/KRO^ZZMVY=5K6M:VP'U*_I56-'TV?G6,:U6GL98Q
MU=C0]CP6N:X2"#HYKFE9K^EMQ/1.#<_'QVVU!^)].DL#FL;736_^B;/9L^S.
MKI_X!)3_`/_3]#ZGC=/MQKJ754V>M90,JLM:=X=;7#<AOY^Z7?SBFSH?3*V>
MG14['8!M#,>RRD`#AK6X]E6UK4^:<7T[?5&+MAGVGUB-LS^A]66_O_S7J*O7
M_P`W]GZ;[!O[[?3C_I)*9MZ#BUN+JLG-83XY>18/\S)NO8F_83'%PLSLY['1
M+/M#F?YMF/Z-[/[-J?\`[&O^Z7_@2!/1MPAO38W#?JR=GE[?I?324VG=`Z,^
MQMM^'5DW5_0NR6^O8V/W;LGU;6_YZOM:UK0UH#6M$-`T``\%F_\`8U_W2_\`
M`E"S_F]L/I?8"[^5Z4?@DIU001(U!2YY611_S?V^\=/#=/3V>F1MC3E%_P"Q
MK_NE_P"!)*;?V#`&4,O[/5]J:"&W[&^H`?I`6QO]RL+%M/1-Q]$=-.GLWFL'
MCW?1:C-_YN;1N^P[H]T>E$^22G43+,=_S<CV_89[3Z4(51Z)O_2#IOIP9VFN
M=WS"2G90<K^;;_QE?_GQBI?]C7_=+_P)!8>G>HW[,WIWK;OT.US=V[\S;L;N
MW?U4E/\`_]D`.$))300A``````!5`````0$````/`$$`9`!O`&(`90`@`%``
M:`!O`'0`;P!S`&@`;P!P````$P!!`&0`;P!B`&4`(`!0`&@`;P!T`&\`<P!H
M`&\`<``@`#8`+@`P`````0`X0DE-!`8```````<``@````$!`/_B`:!)0T-?
M4%)/1DE,10`!`0```9!!1$)%`A```&UN=')'4D%96%E:(`?1``0`%P`1`!,`
M`F%C<W!!4%!,`````&YO;F4```````````````````````#VU@`!`````-,M
M041"10``````````````````````````````````````````````````````
M````````!6-P<G0```#`````)&1E<V,```#D````<7=T<'0```%8````%&)K
M<'0```%L````%&M44D,```&`````#G1E>'0`````*&,I(#(P,#$@061O8F4@
M4WES=&5M<R!);F,N`&1E<V,`````````%D=R87ES8V%L92`M($=A;6UA(#(N
M,@``````````````````````````````````````````````````````````
M````````````````````````````````````````````````````6%E:(```
M`````/-1``$````!%LQ865H@`````````````````````&-U<G8`````````
M`0(S``#_[@`.061O8F4`9(``````_]L`0P`(!@8&!@8(!@8(#`@'"`P."@@(
M"@X0#0T.#0T0$0P,#`P,#!$,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,#`P,
M_\``"P@!J`)L`0$1`/_=``0`3O_$`-(````'`0$!`0$```````````0%`P(&
M`0`'"`D*"Q```@$#`P($`@8'`P0"!@)S`0(#$00`!2$2,4%1!A-A(G&!%#*1
MH0<5L4(CP5+1X3,68O`D<H+Q)4,T4Y*BLF-SPC5$)Y.CLS875&1TP]+B"":#
M"0H8&82414:DM%;352@:\N/SQ-3D]&5UA96EM<75Y?5F=H:6IK;&UN;V-T=7
M9W>'EZ>WQ]?G]SA(6&AXB)BHN,C8Z/@I.4E9:7F)F:FYR=GI^2HZ2EIJ>HJ:
MJKK*VNKZ_]H`"`$!```_`.HV?F1]:U;4K#3]0MHH8[:&>V=.,DB*9)4GE=2:
M5HB<$;['^[,+9/,_F&UL[M[LIZ^E6"7\G[OC]:5[B6./DE3Z/.V@Y<$^S-+_
M`+#)\K5`;I45H??+J.N;DOB/OS<E\1FY+XC-R7Q&;DOB,W)?$9N2^(S<E\1F
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MCC^K<EC''XWD<LO,3<)6=F:5/5'/C)RPVR`?F1H>E+H$ERML%FGO;-99%9P6
M$MU$D@V8?;5B,,O^59>1O^K0G_(V?_JIF_Y5EY&_ZM"?\C9_^JF;_E67D7_J
MT)_R-G_ZJ9O^59>1O^K0G_(V?_JIF_Y5EY&_ZM"?\C9_^JF;_E67D;_JT)_R
M-G_ZJ9O^59>1O^K0G_(V?_JIF_Y5EY&_ZM"?\C9_^JF;_E67D;_JT)_R-G_Z
MJ9O^59>1O^K0G_(V?_JIF_Y5EY&_ZM"?\C9_^JF;_E67D;_JT)_R-G_ZJ9O^
M59>1O^K0G_(V?_JIF_Y5EY&_ZM"?\C9_^JF;_E67D;_JT)_R-G_ZJ9O^59>1
MO^K0G_(V?_JIF_Y5EY&_ZM"?\C9_^JF;_E67D;_JT)_R-G_ZJ9O^59>1O^K0
MG_(V?_JIF_Y5EY&_ZM"?\C9_^JF;_E67D;_JT)_R-G_ZJ9O^59>1O^K0G_(V
M?_JIF_Y5EY&_ZM"?\C9_^JF;_E67D;_JT)_R-G_ZJ9O^59>1O^K0G_(V?_JI
MF_Y5EY&_ZM"?\C9_^JF;_E67D;_JT)_R-G_ZJ9O^59>1O^K0G_(V?_JIF_Y5
MEY&_ZM"?\C9_^JF;_E67D;_JT)_R-G_ZJ9O^59>1O^K0G_(V?_JIF_Y5EY&_
MZM"?\C9_^JF;_E67D;_JT)_R-G_ZJ9O^59>1O^K0G_(V?_JIF_Y5EY&_ZM"?
M\C9_^JF;_E67D;_JT)_R-G_ZJ9O^59>1O^K0G_(V?_JIF_Y5EY&_ZM"?\C9_
M^JF;_E67D;_JT)_R-G_ZJ9O^59>1O^K0G_(V?_JIF_Y5EY&_ZM"?\C9_^JF;
M_E67D;_JT)_R-G_ZJ9O^59>1O^K0G_(V?_JIF_Y5EY&_ZM"?\C9_^JF;_E67
MD;_JT)_R-G_ZJ9O^59>1O^K0G_(V?_JIF_Y5EY&_ZM"?\C9_^JF;_E67D;_J
MT)_R-G_ZJ9O^59>1O^K0G_(V?_JIF_Y5EY&_ZM"?\C9_^JF;_E67D;_JT)_R
M-G_ZJ9O^59>1O^K0G_(V?_JIF_Y5EY&_ZM"?\C9_^JF;_E67D;_JT)_R-G_Z
MJ9O^59>1O^K0G_(V?_JIF_Y5EY&_ZM"?\C9_^JF;_E67D;_JT)_R-G_ZJ9O^
M59>1O^K0G_(V?_JIF_Y5EY&_ZM"?\C9_^JF;_E67D;_JT)_R-G_ZJ9O^59>1
MO^K0G_(V?_JIF_Y5EY&_ZM"?\C9_^JF;_E67D;_JT)_R-G_ZJ9O^59>1O^K0
MG_(V?_JIF_Y5EY&_ZM"?\C9_^JF;_E67D;_JT)_R-G_ZJ9O^59>1O^K0G_(V
M?_JIF_Y5EY&_ZM"?\C9_^JF;_E67D;_JT)_R-G_ZJ9O^59>1O^K0G_(V?_JI
MF_Y5EY&_ZM"?\C9_^JF$NI>5-`\N>:/*<^B68M))[Z:*9EDD;DGU65N)#NP^
MT,Z/FS__T>_YLV1'\R?^49'_`#':?_U%PY+LV%?F6YGLO+NK7ELYCGM[.XEA
MD'572-F5A\B,C&D>5M8O])L+Z7S=JXDN;>&9PK6]`TB*[4_<=*G!O^"]4_ZF
M_6/^"M_^J&;_``7JG_4WZQ_P5O\`]4,W^"]4_P"IOUC_`(*W_P"J&;_!>J?]
M3?K'_!6__5#-_@O5/^IOUC_@K?\`ZH9O\%ZI_P!3?K'_``5O_P!4,W^"]4_Z
MF_6/^"M_^J&;_!>J?]3?K'_!6_\`U0S?X+U3_J;]8_X*W_ZH9O\`!>J?]3?K
M'_!6_P#U0S?X+U3_`*F_6/\`@K?_`*H9O\%ZI_U-^L?\%;_]4,W^"]4_ZF_6
M/^"M_P#JAF_P7JG_`%-^L?\`!6__`%0S?X+U3_J;]8_X*W_ZH9O\%ZI_U-^L
M?\%;_P#5#-_@O5/^IOUC_@K?_JAF_P`%ZI_U-^L?\%;_`/5#-_@O5/\`J;]8
M_P""M_\`JAF_P7JG_4WZQ_P5O_U0S?X+U3_J;]8_X*W_`.J&;_!>J?\`4WZQ
M_P`%;_\`5#-_@O5/^IOUC_@K?_JAF_P7JG_4WZQ_P5O_`-4,W^"]4_ZF_6/^
M"M_^J&;_``7JG_4WZQ_P5O\`]4,W^"]4_P"IOUC_`(*W_P"J&;_!>J?]3?K'
M_!6__5#-Y&FU#U-?T_4+^;4?T=J36UO<7/'U/3]&*0*QC5%^T[?LY+LV;-FS
M9LV;-FS9LV;-FS9LV;-FS9LV;-FS9LV;-FS9LV1'S;_RD7DW_MHS?]0DV2[-
MG__2[_FS9$?S)_Y1D?\`,=I__47#DNS82^;_`/E%-<_Y@+K_`),OBWEK_E'-
M'_Y@K;_DTF7)YB\OPR/#-JUG'+&2KQO<1*RL.JLI:H.-_P`3^6_^KQ8_]),7
M_->;_$_EO_J\6/\`TDQ?\UYO\3^6_P#J\6/_`$DQ?\UYO\3^6_\`J\6/_23%
M_P`UXK;Z[HEY,MM9ZE:W$[UX113QNYH*FBJQ;"O_`!GIR-=&X@N(+:RN_P!'
MW5ZZ*88YO@IS*.SK$?5C_>\.'Q?%AQ!J,$@_>D0,97@C25T!=D;C5.+-RY?L
M_MX[])Z<&*?7(.0(4KZB5JQXJ*5ZLWPXVYU73;0,US=Q1!'2)^3BH>4\8D85
MV9V^SE?I.U:ZBM8769W+!S&\9]/BI;]X.7/XN/%>*MBJW]BP5EN8F5V]-2'4
M@N/V!O\`:_R<!3:_8V^O6WEV;FEY>0/<VK$#TW6,TD0/7^\4?'PI]C$]+\SZ
M7JRWLD$AB@L;IK%YY^,:/*@!;TB3\2_%\+?M8[4/,%EI]Y%I[!IKJ6*>9(XB
ME:6ZB1E;FR<&=6_=\_APP^NVH/!YHTD">HT;.H94Z\F%?L[_`&L"IK-I)J<>
ME1DR236S7D<R4:)HT=8FHX/VN3KC;S6[>QU2QTN:.3U+]9I(IAQ])5MP'E,C
M,PXT5E_9P5^D+`Q&<74/HJW!I?47B&_E+5IR_P`G!((.X[YLV;-FS9LV1'R9
M_P`=3S=_VV&_ZAH,EV;-FS9LV;-FS9LV;-FS9LV;-FS9LV;-FS9LV;-FS9LV
M;(CYM_Y2+R;_`-M&;_J$FR79L__3[_FS9$?S)_Y1D?\`,=I__47#DNS82^;_
M`/E%-<_Y@+K_`),OBWEK_E'-(_Y@K;_DTF1R]_*/\O\`4;RXO[S21)<W4C33
MR>M,.3N>3&BN`-\0_P"5+?EO_P!68?\`(Z?_`*J9O^5+?EO_`-68?\CI_P#J
MIF_Y4M^6_P#U9A_R.G_ZJ9O^5+?EO_U9A_R.G_ZJ8/T7\L/)/E[4H=7TC3!;
MWL'+TI?5E:G)2C?"[LOV6Q&3RCJMS;ZUID]Q;QZ?K=^]Y<O'S:<0N(E:!`P5
M`[B&GJ_L\_L8$N_)&LS(8H)[../ZU<72@J_)?4NHKR,!U7ETB].1/L\OWGQ8
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M/H?NN,;CXN/I_N_W>;3_`"YYAT607MJUI//;P7<-O"3+1C=WBW8Y$BM$3DGV
MO\K##S+Y?O\`6[RTGMGA2."UO[:192U2U[$(5(XJ1QCXU;^;">W\CZI9R)+;
MO8O&!''+93([021_4X[*=V4`?O:Q<TV^-'>-\FMDEU$CQW'I!$;C;"$,!Z04
M!>8;H_+E]GX>."LV;-FS9LV1'R9_QU/-W_;8;_J&@R79LV;-FS9LV;-FS9LV
M;-FS9LV;-F.1/1_-5[<>8[O0=;T]M-,IDET)Y"#]:MX3Z<U:%@LRM^^]/_?$
MG+)9FS9LV;-FS9LV;-D1\V_\I%Y-_P"VC-_U"39+LV?_U.SMYDTU);B&8RPO
M;^D?WD;()!/)Z$30D_;#S?N\:_FG2(P"\K*%!:>J']RHE-L6F_D'KJR?['^3
M#K(C^9/_`"C(_P"8[3_^HN')=FPE\W_\HIKG_,!=?\F7Q;RU_P`HYH__`#!6
MW_)I,-,V;-FS9MLVV;;-MFVRMLO;-MFVRMLVV7MFS;9JC-FS9LV;-D1\F?\`
M'4\W?]MAO^H:#)=FS9LV;-FS9LV;-FS9LV;-FS9LV1O5]=O%\PZ7Y;T<(]U,
M3>:I(X++!8QGB304_>W,M(H/]F_[."/,WEY?,%E''',;/4+.5;K3;]5Y-!.G
M1J;<D=>4<L?^[(VPY0D*`[!G`'(C85\:;TQ^;-FS9LV;-FS9LB/FW_E(O)O_
M`&T9O^H2;)=FS__5ZCJ'EN\U-[^Z>..%[^&.VN[,RO+%.D4P<-R(7T'^K\XX
MVC3E&\G+]C``\E:DMI=V2W"M%J%F-.8R,6>"W2>22'XZ?OW2WG:,N?B:149L
MGBCB`HZ`4R!?F.=<_03<EM/JOU^Q](\I/4_WKBX<AQX]?M9,+(ZN7?\`2*VP
MCI^[^KM(37_*]15VP=A+YO\`^44US_F`NO\`DR^+>6O^4<TC_F"MO^3284W5
MS^8JW,RV6GZ0]J'80/+=7"R%*_"758&57I]KBV"M&G\YR7977[/3H+/@2'L[
MB:63G4<1QEBB7CU_:QNKS^=TO670[+3)['BO"2\N)HI2W[8*1PR)Q_E^/$;&
MX_,%KR!=2T_28[(N!</!=7#RA.YC1X$5F_UFP?KDWFB,P#RY:V-P#R^L?7II
M8>/3AZ?I1R\OVN7+`>FW'GQ[Z)=7L=+AL#7UI+:YGDE&WP\$D@C1OB\7R)W_
M`->M)=2>"26_T/4M3%M<0QN6:PN5FB5)8RK<EM9OL7"?[ID^/[#O@U_/6H-<
MWUO9?5[GT/CA51Z<G&.ZEMIHHTE=><RQQ*ZI,T/-O]>/`M]YNDN;^QOVN$MU
ML)[G_16217:,:>T\=Q-$K>IZ4KMR2/A_L_4RY/S%O5M;RLEK'+:Q7<T,[K5+
MAH%A>*W4*_$2.LS.W&1O@7X/VL-?/,THAL+F*>+U+>&>ZFTN>1[=+J+@HE]&
MX0_N[N#ERM^7/[7^SP+9^:-02[-G]8]&UFGM(('O(_WEI#+8BY5KCXEYO-./
M1YR,J^IB/^+K_6=*O[>\>#3;E+*1I+)A()I8WM9)!=VKU5EC]4+P^%N/[;\^
M.&WEG6?TOY2GDO7"36UL(KJU?X98>,`(]:3D>?JK^_29?AXOD->]U=?+]EHE
MW=3F#2[[3F.I%R/KEK=RQM:QF:M9.,3S+<_\8$Y?;P]F\^Z@]Y/96,MH29X(
M;>61&HHDO7L908^:.QB54D^+T_\`D6R8&L_-EWHS>8+:1U:2UO)Y(?5#%9@T
ML44\L3<G]*"QYM)+!\;\/B_N\/\`0=<U2]U^&TOKRUE@EL))HUM!6*5TN6C6
M6.5J%CZ'#U%3E'R^SD?AUV^TNXUA--GA#3:MJ*%KCE*$CMK(74:QKZB<4,J,
ME/\`+QM_YSN[J;3M24*LME-(RZ5'S]293IK7*2&A^.&25J1_N_V/M>IAC+YS
MU6"TM+TW5A<6TUQQN)[8/*(K1Q'_`*6]"J_Z-(_ISH/]^1_8XOG0000"#4'<
M$=\O-FS9LV1'R9_QU/-W_;8;_J&@R79LV;-FS9LV;-FS9LV;-FS9LV;*8D`D
M"IIL/?(YY2T2\T];[5]:XMKFL3&:]*'DL4:?!;6L3=XK>+_@I&D?))D+\T"X
M\LZK%YVM.<EAQ6U\QVRU:ML#^ZO8T_WY9LQ]7C]NW9_Y,F,,L<\230N)(I%#
MQR*:JRL*JRD=0PQ^;-FS9LV;-FS9$?-O_*1>3?\`MHS?]0DV2[-G_];O^;-D
M1_,G_E&1_P`QVG_]1<.2[-A+YO\`^44US_F`NO\`DR^+>6O^4<TC_F"MO^32
M8:9LV;-FQH1%!"J`#N0!U.48836L:FO78;US>G&6Y%%Y$4Y4%:>%<":EI-GJ
MFGW&F7*%;>Y0Q2>G1&XL.)XL!\/P_#@E8(A$D3*'6,`+S`8_"-COWQS1QMRY
M(&Y4#5`-0.E<LI&QJ5!-.-2!T\,H11`$!%H11MAN!V.8QQE0I12HZ`@4&488
M2:F-2:UK0=<OT8NOIKW[#OURPD:\>*@<11:`;#P&5Z,/^^U_X$9A'&"&"*&`
MH"`*T';,(H0.(C4"A%*"E#N1CP`!0=,V;-FS9LB/DS_CJ>;O^VPW_4-!DNS9
MLV;-FS9LV;-FS9LV;-FS9LV15=5O]7\XG3=,F,>DZ&A.KR``B:ZF7]S:!C6G
MH1GUYN/[7IIDJS8V2-)8VBD4/&X*NC"H*D4((/8X4Z9;Z-Y7MM/\NP3^DLAD
M33K>>3D[!:RM%$6ZK$A^!/V8\.,V;-FS9LV;-FR(^;?^4B\F_P#;1F_ZA)LE
MV;/_U^_YLV1'\R?^49'_`#':?_U%PY+LV$OF_P#Y137/^8"Z_P"3+XMY:_Y1
MS2/^8*V_Y-)A5/YT,$\L'^'=:E])V3U([,,C<33DC>INK?LXS_')_P"I:UW_
M`*0A_P!5,W^.3_U+6N_](0_ZJ9O\<G_J6M=_Z0A_U4S?XZ`^UY;UT#Q^HU_5
M(<%:;YL34[V.R&C:K:&2O[^[M#%"M!7XY"QXU_9PDNO-NKV5[?:9>F*`RW7I
M:%?\*I*$=%GM)U)HMTBNTD6_[Z/_`"HVPWN?.^E6;W45RDL3VA3F7"A>+S-;
M+([<N,*>JGVIN'PLC8A>>;F_2-A'8Q.]F9Y[>^;BK$O#:M=&**CU]1&"K7CZ
M;?9YXH?/>E^A<3+!.[V:3S7<*A"R16W#U)*\^#_WJ<.#?%F\T^8KW0I=)O;=
M4DTR60_I8.#SCMB%7ZQ&P/\`NEY$>1?]]<\`V_G:7]-:M%<JK:=";6+2(H%Y
M2W#W'JU<L3QXM]7=H_\`BKXL7NO.#7$FFKI<$J"6\MK:_%Q%P:,7$3S>@R,R
MNDZKZ;?99?BP5I'FJ*^M+5HHKB]9H8I+J>.)4],S(TD?J1<VX\E3XN'J>GR3
M$(O-IU'4]*@L%,<,]W-9WT4R@N"EI]<CX.C,O=.6)WVLZ^FI>8X[*:W]+1(+
M>Z@@FC-)1)')+)')*K`I_=?`X7X?VN>.A_,'3YK$W\=C=R0);FXF>*/DJ&-$
MEFB9ZJ.<22=_M\'X8)NO-EE;7D3R/(MHT5PT?&-76<Q20Q*T<H?EO).L<:\/
MWG+]GABS^;((KJ.QEL;M;LLJS0+'S:-'D,,<S>F6Y0NZL>:?[K^/!NBZY:Z[
M;R7-F&$<;F(\N->2_:5E4LT;H?A>.3BZX2OYHN+'7-5L[Q&N+:">QM;&&W1?
M4,EZC-^\9W5>/->-<TGG[3?J<MQ;P2R2QV#ZDMNY2-V1`Y95Y-\?%XFCD>/U
M$C?C_-BX\YVPNULY;&Y1A/;6DLU(S$L]VB20IR]3DPXR"KJF(CS_`*:R0R1V
M5VZ2I#(2JQ_")[A[&,-63K]8CX_#_KXM#YUL+B6*"*UNGG:3TKF%(P[6[>L]
MM^^X,R\?5ADJZ%UX?'@:/S]:W(M?JMA<%KJ6T2-9O3CK%>220K,*._V'@D^`
M_%AWHNNVFNQ33688)!(87Y\0P=31E9`2\;K3XHY%5\-,B/DS_CJ>;O\`ML-_
MU#09+LV;-FS9LV;-FS9LV;-FS9LV;$;L7+6LZV3(ET8V%N\H)19"#P9P-RH;
M[6%GE?08_+NCPZ=ZAGN26GOKMOM3W,IYSSM_KO\`9_R..'.;-A)YH\OQ^8M,
M-HLAMKZ!UN=-O5^W;W4?Q12K[5^&1?VX^:XGY3\P/KVGN+R,6VKV$AM-7LZ[
MQ7"=2OC#,O[V!_VHVP_S9LV;-FS9LV1'S;_RD7DW_MHS?]0DV2[-G__0[_FS
M9$?S)_Y1D?\`,=I__47#DNS82^;_`/E%-<_Y@+K_`),OBWEK_E'-'_Y@K;_D
MTF&F;-FS9L*G\O:7-!);7$1GBDNA?TE9G*W"L)%DC)W3BZ_#QP'%Y,T.&66:
M))D:8.K@3R%>,LC3NG!F*\&DDD;A_EXQ_(OEMP4^K.L)!'U=)I5BJT/U1G$:
ML%#O;_NV;`6J?E]I5QIUY!IWJ0WUQ%+$ES)/,P_?(D;B6C?O(SZ4;^DWP\TP
M^N=$L]0CA74$,OIP26SQAF$3).GI3*R;!PZ_S8"E\F:#,SOZ,D;NMLB-%-)&
M8OJ8(M3"49?2:)69>2?S?'CF\GZ(UTMX(I5E5XIB5GE`::`%(IY!R^.95;CZ
MC?:_:QD/DO0;?B(8I506XLWC$\O"2)0RH)DY<96C61UC=_C3'V/D_1=.G@N+
M9)1);R":(O-(]'$/U7D0S&O^CCT\4NO*ND7EU>75RLKG4!&M[%ZT@BF6$%8T
MDC5@I10S?!^U^WBD'ES2[:\N+R")E-U4S0"1_0+,@B>06_+T5=XQP9E3$)O*
M&@3V]O9O:_Z-:VKV,$"NP189.)9:`_:K%&RR?;5DRU\IZ2L\%U2<W$">DTS7
M$Q>9.7/A<L7_`-(57^)?5^SC[?RW8VEW%>VKS12K)ZLY$K'UR(O003U/[T(G
MV>>:;ROI4][-J$BR&XGF@N9&$K@>I:@BW8+7B/3KTQ#_``9H)MH[1X'DMXHY
M(HHWE=@HE5XY.-3569)77;'_`.$M']&6$K,3-+!<-*9I#();552"1).7)&18
MU7;&)Y,T&.-8HX9%1%B15$TFRP3F\BZM^S<,TF.B\H:-!="]A25)^3M(RSR@
M2>I(UP5F4-QE59G>1%?['+&IY,T*-8T2*51"L"PD32506TC30<3R_8DED_X/
M##3]'L=,DGFM4(EN>`GE=B[L(@5C#,W7@IIAAD1\F?\`'4\W?]MAO^H:#)=F
MS9LV;-FS9LV;-FS9LV;-FS9#_+EY=>9=?OO,:3.NAV@?3=)A5B([AD;_`$N]
M9>CKZB^A;G^6-W_;R89LV;-A3JUSI_EZSO\`S%):,[*B/?/;1AIGCC^$,U*-
M(L",S?Y,>&-M<P7=O%=6TBS03HLD,J&JLC#DK*?!ABN;-FS9LV;-D1\V_P#*
M1>3?^VC-_P!0DV2[-G__T>_YLV1'\R?^49'_`#':?_U%PY+LV$OF_P#Y137/
M^8"Z_P"3+XMY:_Y1S1_^8*V_Y-)AIFS9LV;(Y<^<]-M)[BVEAN#-;E`8U12S
M^I.+-64<^GK,OV^'P?'@#4_/"-ICW&CPR&ZBDA%S',@I"KW?U)UFHX^(LDW#
MT_4^QS^SBWFOS#J.B7MJJE+339HV#:E-$TT"71=5BANFC8-;0R*?AN./#U,7
MNO.^E6:SO-#<$6WUL2A$5C6QX>OQ^/XMID:/^?$9O/NGP22P/87QNH/6,]J(
MD,B+!&D[N?WG`JT$R21\&;G_`*^!K;SF/K,\EY.J6"7LT4$L<)(>V2Q2_7U&
M+@QN`[-RX-SX\."X8Q><]-DEMX&@N(9;J8P0+-&(P[!4>L;NP22J2\E5&]3X
M9/@_=XCK7F6YT3S+I]I=",:)=QE+BX8$/!<.Q%N6:O'T9>#1_P#&3A@'3O/$
MRVFK:EK4!2VM+V2WMXX$^)+=($NE><NP_>M')]E?VO@3!\_GK2;>6Y22"Y"V
MOU@-+P7B[6J)-,L?Q\B?2E5UY*O+_6Q/4/--Q->6^FZ3&\<LEW-:7%Q)&K\#
M!;"\)2+FAD61'3_*_P!G@B#SIIMUSCMH+B:[0MRLT13+Q2..=V`Y\-DFC^#G
MS]3]W]K$E\\6:"Z:YM)XOJ\E\J@!&+KIZJ\[4Y#BQ5O@1L<_GC34DFC%K=L8
MI#;J1&M)9A$+DQ1?'5F]!O4Z<?\`98-TKS';:Q>36=K:W2?5U1IIYHQ&BF6-
M)DC(9O4]3TY1\/I_#A'8^>OJ]B9=9BDFG,E\P-I$."V]C<"V>1^<GVAR1VX_
M[#%[SSM#;ZI:\0?T0R7JS7)2I>:U>*$)!1N7][*T?Q1_$V#(O.%E+<V-H;2[
MCGU%Y8K99(@@,D#<9D)9OV4_?\A\$D/QQY(QFS9LB/DS_CJ>;O\`ML-_U#09
M+LV;-FS9LV;-FS9LV;-FS9LV%^MV$FK:7=Z7!=M92741B^LQ`&1%?9B@/[3+
MR4-^SB^GV%II=C;:=8QB&UM8UA@C7HJ(.(&"<V;-FRF574HP#*PH5(J"#V.0
MWR]#<^5=;D\IF-WT2[$EWH,X!98*'E<Z?(W["QEO5M>7^ZV]+]C)GFS9LV;-
MFS9$?-O_`"D7DW_MHS?]0DV2[-G_TNEK=W5AKFH/8B:^M+FWB:%[:4W:K*)6
MCGDDB8\8Y5#_``I"W!TB^SD;M=8U6;1I)S-=)<6VFI+I?K$K)-=_6Y8W)7_=
MK-QMXJ']B3[.=64F@Y"AIN/?()^9&M:0V@M:B]A-Q'?V(DBYCD.%W$7JO^2!
MDQL]6TS4'>.QNXKAXQ5UB<,0*TJ:8,PE\W_\HIKG_,!=?\F7Q;RU_P`HYH__
M`#!6W_)I,-,V;-FS9&_\$:'Z[W%)PTCF4J)Y.()G6\V4G9?K*>IE2>1M!DY?
M#,HD),P6>1?5K.;Q1+Q/Q^G<,TD?\G+C]C!^I^7=/U=Y&O#*4GB%M<PI(RQR
MQ!B_"1!L=V/Q?;X_#A1K/D:PO;;46L"T-]>QW"1&260P1O=*D<[B)31>:Q)T
MR[GR:EQJ%E<<R(0ER-3)E?UIVN(XX?[RF\:QP\./P?#@U_)NAR.[/"Y225YW
MAYMZ9:2#ZFXX=.'U8>EPRU\HZ3]4BLIFN+F")E8"XG>4GTRK1!C(6/[HQKZ?
M[2_[+!.I>7=+U>25]1C-Q'/$D$L#L?2*QR"=/@_F61>7/`-UY(T.]:Y:<3DW
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MM<32VS))!<23NTJ21OZGJ+(3R#O]B3^>+]W]C#W-FS9$?)G_`!U/-W_;8;_J
M&@R79LV;-FS9LV;-FS9LV;-FS8A>WEMI]I/?7D@AMK:-I9I6V"H@Y,Q^@9&/
M)=I=WIO/..J*T=YKG$VML]?]&L(Z_5(>/:1PWUB;_BR7_)R79LV;-FS93<N)
MXTY4VKTKA#Y7\POK<%U!?0"SUC39FMM3L@>01_M1R1L?MP3Q<9(I,/\`-FS9
MLV;-D1\V_P#*1>3?^VC-_P!0DV2[-G__T^]QP0P@K#&L88\B$`6I/4[99AA)
M0F-28S5*@?"?%?#'TR'_`)DH@\M`A14WVG[T_P"7N')<$134*`3U(&.PG\VJ
MS^5M:1069K&Y`4;DDQ-MD;T'\Q/)MKH>F6T^J*DT-I!'*ABFJK+&JLI_=]B,
M,/\`E9?D?_J[+_R*G_ZIYO\`E9?D?_J[+_R*G_ZIYO\`E9?D?_J[+_R*G_ZI
MYO\`E9?D?_J[+_R*G_ZIYO\`E9?D?_J[+_R*G_ZIYO\`E9?D?_J[+_R*G_ZI
MYO\`E9?D?_J[+_R*G_ZIYO\`E9?D?_J[+_R*G_ZIYO\`E9?D?_J[+_R*G_ZI
MYO\`E9?D?_J[+_R*G_ZIYO\`E9?D?_J[+_R*G_ZIYO\`E9?D?_J[+_R*G_ZI
MYO\`E9?D?_J[+_R*G_ZIYO\`E9?D?_J[+_R*G_ZIYO\`E9?D?_J[+_R*G_ZI
MYO\`E9?D?_J[+_R*G_ZIYO\`E9?D?_J[+_R*G_ZIYO\`E9?D?_J[+_R*G_ZI
MYO\`E9?D?_J[+_R*G_ZIYO\`E9?D?_J[+_R*G_ZIYO\`E9?D?_J[+_R*G_ZI
MYO\`E9?D?_J[+_R*G_ZIYO\`E9?D?_J[+_R*G_ZIYO\`E9?D?_J[+_R*G_ZI
MYO\`E9?D?_J[+_R*G_ZIYO\`E9?D?_J[+_R*G_ZIYO\`E9?D?_J[+_R*G_ZI
MYO\`E9?D?_J[+_R*G_ZIX&_+Z\M]1N/,^H6;&2TN=6:2"7BRAU]"%>2APK4Y
M+DUS9LV;-FS9LV;-FS9LV;-FPGU?3M*\S02Z-=S^I';S0R7MK#(`3P(FCAN%
M%3Z4M%9D/]XN&X``H-AV&7FS9LV;-FR*Z_HVH0:U8^:O+\8DOHRMGJEIR""Z
MLG;NS?#Z]HQ]:%F_9]2/]K)5FS9LV;-FR(^;?^4B\F_]M&;_`*A)LEV;/__4
M[_FS9$?S)_Y1D?\`,=I__47#DNS9LV;-FS9LV;-FS9LV;-FS9LV;-FS9LV;-
MFS95,O-FS9LV;-FS9LV;-FS9LV%'F;78?+FC7&J2H9I$I':VR_;GN)#P@@3_
M`"I9"JX&\H:%-HFEEM082ZQJ$C7NK7`_;N9=V53_`+Z@7C##_D)D@S9LV;-F
MS9LV15M8U#1_-HTS5Y!)I6M4_0MSQ"B&YC7][8R$=?64>O;NWVOWD>2K-FS9
MLV;(CYM_Y2+R;_VT9O\`J$FR79L__]7O^;-D1_,G_E&1_P`QVG_]1<.2[-FS
M9LV;-FS9LV;-FS9LV;-FS9LV;-FS9LV;-FS9LV;-FS9LV;-FS9LV;-FPFC_0
M/F:2*\CX7K:->2+%)\7&*[B!BDIT5VCYLO+XOBPYS9LV;-FS9LV;"KS%H5KY
MCTFXTJZ)024>&=-I(9D/.&>(_LR12!77!6F1WT.GVT6IS)<7T<:K<SQJ4220
M"C.J$GCR.^"\V;-FS9$?-O\`RD7DW_MHS?\`4)-DNS9__];O^;-D1_,G_E&1
M_P`QVG_]1<.2[-FS9LV;-FS9LV;-FS9LV;-FS9LV;-FS9LV;-FS9LV;-FS9L
MV;-FS9LV;-D9\YZQ=V5E!I&CL/T[K4GU/3N_I@BL]VP_WW:Q<I/]?T\-=#T>
MST#2;31[`$6]I&$4G=F/5Y'/=Y'+.Y_FPQS9LV;-FS9LV;-D4\X6VI636OFO
M1_4FNM(#?7-/5CQNK)Z&XC5/L_6(^/K6[?S)Z?[>2'3M1M-6L;?4K"436EU&
MLL$J]&5A4?\`-V"LV;-FR(^;?^4B\F_]M&;_`*A)LEV;/__7ZK<>;)K34+O3
M9X(FGC>TCMDBFJW*]E,,:SJ5!3CQ]5FCYIP^#[>!V\]!3J:"U#/H09M7H^RA
M93$/1V^+E$C3_'_QCR8@@@$=#N#D2_,G_E&1_P`QVG_]1<.2[-FS9LV;-FS9
MLV;-FS9LV;-FS9LV;-FS9LV;-FS9LV;-FS9LV;-FS9LV;&2RQPQ/-*P2.-2\
MCL:!5459B?`#"S1[S3/,-K9^8[6W/[Q'%I/-&%E$3-0E*_$L<W!77^=.&&V;
M-FS9LV;-FS9LV;"33=.TCRI'-%%/]6M;^\:2&"9P(TGN#_<6P-.*R2<G6+^=
MFXX=YLV;-D1\V_\`*1>3?^VC-_U"39+LV?_0['<>68;YA/?W#SWD?'ZO=<41
MHQ',+F.@0<6XR(GVOM+@9O)6FM]9)EDY:@&&J$4'U@-*9R&V^#=FC^#_`'3\
M&22@Z#ID"_,>QOQH3S'4Y3"U_8\+?TX>*UNH@M&X<_@_RFR865G>6TCO=:A)
M>*PHJ2)$@4UZCTD3!V;-FS9LV;-FS9LV;-FS9LV;-FS9LV;-FS9LV;-FS9LV
M;-FS9LV;-FS9LAGF^2;7M0L_(UH66.^7ZUKDZU'IZ>C4,0;_`'Y>RCT!_P`5
M>KDPBBC@B2&%!'%&H2-%%`JJ**H'@!C\V;-FS9LV;-FS9LV%NO:)9>8=*N=)
MOU)AN%H'79XY`>4<T;?LR1.%=&PI\H:U>W,5SH.N$?I_1F6&\(V%Q$?]Y[Z,
M?[[N$^W_`"3>HF2C-FS9$?-O_*1>3?\`MHS?]0DV2[-G_]'O^;-D1_,G_E&1
M_P`QVG_]1<.2[-FS9LV;-FS9LV;-FS9LV;-FS9LV;-FS9LV;-FS9LV;-FS9L
MV;-FS9LV%^MZQ9Z!I5WJ]\W&WM(S(P'VF/1(T'=Y'*HG^5BVGSRW=E;7ES;&
MTN)XD>6V<AGC+#D8V9>I2N"LV;-FS9LV;-FS9LV;-@&[M["VFDUQ[7G>6]N\
M?K1IRG,*_O6A2F[59?A3^?':3JEEK6G6VJZ=)ZMI=H)87Z&A[,/V64_"Z_LM
M@S-FR(^;?^4B\F_]M&;_`*A)LEV;/__2[_FS9$?S)_Y1D?\`,=I__47#DNS9
MLV;-FS9LV;-FS9LV;-FS9LV;-FS9LV;-FS9LV;-FS9LV;-FS9LV;-D/U.TNO
M,OFRVL+B%TT+0?3O9C(I"7=\X)MD2O\`>16B_OG_`.+_`$_Y,F&;-FS9LV;-
MFS9LV;-FS9J9"((Y/)OF@6\2,?+GF28M&J`E;/4V^)EH/L6]\!R_E2Y_XR9-
M\V;(CYM_Y2+R;_VT9O\`J$FR79L__]/O^;-D1_,G_E&1_P`QVG_]1<.2[-FS
M9LV;-FS9LV;-FS9LV;-FS9LV;-FS9LV;-FS9LV;-FS9LV;-FS9L(O-6OMH.G
M(]I"+K4[V9+33+,FGJW$AV#$;K'&O*69_P!F-,.X^?IKZE.=!SXUX\N_&O;'
M9LV;-FS9LV;-FS9LV;-FRB,(]'\PF_U75-#O;?ZIJ.G2<EB+<A-:2?W%W&U%
M^%_B21?]U2+PP]S9$?-O_*1>3?\`MHS?]0DV2[-G_]3ND&IZ?<R7$5O=Q2R6
MAI=(CJ3$>O[P`_!T_:R_TE84B/UF,"?^Y)8#GOQ^'Q^+;!61'\R?^49'_,=I
M_P#U%PY+LV;-FS9LV;-FS9LV;-FS9LV;-FS9LV;-FS9LV;-FS9LV;-FS9LV;
M-FR*V.E7^H^;;O7]7A,-MIH-CH-NQ!V<!KJ^^$D!I]H8OVEB3_+R59LV;-FS
M9LV;-FS9LV;-FS9LBWF_1KZ?ZKYBT%`=?T<L]M'7B+J!J?6+&1OY9E%8O]]S
MJC9)8)&EACE>-HF=59HGIR0D5*-2HY+TQ3(CYM_Y2+R;_P!M&;_J$FR79L__
MU9_JFG2ZP]Z;;2[NTI]6MI`8UB$MC#=++<)&P=O4DG')E7C_`'7P_P"[,#W&
MB^8[E-76XCDN#J%K]1TF5PH>%([J1X6N*4$;>G)'-SX_[I_W[G1P"``34TH3
MD!_,?56;0WMOJ%V.%_8_OC$/3;C=Q'X6Y[\J?#MDQL=2-Z[H;*YMN`KRN8PB
MMO2BD,U<'9LV;-FS9LV;-FS9LV;-FS9LV;-FS9LV;-FS9LV;-FS9LV;-FS9L
MV1KS'K=[!J6E^7M$X'5=1D]65W7FMO8PD&YN'6H^WM!#_-+)_D9)<V;-FS9L
MV;-FS9LV;-FS9LV;-D8UK6[_`$#7K"6^96\N:CQLVE"T:UO&;]S)*_\`OBYK
MZ/\`Q7+P_GR3C(CYM_Y2+R;_`-M&;_J$FR79L__6[_09J9LB'YD_\HR/^8[3
M_P#J+AR7YLV;-FS9LV;-FS9LV;-FS9LV;-FS9LV;-FS9LV;-FS9LV;-FS9LV
M;(WY<T.]M;_5-?UK@^K:G+P41GDD%G"2MK;QL0.W[Z7^:63))FS9LV;-FS9L
MV;-FS9LV;-FS9L!ZIIMEJ^G7.EZA$)K2ZC,4T9[JWAX,OVE;^;`OERRU73=)
M@T_5[I;VXMN427:@AI(5)$#2U_W=Z7'U?\O";S;_`,I%Y-_[:,W_`%"39+\V
M?__7[_FS9$?S)_Y1D?\`,=I__47#DNS9LV;-FS9LV;-FS9LV;-FS9LV;-FS9
MLV;-FS9LV;-FS9LV;-FS9LBEYJ>H:IYOMM!TB<PV>D@7NO7"`'D7!%K85(.\
MN\\W_%:I_/DKS9LV;-FS9LV;-FS9LV;-FS9LV;-D?\W:?J]UI\=[H$S1ZKID
M@N[6#D5BN>((DM)U&S)/&61?]]R<'R/7NMV?F*\\BZM8U6.>_GYQ/M)%(MK,
MLL,J_LR12!D<9T'-G__0[_FS9$?S)_Y1D?\`,=I__47#DNS9LV;-FS9LV;-F
MS9LV;-FS9LV;-FS9LV;-FS9LV;-FS9LV;-FS8R3GP;TR`]#Q+;@&FU:83>5M
M`/E_3FAN)OK6HW<KW>I7M*>M<2FKM3]E%'&.)/V(TP\S9LV;-FS9LV;-FS9L
MV;-FS9LV;-FSGFMZ%:Z5YST"_LW=$U74WFN+3;TA.MG,KSHM*K),O'U=_BX\
MLZ'FS__1[_FS9$?S)_Y1D?\`,=I__47#DNS9LV;-FS9LV;-FS9LV;-FS9LV;
M-FS9LV;-FS9LV;-FS9LV;-FS9#M*NKCS-YKN=4@F=="T/U+"T5&(2ZO&VNYF
MI_>16W]Q%^SZOJMDQS9LV;-FS9LV;-FS9LV;-FS9LV;-FS9$?-O_`"D7DW_M
MHS?]0DV2[-G_TNMI_B`ZAJ%LVH)]4]%'%R(4'U:8N><45?AE7T/C_>\^#_ZW
M#".3S+YAL[2\:[=?7TJP2_8F,*;H/<2I'S3_`'47MH!R2/[,TW^PR?JU0#TJ
M*T/OD2_,G?RR*?\`+=I__47#DNKFS9LV;-FS9LV;-FS9LV;-FS9LV;-FS9LV
M;-FS9LV;-FS9LV;-@3487O;*YL(+IK2XN(G2.XCH9(^0X^JBMW2N)Z-I-GH6
MEVFD6"<+:SC$4==R:?:=CW=VJ[M_-@_-FS9LV;-FS9LV;-FS9LV;-FS9LV;-
MD1\V_P#*1>3?^VC-_P!0DV2[-G__T^R?X2T#C<I]5;C=U^L`S3'E5_5/^[/@
MY2?$W#CBR>7-%2..-;4%(M@&9W+#F)>,A=F:5?5'/C)R^+#6F0#\Q]#TQ=":
M[$3>M)?V/-O5EH>=W$&^#GP'7LN3&QTBPTZ1Y+2-D:04<M)))45KTD9Z8.S9
MLV;-FS9LV;-FS9LV;-FS9LV;-FS9LV;-FS9LV;-FS9LV;$YYHK:&2XG<1PQ*
MTDLC&BJBCDS$^`&1#R=%/K5]>>>;]60ZBOU;18'V,6FHW*-RO:2\D_TA_P#(
M]+)GFS9LV;-FS9LV;-FS9LV;-FS9LV;-FS9$?-O_`"D7DW_MHS?]0DV2[-G_
MU._YLV1'\R?^49'_`#':?_U%PY+LV;-FS9LV;-FS9LV;-FS9LV;-FS9LV;-F
MS9LV;-FS9LV;-FR-:WYRT_2[K]$V$4FKZZPK'I-E1Y%KT>YD_NK6+_BR=E_R
M>6#KO28?,>CPV?F.T4"01RW5BLK-&)%^+TF=/3]:/E]I3\$F&J(D:+'&H1$`
M5544``V``&.S9LV;-FS9LV;-FS9LV;-FS9LV;-FS9LB/FW_E(O)O_;1F_P"H
M2;)=FS__U>_YLV1'\R?^49'_`#':?_U%PY+LV;-FS9LV;-FS9LV;-FS9LV;-
MFS9LV;-FS9LV;-FS9LV;"K7/,>C>7+=;C5KI8?4/&"$`O-,_:."%`TLKG^5%
MQ.,R^9M`83Q7FBF]1EX\EBO(EY;-R0R>D[H/]=.7\V+:+Y?T?R]:_5-(M4MH
MV/*5A4R2/WDFE:LDKG^>1L,\V;-FS9LV;-FS9LV;-FS9LV;-FS9LV;-FR(^;
M?^4B\F_]M&;_`*A)LEV;/__6[_FS9$?S)_Y1D?\`,=I__47#DNS9LV;-FS9L
MV;-FS9LV;-FS9LV;-FS9LV;-FS9LV;-FQ"ZO+6QMY+N]F2WMH1REFE8(B@=V
M9J`87:7K5KYFTV>[T666.%B\-M>R0LJL0-IX4E"^M%R/P/\`8?`NA^3=,T>X
M.ISO)J>MR"D^KWI]2<^*Q?L6T7\L4"HN2+-FS9LV;-FS9LV;-FS9LV;-FS9L
MV;-FS9LV;(CYM_Y2+R;_`-M&;_J$FR79L__7[7+K^G0F]621E:PEAMYP5(_>
MW`0PHE:!N?JIOB#^:M(C%7D<<`6N*H?W*B4VQ:;^5?65DVY?99_L8=Y$?S)_
MY1D?\QVG_P#47#DNS9LV;-FS9LV;-FS9LV;-FS9LV;-FS9LV;-FS9LV;-A=8
M:WI6JSW=MIEY'=36+".Z$1Y+&["H0N/AY?S*K?#A#;^2FU"\74_.5Y^F[F)R
M]K8\?3T^WH?@,=I5A-*!_NZX:1OY>.2X*J@!10`4`'0#+S9LV;-FS9LV;-FS
M9LV;-FS9LV;-FS9LV;-FS9$?-O\`RD7DW_MHS?\`4)-DNS9__]#J][Y>O;LZ
M\K>BT.K2VSK$]2'AA2..:*3;]VTJQL$=/[OERPL'DB^6TN[);A3#?V@TYQ(S
M,\%ND\DL(5Z5G9()WBY/Q9GX/DY"@`*.@%!D#_,?]-_H)N0M/JWU^Q](UD]3
M_>J+ARVX]?M9,++]+EW_`$B+81T_=_5S(6K7]KU!@[-FS9LV;-FS9LV;-FS9
MLV;-FS9LV;-FS9LV;-FP.+VT:[:P6>,W:H)6MPP]01D\0Y2O+AR_:R,7GEW7
M_,EY/'Y@O_J>A)(RPZ5IKNCW,8/PM>W?PR\7'VK:#TU_GD?)+I^FV&DVD=CI
MEM':6D(I'!"H1!]"X*S9LV;-FS9LV;-FS9LV;-FS8'AOK.YEF@MKB*::W;A<
M1QNK-&W7C(JDE#_K8(S9LV;-FS9LV;-FR(^;?^4B\F_]M&;_`*A)LEV;/__1
M[_FS9$?S)_Y1D?\`,=I__47#DNS9LV;-FS9LV;-FS9LV;-FS9LV;-FS9LV;-
MFS8TLH(4D!FKQ'<T\,C&KQ^<M7OY=,TUTT32(Z"75ZK/=S5%66TA_N[>GV?6
MGYM_)%AAH/E?1_+B2?HZ$FXG/*[OIV,MS.W\T\[U=_\`5^PO[*X<YLV;-FS9
MLV;-FS9LV;-FS9L#7U_9:9:RWVH7$=M:0*7FGE8*B@>).<FO?.7FS\RKJ71?
MRZC?3M$1O3O?,LZE*C]I;8=1_L?WW_&'%V_(RQT^WANO+6MWVFZ_""7U/F6$
M[DU)EC!'$$_RM_K^IC!YY_,'R(P@\_Z.=5TQ30:]I@K1>G*:,!5_X)8/]GG0
M/+GG'RWYL@]?0M0CN2!5X*\9D_UX6HZ_=A]FS9LV;-FS9LV1'S;_`,I%Y-_[
M:,W_`%"39+LV?__2[_FS9$?S)_Y1D?\`,=I__47#DNS9LV;-FS9LV;-FS9LV
M;-FS9LV;-FS9LV;-FKD;UW5?,8O%T?RWI?J7#H))=6O3PL8%8D?L'UKF;;^Y
MCX_Y<F5HGE&+3[W]-ZK>S:QKK*4-_<'BD2M]J*TMD_<VT1_R1ZC?MR9)<V;-
MFS9LV;-FS9LV;-FS9LV;(EYT_,/0?)4`6]<W.IS;6FEV_P`4\A.RU45]-"?V
MV_V'/(78>2O-7YCW<6M_F/(UCHZ-ZECY9@8IM^RUR?M*?G^^_P",.=9LK&ST
MVUBLK"!+:U@4)#!$H5%4=@HP1E%0P*L.2G8@[@@]LY]YD_*#RSK,_P"D]),F
M@:PIYQWVG'TQR\7A4JG_`"+]-L(OT]^:GY?_``^9+$>:]#C_`.EG9;72)_-*
M@%33_+3_`)[Y-O*WYA^4_-Z!=(OU^M4^*QG_`'5PI[_NV^W_`*T?-<E.;-FS
M9LV;-D1\V_\`*1>3?^VC-_U"39+LV?_3[_FS9$?S)_Y1D?\`,=I__47#DNS9
MLV;-FS9LV;-FS9LV;-FS9LV;-FS9LV:N$/F#S&VCO!966GW&JZK=AC:V=NM%
MHM`SSW#TAMXEK\3.W+^1&P#IF@:_>W\&M^:M2/K0-ZEKHVGLT=E"2"/WK[2W
MLH!^U+QB_DAR69LV;-FS9LV;-FS9LV;-FS9LV->1(T:21@B("SNQH`!N22>@
MSE6N?F7JOF+4)/*_Y76XO[T?#=ZVX_T6V%:%D9OA<^#GX?\`?22X=>2_RPTW
MRU<'6]6F;6O,LYYW&J7-6XL>OH*]>'_&0_O/]3[&3W-FS9LV0GS3^5?E+S0[
M7<EL=/U/[2:C8D0RANS.!\$G^R7G_EY%J_FU^7O4#SIH,??=;Z-!_P`'(U!_
MS$?[#)3Y5_-/REYI9;6*Z-AJ?V7TZ^_=2ANZH6^"3_8-R_R<FV;-FS9LV1#S
M;_RD7DW_`+:,W_4)-DOS9__4[_FS9$?S)_Y1D?\`,=I__47#DNS9LV;-FS9L
MV;-FS9LV;-FS9LV;-FS84R^:/+L%_#I<FJ6WU^X<10VBRJTK.?V?34LP_P!E
MB6N:KK=C)#;Z+HKZI+,K%I3/';P1<:4]5WY2?%7_`'7$^%<6F>>M4N(9-9U.
MVTJRC=9&LM)5GFDXGD(Y;RXZ1G_=GI0+S_GR74R\V;-FS9LV;-FS9LV;-FS9
MLV;"/S/YNT'R?IYU#7+I84W$,(^*:5A^S%']IS_PJ_M9S1+'SI^<$BSZL9?+
M?DHMRBL4-+J\3L9"?V&_RAZ7\B2?WF=4T+R_I'EO3X]+T6U2TM8Q]E!NQ[O(
MQ^*1S_,V&>;-C'ECC^VZK3^8@?KP-)JVE1?WM];QT_FE0?K;`DGFORO#_>ZW
M8(?!KJ$'_B>!)//ODJ+[?F"P'RN(S^HG`Q_,SR&#1==MY".T?.3_`(@K8QOS
M+\G?[KO)IO#T;.[DK_P$)R*^:7_+CSDC-?Z+J<UW3X+^TTVZBN`>W[PQ)S_Y
MZ\\BVG:G^9?E&Z2W\LV^J^9-#[6NK6,L,D:C]E)B2W^KQ^#_`(IR4VOY[:--
M<QZ9<Z-?VNKL>$EE+Z,060?L>I<20C_5YA,E*^;/,\N\'DR]*G<-+=62`_=,
M^..O^>7'[KR@J_\`&;4H%_XA')C?TG^8\GV=`TV'_C)J#O\`\0MQF];\SY/L
MVNA0C_+FNY#_`,+&F7Z/YFO]J[T2'_4@NI/^)2)A'J5KYKA\T>4G\P:C9W<+
M7TPBAM+5X"K_`%67XFDDFFY"G[/!<Z5FS__5ZG%J%Y!J7F00+/=F.YM8XHH_
MWIB62WC+NB.RCBIY/P_GR)6NJ:M+HSRM)=QW%OIJ/I0G)$DMW]<E1V-"?4=N
M-M%_QC?.L*30%A0]P/'('^8^M:2V@M:K>1&>._L0\7+XAPNXB]1_DTR86>KZ
M9J+O'8W4=P\8JZQFI`K2IP;FS9LV;-FS9LV;-FS9LV;-FS5Q(75LTYM5F0W"
MKS:$,.87IR*5Y<<CVI^;+FVOI=,TK0=1U2[A(#O'&L%J"P#?[UW#1QMU_P!U
M^IC])F\[7=ZD^KVMAIVF@-RM(I9+FZ)(^"LW&*!*'[7%9/\`6Q^L^3]+\P7@
MN=6ENYX%0)^CUN98K4T)/-H863FS5^+FV#=*\O:'HB<-(TVVLATK!$J,?]9@
M.3?3AGFS9LV;-FS9LV;-FS9LV;-FS9LU<YOYM_-*.TOSY8\EVIU[S+)5/3A^
M*"W/0M.Z[$I^TG+BG^[9$Q'RO^5LCZ@/-/Y@77Z=\P/1XX7^*UMNX2./[#\.
MWP^DO["?MYTT;#Y87ZGY@T/1D+ZMJ-M9`=IY40GY*QY-]&$!_,/3;NJ^7].U
M'7&Z![.U=8*^]S<^A#_P+-F^N?F/J?\`O-IFGZ'$?V[V=KR8#Q]&V$<-?^CA
MLW^#=9O]_,'FF_N5/VK>P":?#\OW`:=A_K3X]/RR\B@#U=&BN&[R7+23NQ\6
M>9W+'!47D'R3#3T_+]@*?\N\9_6,&1^5/+$/]UHM@A'0BVAK]_#!<>DZ5%_=
M6-NG^K$@_4N"5BB041%4>``&/S9L(?,GDSRUYL@,.NZ?'<L!2.>G"9/]29*.
MOW\<Y^WD?\PO(C&;R#K!U;2T^+]`ZF02%_EADJJ_\"T'^SPRT3\Y-(DNAI'G
M"SF\L:NOPO%>*1`Q\5F('%?^,B\/\O.D13PW$23P2++%(.221D,K`]U9:@XI
MFR(>;?\`E(O)O_;1F_ZA)LE^;/_6[Z(T5BRJ`S?:(%"?GE&*,\24!X;IL-C[
M>&/ID1_,C;RR/^8[3_\`J+AR74S9LV;-FS9LV;-FS9LV;-E$@"IZ#KD1?\Q=
M&G9HM!M;W7IEJ"-.MG:('P:YF]*W'_(W#;0]0UW4!/)K&D#28P5^JQFX2>5@
M0>1E$0]./_5#R86W7DRXU2YFEUGS!J5Q:R.6BL+:1;*%$)^&-OJP2:7B/AY/
M-\6&>B^5?+WEXN^C:?%:RR#C+.H+3..M'F<M*^_\SX<9LV;-FS9LV;-FS9LV
M;-FS9LV;-FS8`U?6=,T&QEU+5[J.TLX15Y9#05[*HZNY_91?BSBFM_F!J7G]
MY+33=2B\J>4`QCN=6NI%2[NEZ,EO"&]3XOY(_P#GI)_NO)1Y2NO*_EBQ^H^1
M/+^I:O(]!/J*VYA$S?S2WEY]77C_`)$?P?RIDA];\R-3KZ5KIN@0G]J=Y+^<
M#_4B^KP5_P">C9?^"+Z_W\P^9M2OP?M6]LZV$!]N%H%E(_UI\,=,\D^4](?U
M;#2+9)^]Q(GJS'_GM-ZDO_#X?@`"@Z#IFS9LV;-FS9LV;-3"O7/+FA^9+0V6
MN6,5["?LB5:LI\8W%'C/^HV<WE_++S5Y0D>]_+/7'C@KR;0M0/J6[?Y*.WPC
M_9*C_P#%V"=-_.$:==)I'YB:3-Y=U`["Y*M):2?Y2N.3*O\`J^JG_%F=+LK^
MRU*V2\T^XCNK:05CFA8.A'LRU&1GS;_RD7DW_MHS?]0DV2[-G__7[_FS9$?S
M)_Y1D?\`,=I__47#DNS9LV;-FS9LV;-FS8G-<06T3SW,J0PQBKRR,%51XLS4
M`R,7'YC>5ED-OIUQ+K-R-OJ^E0R7C5_UX085_P!G+AQ9WU_J>DF[BLWTZ]D1
M_0M;\#DC"HC,RPLWPMLW%7Y<<(1Y6\T:D`=?\TW"(?M6NCQ)91CV]9O7N6_Y
M&)A]HNA:?H%JUIIXDX2.997GFDGD=R`"[23,[;TPR554!5``'0#89>;-FS9L
MV;-FS9LV;-FS9LV;-FS9LU<)=4\W>6-%/'5-6MK>3_?+2*TI^42<I#_P&%/^
M/&OCQ\NZ!J>JU^S.8?J=N??UKTP[?ZL>0KSG^97F_1&73HETZUUFX(6UT>U]
M74KRK?9]4J(+>'_5_>/_`"KC]#_++7_-TD.N?FQ?27CJ*VNB1MZ<<0;O-Z/%
M5?\`R(O^>DG[&='TGR?Y7T/C^BM(M;5EZ2)$ID_Y&,#)_P`-AWFS9LV;-FS9
MLV;-FS9LV;-@/4M*TW6+5K+5;2*\MG^U#.@=?G1AL?\`*SFE[^4=_H5R^J_E
MIK4VBW!/-]-G8R6DG?COSI_ST6;_`&.`;;S'YPOO-_E;0O.>B?H^^M;R:5-0
M@-;6X46TJ?!]I>>_+X9/]@F=ES9__]#O^;-D1_,G_E&1_P`QVG_]1<.2[-FS
M9LV;-FS87:MK^BZ#$LVLW\%C')41F>14+D=0@)Y/_L<(?^5B:5='CH>GZEK1
M[/9V<@B_Y'W/H0_\/A[J[:Z;-?T`MJ+QF7E]?,@C5"#R-(?B9U_EK_LL(?\`
M#?G"_P#^.OYKD@0_:M])M8K8#V$\_P!9F_XCDA_1-G)IB:1?*=0M@BQR?7:3
M&4)N&FY"DC5'+I@JWMK>UB6"UB2"%?LQQ*$4?)5`&*TS9LV;-FS9LV;-FS9L
MV;-FS9LV;`%UK>C6()O=1MK<#KZLT:?\2882S?F1Y'@)7].6TS#;C;%K@U\*
M6ZR8B/S#TR8TT[3-7U#P-OI\X7_@YEB3_ALW^*_,]Q_QS_)MZ1V:]N+6U'S(
M]29O^%RO1_,G4_[RYTW08CV@22_N`/\`7E^KV]?^>;Y0\@07N_F+6=3UDG=H
M9;@V]N?^C>S]!*?ZW+#6TT'RKY8MGNK2PL]-AA4O+<\$0J!U9YF^+Z6?.>ZG
MY^\Q^>[V7R]^6$)CM4/IWWF:8%8HP>OU>H^U_*W][_(B_P!YDK\D_EOHGDU6
MNEY:AK4]3=ZM<_%,[-NP2O+TT/\`P;?MNV3/-FS9LV;-FS9LV;-FS9LV;-FS
M9LB/FW_E(O)O_;1F_P"H2;)=FS__T>_YLV1'\R?^49'_`#':?_U%PY+LV;-F
MRN0KQKOUIWID<U/SUY=TN]ETQY9KK48:"2RLK>:YE4L.2AO21D6JG]M\VE>8
M]6U:^CB7RY>V.GL"7OK]H82*#X0+8/),>1\>&+:SIWFB^ND72-9ATJQX4D(M
M1<7!>IJ5>5_11>/_`!2^`[3R0B74%]J>M:IJEQ`ZRH)[DQP!U-0?JUL(8BO^
M2_/)'-9VEQ)'-<6\<LD-?2>1%9DK]K@6!XUI^SBX%/EFS9LV;-FS9LV;-FKA
M?J.NZ+HZ&35=0MK-1N?7E2,_0&(.0K4_SN\@V#^C:W<NJ3_LQ6,+/4^`=_33
M_@6PL_Y67Y\UN@\J>1[D1M]FZU)_13Y\3Z2_\E<<MC^?-Y_I;ZGI.GL/LV`C
MYJ:_S/Z<O_)W,-1_/G3Z^MI6DZJH[PR>FQ_X*2+_`(CF'YD?F'8;ZS^7]R4'
MVI+27F/P23_B6()_SD%Y:@F-OK&DZCITZ_:C>-&(^CFC?\+AS:?GA^7%T#RU
M-[<@5I/!*/\`B*.,9_RN_P`C33BVT^6YOYC]E88>`/\`LKAH%PR@\Y>8-2!;
M2/*LLR?LR7%_9Q`_1%)<O_PN+?6/S,NMX[#1]/4_[_N+BY8?1%'"I_X+,-(_
M,&YK]9\RVEG7]FRTX,1_L[J:7_B&8>2M1GWU'S;K$_BL$D-JI^B"$-_P^8?E
MKY7DWOQ>:B3U-[?74P/^Q,O#_A<'6GD7R;9$-;Z#8JPZ.T".W_!2!FP[@L[6
MU'&V@CA4=!&BH/\`A0,6S9LC'G'SWY?\E68N-6GY7,@/U6PBHT\Q[<4_96O^
M['^#(%;>6/.'YJ3QZGYW:31?+((DL_+\!*RRKU5[ANO^R?X_]]QQ9UC3-+T_
M1K*+3M+MH[2TA%(X8EXJ/?W8_M,<&9LV;-FS9LV;-FS9LV;-FS9LV;-FR(^;
M?^4B\F_]M&;_`*A)LEV;/__2Z]=>:%MI[^V:W)EM;NUL+<<MI9+Q4:,G;]VJ
M>I\?^I@%O/42G45^JU;10S:N`^R!93%^ZV^/DB-/\7#X/\O)<""*@U!W&1+\
MR?\`E&1_S':?_P!1<.2UF55+,0JC<D[`8C'>VDT#W%O,DT4?(.\3"0`I]I?@
MY?$/Y<BP\]RWH_W`^7=5U*OV)G@%E`?^>MZT+?\`)/#G0[OS!=I-)KNG0Z;\
M0^K0PW'UERM/B]5@D:*U?Y.>%5SY1U34;B634_,^HFW=F,=G8F*R14)^%#)$
MAG>@^'EZN&&A^4=!\OS276FV[B[F7TYKN>66>9UKRHTDSNU.6'84`D@4)ZGQ
MRZ9LV;-FS9LV;-FS93,J*6<A5&Y)V`R-ZM^8'DO0R5U+6[6-UZQ)()9/^1<7
M-_PR(W/YZ:!*WI>7=*U'6I>@,,)CC_X-ZO\`\D\)KW\R?S%O:B"TT;RU">DV
MJWL1D`/_`!7ZBM_R0PGDEOM:=D\Q?F7-,&^U9:!;3NI_R0\$:+_PC8.TWR=^
M7\+BX3RQYB\Q7!_W=>02(K'^8^NUHO\`P2Y-=,;5-.4)Y=_+V+3U'V9)KBTM
MC](A$\N&7J_F=<CX;;1;`'_?DMS=,/\`@$MES#1//MS7ZUYI@M0?V++3TJ/D
M]Q)-_P`0RO\``]Y./]R/FO6KBOVA%/':J?HMHH]O]ECD_+7RHQY7D%Q?L>K7
MMY<S_P#"O+P_X7#*T\F>4K"AM-$LHR.C?5XRW_!,I;!%SY;\NWJ\;O2;.<=/
MWEO$WZUPAN_RI_+R]KZN@6R%N\(:'_DTR813?D/Y%9B]E]=L'[-;W+;?\C`^
M(#\G=4LJG1//&KVA'V%D<RJ/^!>+,OD_\Y-/)-AYT@O5'1+VW&_S;A*?^&S"
M[_/O3S^\L='U55_D<QD_>\'_`!',/S#_`#+L3_N6\@32*.KV4W/[E59O^)9:
M_GC86S<=:\MZQIM-F+P!@/\`@C'@^T_/'\NKEN,FH2VK=UN+>5:?,HKKA_9?
MF+Y%U`A;7S!9%CT5YEC/W2\,/8-2TZZ7G:WD$R]2T<B.*?-2<YQYC_-"[U#4
M6\J_EM;#6-:)XSWXWM+8="Y<_!(5_F_NO^,GV,&^3_RNM=)O#YC\T7!U[S/*
M>;WEQ\<<+>%NC?R_LR'_`)YI'G1,V;-FS9LV;-FS9LV;-FS9LV;-FS9LV1'S
M;_RD7DW_`+:,W_4)-DNS9__3[%/Y9@N)K^XDG?U+RXMKR,@#]S+:!%B*_P`P
M_=KS#8$;R18-];)G?EJ89=58`?Z0&E,]/^*_M-%\/^Z?^"R3T'0=!VSGWYH:
M9?2>6+CT]5N$]>[LUB3C%QB+W,:HRE8UE_=D\E_>9$=3_)KSS?W0N9_.(U,H
M:K%?I*8S_K1<Y8_^$PPL=!_.OR[;K9:1+H,EHA)6"*$0+4]3QCCA'(XJ^O?G
MQ9C][Y<TV\`[P2`$_?.,"R?F3^;5F*WGD)W`ZF'U6'_">M@5OSU\QVA_W)>2
M;J&G4\I4_P")P8U?^<D=-1N-UY>NHF[@3(3_`,,D>#;;_G(SRK,:2Z9?1>_[
M@C\95PZM_P`[O*5P`5M[[?LL<;_\0E;#6#\T?+4XY"'4%'B;*9O^3:O@E?S)
M\H'^\NYX3X36=VGXM#3'C\R?(A-&UZUC)[2L8_\`DX%P7%YW\G3_`-UK^GM7
M_EZB'ZVP;%K^A3_W&J6DO^I<1-^IL&1W-O-_=3))_JL#^HY4]W:VJ\KF:.%?
MYI'51_PQ&$UUYY\G61I<Z[8HW\HN(V;_`(%&8X4WOYK^1[%#(]])*JBI,5M.
MPI[,8U0_\%D8O/\`G(CR5!46EM?7;=!QB1`?^1D@/_"XV#\W_,^MK3RSY&O;
MFOV9IW*1;^+>F$_Y*XM]7_/77R?5N=-\M6[_`+,8$TP'W3[_`.S3$9_R3U#6
M:/YG\Y:CJ#G[:+\$?^Q5WD7_`(3!5I_SC]Y`MP/7%Y=D=3+/Q!^B%8\DEI^5
MOD2S4)'I"2`"E)I)9!_P+N4_X7#FS\J>6-/`%EHUE!3H8[>)3]X6N&J1I&O&
M-0BCHJ@`?ACLV;-FS9LV;-FS9LV40"*'<'J#@"ZT'1+X$7NFVMP#U]6"-_\`
MB2G(_=_E9^7M[4S>7[52>IA5H3_R29,(KC\A_($I9K:*[LF;:MO<OW_XR^ID
MU\N>5]$\IZ>NFZ':K;0"AD8;R2-_/+(?B=L.,V;-FS9LV;-FS9LV;-FS9LV;
M-FS9LV;(CYM_Y2+R;_VT9O\`J$FR79L__]3O^;-D1_,G_E&1_P`QVG_]1<.2
M[-FS9NO7`T^GV%S_`+TVL,W_`!DC5O\`B0.%-UY(\G7M?K.@V$A/4_5H@?O5
M1A/<_E%^7-U7GH,*5[Q-)'_R;=<*I/R(\A'>V2]M#U!@NGV_Y&>I@=OR4AA_
MXYGFO6K.GV5%QR4?0.&)R?E?YYMQ33O/MRR_R7<`E'T\G?\`XC@.7R'^:T0(
M&K:)J8\+NPAJ?F?JY_XE@%_*OYE05^L>3_*VI`=3'!%$Q^FL.`9-.\P0-74/
MRELY:=6L9N!_V/I-*<N'3O,.I2D:#^5UI9'H;G6I&F"D>"SM'M]#8=6?Y:?F
M)?4_2.O6&@P-LUMHEG'&0#V$D:6[?\.^&UG^1OE0.LVMW5_K<X-6:[N&"G_8
MQ\6_X?)EI7DSRIH@'Z+T:TMF7I(L2E_^1C!G_P"&P]H!L.F;-FS9LV;-FS9L
MV;-FS9LV;-FS9LV;-FS9LV;-FS9LV;-FS9LV;-FS9LV;-FS9$?-O_*1>3?\`
MMHS?]0DV2[-G_]7O^;-D1_,G_E&1_P`QVG_]1<.2[-FS9LV;-FS9LV;-FS9L
MV;-FS9LV;-FS9LV;-FS9LV;-FS9LV;-FS9LV;-FS9LV;-FS9LV;-FS9LV;-F
MS9LB/FW_`)2+R;_VT9O^H2;)=FS_UN_YLV1'\R?^49'_`#':?_U%PY+LV;-F
MS9LV;-FS9LV;-FS9LV;-FS9LV;-FS9LV;-FS9LV;-FS9LV;-FS9LV;-FS9LV
M;-FS9LV;-FS9LV;-FR(^;?\`E(O)O_;1F_ZA)LEV;/_7[\S!5+,0`-R3L`!B
M'UZS_=?Z1'^__N?C'Q[T^#?XL$9$?S)_Y1D?\QVG_P#47#DNS9LV;-FS9LV;
M-FS908-T->VWMEYLV;-FS9LV;-FS918`\:[GH,O-FS9LV;-FS9LV;*8A14[`
M=2<O-FS9LV;-FS9LV;-E`@UH:TV.7FS9LV;-FS9LV;-D1\V_\I%Y-_[:,W_4
M)-DNS9__T.Q>;K*ZU#25MK?U&B-S;M>QP_WCVRRJTZ)_-5!\2_MIR3(G<:5Y
MCNH]46ZBDGEOK9+/2)^(5D6&[D>)YPH587])X9V;BG+TO]^?#G2-P!4U/CD%
M_,.\N[C09;:WTJ\E:*\LW#*D?%Q'=1-\'[ROQT^#X<'?XUOJ_P#*)ZU_R*M_
M^RC-_C6__P"I2UK_`)%6_P#V49O\:W__`%*6M?\`(JW_`.RC-_C6_P#^I2UK
M_D5;_P#91F_QK?\`_4I:U_R*M_\`LHS?XUO_`/J4M:_Y%6__`&49O\:W_P#U
M*6M?\BK?_LHS?XUO_P#J4M:_Y%6__91F_P`:W_\`U*6M?\BK?_LHS?XUO_\`
MJ4M:_P"15O\`]E&;_&M__P!2EK7_`"*M_P#LHS?XUO\`_J4M:_Y%6_\`V49O
M\:W_`/U*6M?\BK?_`+*,W^-;[_J4M:_Y%6__`&486Z+YPO8K>X`\K:Q)RN[M
MZI%`0.4[MP-9Q\25XMAE_C6__P"I2UK_`)%6_P#V49O\:W__`%*6M?\`(JW_
M`.RC-_C6_P#^I2UK_D5;_P#91F_QK?\`_4I:U_R*M_\`LHS?XUO_`/J4M:_Y
M%6__`&49O\:W_P#U*6M?\BK?_LHS?XUO_P#J4M:_Y%6__91F_P`:W_\`U*6M
M?\BK?_LHS?XUO_\`J4M:_P"15O\`]E&;_&M__P!2EK7_`"*M_P#LHS?XUO\`
M_J4M:_Y%6_\`V49O\:W_`/U*6M?\BK?_`+*,W^-;_P#ZE+6O^15O_P!E&%MQ
MYPO6URQF_P`+ZP"EO<J(C%!R;DT'Q*/7I1./Q;_MX9?XUO\`_J4M:_Y%6_\`
MV49O\:W_`/U*6M?\BK?_`+*,W^-;_P#ZE+6O^15O_P!E&;_&M_\`]2EK7_(J
MW_[*,W^-;_\`ZE+6O^15O_V49O\`&M__`-2EK7_(JW_[*,W^-;__`*E+6O\`
MD5;_`/91F_QK?_\`4I:U_P`BK?\`[*,W^-;_`/ZE+6O^15O_`-E&;_&M_P#]
M2EK7_(JW_P"RC-_C6_\`^I2UK_D5;_\`91F_QK?_`/4I:U_R*M_^RC-_C6__
M`.I2UK_D5;_]E&%^N><+Z;1M0B/E;6(@]M,OJ/%`%6J$<F(G)XK@Z/SI?"-!
M_A/6C11OZ4'A_P`Q&._QK?\`_4I:U_R*M_\`LHS?XUO_`/J4M:_Y%6__`&49
MO\:W_P#U*6M?\BK?_LHS?XUO_P#J4M:_Y%6__91F_P`:W_\`U*6M?\BK?_LH
MS?XUO_\`J4M:_P"15O\`]E&;_&M__P!2EK7_`"*M_P#LHS?XUO\`_J4M:_Y%
M6_\`V49O\:W_`/U*6M?\BK?_`+*,W^-;_P#ZE+6O^15O_P!E&;_&M_\`]2EK
M7_(JW_[*,W^-;_\`ZE+6O^15O_V49O\`&M]_U*6M?\BK?_LHPMTWSA?1WFK-
M_A;6']2Z5BJQ052EO"O%OWX^+X>7^RPR_P`:W_\`U*6M?\BK?_LHS?XUO_\`
MJ4M:_P"15O\`]E&;_&M__P!2EK7_`"*M_P#LHS?XUO\`_J4M:_Y%6_\`V49O
M\:W_`/U*6M?\BK?_`+*,W^-;_P#ZE+6O^15O_P!E&;_&M_\`]2EK7_(JW_[*
M,W^-;_\`ZE+6O^15O_V49O\`&M__`-2EK7_(JW_[*,W^-;__`*E+6O\`D5;_
M`/91F_QK?_\`4I:U_P`BK?\`[*,W^-;_`/ZE+6O^15O_`-E&;_&M_P#]2EK7
M_(JW_P"RC"B_U>_USS+Y6#:%J&G1VU[+))/>I$J4-K,`H,<LIY?['.B9L__1
M[_E4R\":A9+?VQM6<H"\4G("O]U(LP&_\WI\<%YLV;-FS9LV;-FS9L"6%DMC
M'+$KEQ+--<$G:AFD:4K_`+'E@O-FS9LV;-FS9LV;`DMDLFH6]^7(:WCEB"=C
MZQC))_U?2P7FS9LV;-FS9LV;-@;4+1;^QN;%F*+<Q/"7&Y`=2M1]^+HO%%7P
M`'W8[-FS9LV;-FS9LV8X$M;);6>\G5RQO)1,P(^R1&D/$?\`(KE@O-FS9LV;
M-FS9LV;`EW9+<SV<Y<J;.5IE4?M%HWAH?^1O+!8S9__2[_B-S=VUE";B[E6&
M%2`TDA"J"Q"J*G^9C3$&U;34U!-):ZC%_(I=+8L.94"IH/\`5^+C_+C!KNCF
M[BL/KL/UJ8NL4/(<F:,D.J_Y2\'^'_)QZ:OIDD,UPEU&T4`!F<-LH;[+'_)?
M]AOVLH:QI;1SRB[C].V7G.W(45-QS/\`DU5OBQ>TN[:_MX[NSD6:WE%8Y4W5
MA6E1B^;-FS9LV;-@"XUO2;6UEO9[R)+:"1H9IN0*K(NSH:?M+^T,N?6-+MXD
MGFNXUBDC]>-PU0T0X_O$XUY+\:?9Q2/4M/E^J^E<QO\`75,EGQ8'U55>;-'_
M`#@*>6,;5],28V[748E#^D4+;AZ@<3X?$RK_`*V+QW=M+/);Q2*\T-/5134I
M7<!J?9;_`"<6S9LV;-FS9L1>ZMH[B*UDE5;B<,T,1(#.$IS*KWXU^+`L&NZ/
M<I=26][%(EB:795A^[VK\?L1]D_M9<>M:5*;I8[N(FR'*[^(#TUH3S>O['PM
M\7V<4EU/3X(X9I;F-([@<H'+"CBG.J_S?#@6X\RZ!:+$]SJ,$2S<O2+N!7BW
M!OEQ?X6K^UAJ#7-FS9LV;-FQ.>>&UADN+AUBAB4O)(YHJJHJS,3V&!9=9TJ"
M>UM9KR*.:]I]41F`,G+=>'^M^Q_/E3:UI-O,MO/>11S/*+=49J'U2`1'[,>:
M?\%BXOK,O<1B="]I0W2AA6,%>8]3^6J?%B*:UI4G,I>1$(AE8\@`$%*M4_R\
MEY?RX(MKJWNXS+;2"1`Q1B.S+]I6'56'@<6S9LV;-FS9L!R:KIT*7+R7,:K9
MD"[^(?NRP#*''9F4_"N-76=*>U@ODNXFM;D%K>8,"KA06;B1UXJK9<.L:7/!
M;W,-W$T-V_I6SAA1Y-QZ:U_W9\+?!]K-<:OIEK(\5Q=1QR1T]1&:A4,*@M_*
MM/VL>FHV+W1LDN$:Y%:Q`CE\-"P^:\EY?RX*S9LV;-FQ&:[MK=H4GE6-[A_2
M@5B`7>A;@G\S<5)P/#K.EW%S<V<%W$]S:+RN8@PY(O\`,P_EV^UFMM9TN[N#
M:VUW'+.L8G,:MOZ9I1QXKN,=^E=-^JQ7HNHS:SGC#/R'!CO]ENG[+8A%YAT2
M:U6]BOHGMF=HA(&VYH*NI'V@R`<G_E7XL$?I33A/]6-U'ZW'GQY#[/'U.O3^
M[_>?\8_CQ+].:1Z/UCZY%Z7+ARY?M<?4I3K_`'?[S_C'\?V<_]/O^$GFVSNK
M_0+NTLXC-<2&+A&"`3QE1VW8@?97`6L&]DU.,V^CS3+8\[FTN%,*Q/=-$T:L
MY:02TC5O3_N_B;_)3`SZ5(@TS0Y=,FGM+<)+/?1&((]PR,CR.S.LP]/U'D^&
M-F9N.!++RQJ2W423\I+`I9V'[T(KFTT\R3J\RH3\<TS10K3_`'6K._#GE6_E
M9X&D6^AN;S2XK6+2[2!"([EHQ/\`6/K#M')&?W#"-48/ZK<7D]/)9H-M>V>D
MVUKJ$K3W$093+(>4A3DWI"1Q]N18N"R/^T^&.;-FS9LV;-D2MX=3TVPU1DTV
M6>XN=2NI+=4](LL4YVN!ZCHOV?V.7/-IVG36<4DIL+F"%+>WTRPAB,37$,(4
MM)-7D8PWJ/\`%Q+?W6)V>CZI8'RPDD/K_HI+M;ATX+16B9+<-3B/4<<%DX+Q
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M_95?]U_`^*W>F:G+?:^L,#+%JKV,"SU6GHJGIW;TK7X(^2X77_E&\=[B*SC,
MMA;1WYM;:;BADEOV5GBC=3R]&'B[Q._!O4]+_??/)%Y5L;W3K":WO2\A^L2/
M#<S<1<31L%*R77#X#/\`:3DOVD1/AP]S9LV;-FS9CD86&_L+_P`Q:BNG/=&>
M6VDL8E,=93'`D3,.;*%]-U_;*_Y.!]+L;FU9+N33IT@L8)6AMV]$SR7-W,9+
MF551VB7CQJJ^I_NS$H]#U2WLM-MN+7`AUKZZ'?@)5MF:1R]P5XJ\O*3XN/Q8
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M]9^M_I'D.!3ZGZ'I5^WR,G^C?9_N?CPS_0>K?XI_Q/\`4V^J>A]5_1]4]3G]
M7]/U^->'V_\`1_M?W?Q_9S__V0``````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
M````````````````````````````````````````````````````````````
8````````````````````````````````
`
end
</TEXT>
</DOCUMENT>
</SUBMISSION>
